-	Regeneron's REGN-COV2 Antibody Cocktail Reduced Viral Levels and Improved Symptoms in Non-Hospitalized COVID-19 Patients
-	Baricitinib in Combination with Remdesivir Reduces Time to Recovery in Hospitalized Patients with COVID-19 in NIAID-Sponsored ACTT-2 Trial
-	"Low-cost dexamethasone reduces death by up to one third in hospitalised patients with severerespiratory complications of COVID-19"
-	Gilead Announces Results From Phase 3 Trial of Investigational Antiviral Remdesivir in Patients With Severe COVID-19
35905465	Treatment of COVID-19 patients with hydroxychloroquine or chloroquine: A retrospective analysis.
34311528	Efficacy of propolis as an adjunct treatment for hospitalized COVID-19 patients: a randomized, controlled clinical trial.
33573699	Safety and Effectiveness of High-Dose Vitamin C in Patients with COVID-19
35438223	Association between SSRI Antidepressant Use and Reduced Risk of Intubation or Death in Hospitalized Patients with Coronavirus Disease 2019: a Multicenter Retrospective Observational Study.
35631275	The impact of vitamin D supplementation on mortality rate and clinical outcomes of COVID-19 patients: A systematic review and meta-analysis.
-	Ivermectin shows clinical benefits in mild to moderate COVID19: A randomised controlled double blind dose response study in Lagos.
33737631	Lack of Association of Baseline 25-Hydroxyvitamin D Levels and Cholecalciferol Treatment With Disease Severity and Mortality in Indian Patients Hospitalized for Covid-19.
34294455	Prophylactic use of Hydroxychloroquine among Physicians working in Pandemic Hospitals.
33330889	Credible learning of hydroxychloroquine and dexamethasone effects on COVID-19 mortality outside of randomized trials.
-	Exposure to Renin-Angiotensin System Inhibitors Is Associated with Reduced Mortality of Older Hypertensive Covid-19 Patients.
35440611	Efficacy and Safety of Indomethacin in Covid -19 patients.
35812412	A Phase 1: Safety and Immunogenicity Trial of an Inactivated SARS-CoV-2 Vaccine-BBV152.
33574135	Early initiation of prophylactic anticoagulation for prevention of COVID-19 mortality: a nationwide cohort study of hospitalized patients in the United States.
-	BNT162b2 induces SARS-CoV-2-neutralising antibodies and T cells in humans.
-	The effect of early treatment with ivermectin on viral load, symptoms and humoral response in patients with mild COVID-19: a pilot, double-blind, placebo-controlled, randomized clinical trial.
-	Galectin antagonist use in mild cases of SARS-CoV-2 cases
-	A first-in-human evaluation of the safety and immunogenicity of SCB-2019, an adjuvanted, recombinant SARS-CoV-2 trimeric S-protein subunit vaccine for COVID-19 in healthy adults
-	Detailed disease progression of 213 patients hospitalized with Covid-19 in the Czech Republic: An exploratory analysis.
33705495	Interventions for treatment of COVID-19: second edition of a living systematic review with meta-analyses and trial sequential analyses (The LIVING Project)
33835886	A two-arm, randomized, controlled, multi-centric, open-label Phase-2 study to evaluate the efficacy and safety of Itolizumab in moderate to severe ARDS patients due to COVID-19.
-	Convalescent Plasma in COVID-19. Mortality-Safety First Results of the Prospective Multicenter FALP 001-2020 Trial.
-	Low Dose Hydroxychloroquine is Associated with Lower Mortality in COVID-19: A Meta-Analysis of 27 Studies and 44,684 Patients.
33895559	Clinical Efficacy of Eucaloric Ketogenic Nutrition in the COVID-19 Cytokine Storm: a Retrospective Analysis of Mortality and ICU Admission.
33484407	The efficacy and safety of hydroxychloroquine in COVID19 patients: a multicenter national retrospective cohort.
33293554	Predictors of QT Interval Prolongation in Critically-ill Patients with SARS-CoV-2 Infection Treated with Hydroxychloroquine
-	Ivermectin as an adjunct treatment for hospitalized adult COVID-19 patients: A randomized multi-center clinical trial.
33235105	First Clinical Study Using HCV Protease Inhibitor Danoprevir to Treat Naïve and Experienced COVID-19 Patients.
33406353	Prevention of severe COVID-19 in the elderly by early high-titer plasma.
35859298	Effectiveness of remdesivir with and without dexamethasone in hospitalized patients with COVID-19.
-	5-Alpha-Reductase Inhibitors Reduce Remission Time of COVID-19: Results From a Randomized Double Blind Placebo Controlled Interventional Trial in 130 SARS-CoV-2 Positive Men.
-	Effect of Vitamin D3 Supplementation vs Placebo on Hospital Length of Stay in 2 Patients with Severe COVID-19: A Multicenter, Double-blind, Randomized 3 Controlled Trial.
33785743	Peginterferon-lambda for the treatment of COVID-19 in outpatients.
35726131	Efficacy and Safety of Ivermectin for Treatment and prophylaxis of COVID-19 Pandemic.
-	Vitamin D status and seroconversion for COVID-19 in UK healthcare workers who isolated for COVID-19 like symptoms during the 2020 pandemic.
-	Mathematical analysis of Córdoba calcifediol trial suggests strong role for Vitamin D in reducing ICU admissions of hospitalized COVID-19 patients.
33571009	Corticosteroids are associated with increased survival in elderly presenting severe SARS-Cov2 infection.
35641155	Therapeutic use of convalescent plasma in COVID-19 patients with immunodeficiency.
-	Evaluating the Efficacy of Tocilizumab in Moderate to Severe COVID-19 with Progressive Illness despite Steroids: Identifying the Optimal Timing of its Administration in C3G study.
-	Reducing the use of empiric antibiotic therapy in patients on admission to the hospital with COVID-19.
-	"Repurposing of drugs for Covid-19: asystematic review and meta-analysis"
35126138	A systematic review of Anakinra, Sarilumab, Siltuximab with meta-analysis of Tocilizumab for Covid-19.
-	Remdesivir-based therapy improved recovery of patients with COVID-19 in the SARSTer multicentre, real-world study
33958057	Evidence favoring the efficacy of convalescent plasma for COVID-19 therapy
-	Early Tocilizumab Dosing is Associated with Improved Survival In Critically Ill Patients Infected With SARS-CoV-2
33592050	Role of ivermectin in the prevention of COVID-19 infection among healthcare workers in India: A matched case-control study
-	The use of compassionate Ivermectin in the management of symptomatic outpatients and hospitalized patients with clinical diagnosis of COVID-19 at the Medical Center Bournigal and the Medical Center Punta Cana, Rescue Group, Dominican Republic, from may 1 to august 10, 2020
-	Efficacy of Convalescent Plasma Therapy compared to Fresh Frozen Plasma in Severely ill COVID-19 Patients: A Pilot Randomized Controlled Trial.
33140042	Treatment with Zinc is Associated with Reduced In-Hospital Mortality Among COVID-19 Patients: A Multi-Center Cohort Study
-	Low dose hydroxychloroquine is associated with lower mortality in COVID-19: a meta-analysis of 26 studies and 44,521 patients
34322971	The Role of Vitamin D in The Age of COVID-19: A Systematic Review and Meta-Analysis
-	Equine hyperimmune globulin raised against the SARS-CoV-2 spike glycoprotein has extremely high neutralizing titers
-	Phase II Clinical trial for Evaluation of BCG as potential therapy for COVID-19
33173896	Safety, Tolerability, and Immunogenicity of COVID-19 Vaccines: A Systematic Review and Meta-Analysis
33420963	Pilot Trial of High-dose vitamin C in critically ill COVID-19 patients
-	Tocilizumab in nonventilated patients hospitalized with Covid-19 pneumonia
33643746	Early use of nitazoxanide in mild Covid-19 disease: randomized, placebo-controlled trial
-	Effectiveness of Ivermectin as add-on Therapy in COVID-19 Management
-	Controlled randomized clinical trial on using Ivermectin with Doxycycline for treating COVID-19 patients in Baghdad, Iraq
-	Hydroxychloroquine, nitazoxanide and ivermectin have similar effects in early COVID-19: a head-to-head comparison of the Pre-AndroCoV Trial
-	Clinical Course and Outcomes of coronavirus disease 2019 (COVID-19) in Rheumatic Disease Patients on Immunosuppression: A case Cohort Study at a Single Center with a Significantly Diverse Population
33608891	Dexamethasone use and Mortality in Hospitalized Patients with Coronavirus Disease 2019: a Multicenter Retrospective Observational Study
35860245	Intravenous Mesenchymal Stem Cells in Extracorporeal Oxygenation Patients with Severe COVID-19 Acute Respiratory Distress Syndrome
-	Treatment with human umbilical cord-derived mesenchymal stem cells for COVID-19 patients with lung damage: a randomised, double-blind, placebo-controlled phase 2 trial
34801738	Efficacy and Safety of Arbidol in Treatment of Patients with COVID-19 Infection: A Randomized Clinical Trial
-	Large population study identifies drugs associated with reduced COVID-19 severity
-	Tocilizumab is associated with reduction in inflammation and improvement in P/F ratio in critically sick COVID19 patients
35870876	Pharmacological treatment for patients with coronavirus disease 2019: systematic review of randomized controlled trials
35894476	Repurposed antiviral drugs for COVID-19
35581997	Melatonin is significantly associated with survival of intubated COVID-19 patients
33813110	A placebo-controlled double blind trial of hydroxychloroquine in mild-to-moderate COVID-19
33685275	CLINICAL COURSE AND OUTCOME OF COVID-19 ACUTE RESPIRATORY DISTRESS SYNDROME: DATA FROM A NATIONAL REPOSITORY
34251307	Tocilizumab in Treatment of Severe COVID-19 Patients: A Systematic Review and Meta-Analysis of Cohort Studies
-	Enoxaparin is associated with lower rates of thrombosis, kidney injury, and mortality than Unfractionated Heparin in hospitalized COVID patients
35859991	Clinical Outcomes With the Use of Prophylactic Versus Therapeutic Anticoagulation in COVID-19
35761219	Effect of convalescent plasma on mortality in patients with COVID-19 pneumonia
35232458	Montelukast in Hospitalized Patients Diagnosed with COVID-19
-	COVID-19: Ivermectin prophylaxis in adult contacts. Report on First Cases of Prophylaxis for Healthcare Personnel and PostExposure Prophylaxis
-	Renin Angiotensin System Inhibition and Susceptibility and Outcomes from COVID-19: A Systematic Review and Meta-analysis of 69,200 COVID-19 Patients
-	Real-world effectiveness of hydroxychloroquine, azithromycin, and ivermectin among hospitalized COVID-19 patients: results of a target trial emulation using observational data from a nationwide healthcare system in Peru
33194485	Comparison of Efficacy of Dexamethasone and Methylprednisolone in Improving the Partial Pressure of Arterial Oxygen and Fraction of Inspired Oxygen Ratio among COVID-19
-	An open-label prospective observational study of antiandrogen and non-antiandrogen early pharmacological approaches in females with mild-to-moderate COVID-19. The Pre-AndroCoV Female Trial
-	Azithromycin with nitazoxanide, hydroxychloroquine or ivermectin, with or without dutasteride, for early stage COVID-19: an open-label prospective observational study in males with mild-to-moderate COVID-19 (The Pre-AndroCoV Male Trial)
34353699	Low-density lipoprotein cholesterol levels are associated with poor clinical outcomes in COVID-19
35230215	Anakinra After Corticosteroid and/or Tocilizumab Treatment in Patients with Severe COVID-19 Pneumonia and Moderate Hyperinflammation. A Retrospective Cohort Study
33641159	Systematic review and patient-level meta-analysis of SARS-CoV-2 viral dynamics to model response to antiviral therapies
35783610	Convalescent plasma treatment of severe COVID-19: A matched control study
-	Early transfusion of a large cohort of COVID-19 patients with high titer anti-SARS-CoV-2 spike protein IgG convalescent plasma confirms a signal of significantly decreased mortality
-	A Novel Protein Drug, Novaferon, as the Potential Antiviral Drug for COVID-19
-	Hydroxychloroquine as Post-Exposure Prophylaxis for Covid-19: Why simple data analysis can lead to the wrong conclusions from well-designed studies
-	Pre exposure Hydroxychloroquine use is associated with reduced COVID19 risk in healthcare workers - a Retrospective cohort
-	Pathogenesis-based pre-exposure prophylaxis associated with low risk of SARS-CoV-2 infection in healthcare workers at a designated Covid-19 hospital
-	A Randomized Controlled Study Of Favipiravir Vs Hydroxychloroquine In COVID-19 Management: What Have We Learned So Far?
-	Corticosteroid pulses for hospitalized patients with COVID-19: Effects on mortality and in-hospital stay
-	Comprehensive Systematic Review to Identify putative COVID-19 Treatments: Roles for Immunomodulator and Antiviral Treatments
35299062	Impact of tocilizumab administration on mortality in severe COVID-19
32935090	Patient-Reported Health Outcomes After Treatment of COVID-19 with Nebulized and/or Intravenous Neutral Electrolyzed Saline Combined with Usual Medical Care Versus Usual Medical care alone: A Randomized, Open-Label, Controlled Trial
-	Evaluation of the Efficacy of Methylprednisolone Pulse Therapy in Treatment of Covid-19 Adult Patients with Severe Respiratory Failure: Randomized
-	A Randomized Trial of Ivermectin-Doxycycline and Hydroxychloroquine-Azithromycin therapy on COVID19 patients
-	Engineered interferon alpha effectively improves clinical outcomes of COVID-19 patients
33936897	Clearing the fog: Is HCQ effective in reducing COVID-19 progression: A randomized controlled trial
-	Randomized Controlled Trials of Early Ambulatory Hydroxychloroquine in the Prevention of COVID-19 Infection, Hospitalization, and Death: Meta-Analysis
-	Brief communication: A meta-analysis of randomized trials of hydroxychloroquine for the prevention of COVID-19
34735523	Efficacy of Famotidine for COVID-19: A Systematic Review and Meta-analysis
34964849	The Impact of Colchicine on The COVID-19 Patients: A Clinical Trial Study
-	Pulmonary radiological change of COVID-19 patients with 99mTc-MDP treatment
33440088	Safety and immunogenicity of the Ad26.COV2.S COVID-19 vaccine candidate: interim results of a phase 1/2a, double-blind, randomized, placebo-controlled trial
-	"High-dose vitamin C infusion for the treatment ofcritically ill COVID-19"
35887283	Tocilizumab in Hospitalized Patients With COVID-19 Pneumonia
33657114	Early Anti-SARS-CoV-2 Convalescent Plasma in Patients Admitted for COVID-19: A Randomized Phase II Clinical Trial
-	Pentoxifylline and Covid-19: A Systematic Review
-	The use of intravenous immunoglobulin gamma for the treatment of severe coronavirus disease 2019: A randomised placebo-controlled double-blind clinical trial
34781981	Hydroxychloroquine as pre-exposure prophylaxis for COVID-19 in healthcare workers: a randomized trial
-	Pre-exposure prophylaxis with hydroxychloroquine for COVID-19: initial results of a double-blind, placebo-controlled randomized clinical trial
33982938	Comparative Effectiveness of Famotidine in Hospitalized COVID-19 Patients
33990619	Mortality outcomes with hydroxychloroquine and chloroquine in COVID-19: an international collaborative meta-analysis of randomized trials.
33115675	Clinical Outcomes and Plasma Concentrations 1 of Baloxavir Marboxil and Favipiravir in COVID-19 Patients: An Exploratory Randomized, Controlled Trial
34020215	Effect of Arbidol on COVID-19: A Randomized Controlled Trial
33928532	Combination of Tocilizumab and steroids to improve mortality in patients with severe COVID-19 infection: A spanish, multicenter, cohorty study
35134505	Safety and Efficacy of Antiviral Drugs for the Treatment of Patients with SARS-CoV-2 Infection: A Systematic Review and Meta-analyses
-	The therapeutic effectiveness of Convalescent plasma therapy on treating COVID-19 patients residing in respiratory care units in Baghdad, Iraq
-	Safety and Efficacy of the combined use of ivermectin, dexamethasone, enoxaparin and aspirin against COVID-19
-	Early viral clearance among COVID-19 patients when gargling with Povidone-iodine and essential oils – a clinical trial
-	The Effect of Early Hydroxychloroquine-based Therapy in COVID-19 Patients in Ambulatory Care Settings: A Nationwide Prospective Cohort Study
33349815	Hydroxychloroquine for prevention of COVID-19 mortality: a population-based cohort study
33615173	Treatment with an Anti-CK2 Synthetic Peptide Improves Clinical Response in Covid-19 Patients with Pneumonia. A Randomized and Controlled Clinical Trial.
32910830	Role of Drugs used for chronic disease management on Susceptibility and Severity of COVID-19: A Large Case-Control Study
-	Characterization and Phase 1 Trial of a B Cell Activating Anti-CD73 Antibody for the Immunotherapy of COVID-19
-	The link between vitamin D deficiency and Covid-19 in a large population
-	"Beneficial and Harmful Outcomes of Tocilizumab in Severe COVID-19:A Systematic Review and Meta-Analysis"
-	Addition of Tocilizumab to the standard of care reduces mortality in severe COVID-19: A systematic review and meta-analysis
-	Evidence favouring the efficacy of convalescent plasma for COVID-19 therapy
33093056	Convalescent plasma in the management of moderate COVID-19 in India: An open-label parallel-arm phase II multicentre randomized controlled trial (PLACID Trial)
35862475	Convalescent plasma as potential therapy for severe COVID-19 pneumonia
33728141	Effect of Renin-Angiotensin-Aldosterone System inhibitors on outcomes of COVID-19 patients with hypertension: Systematic review and Meta-analysis
-	COVID-19 mortality risk factors in older people in a long-term care center
-	Hydroxychloroquine is Effective and Safe for the Treatment of COVID-19, and May be Universally Effective When Used Early Before Hospitalization: A Systematic Review
-	Lack of protective effect of chloroquine derivatives on COVID-19 disease in a Spanish sample of chronically treated patients
-	Hydroxicloroquine for pre-exposure prophylaxis for SARS-CoV-2
35791663	Positive association of Angiotensin II Receptor Blockers, not Angiotensin-Converting Enzyme Inhibitors, with an increased vulnerability to SARS-CoV-2 infection in patients hospitalized for suspected COVID-19 pneumonia
32817978	Effect of Convalescent Plasma on Mortality among Hospitalized Patients with COVID-19: Initial Three Month Experience
35780813	Convalescent Plasma for COVID-19: A multicenter, randomized clinical trial
33483491	A COVID-19 vaccine candidate 1 using SpyCatcher multimerization of the SARS-CoV-2 spike protein receptor-binding domain induces potent neutralising antibody responses
-	Immune response to vaccine candidates based on different types of nanoscaffolded RBD domain of the SARS-CoV-2 spike protein
34487721	Evaluation of the current therapeutic approaches for COVID-19: a meta-analysis
33446136	Hydroxychloroquine in the treatment of outpatients with mildly symptomatic COVID-19: A multi-center observational study
32839784	RNA-Based COVID-19 Vaccine BNT162b2 Selected for a Pivotal Efficacy Study
-	An effective, safe and cost-effective cell-based chimeric vaccine against SARS-CoV2
-	Pleiotropic effect of Lactoferrin in the prevention and treatment of COVID-19 infection: randomized clinical trial, in vitro and in silico preliminary evidences
33015643	Anti-C5a antibody (IFX-1) treatment of severe Covid-19: an exploratory phase 2 randomized controlled trial
-	OpenSAFELY: Do adults prescribed Non-steroidal anti-inflammatory drugs have an increased risk of death from COVID-19?
33068758	Outcomes of Persons With COVID-19 in Hospitals With and Without Standard Treatment With (Hydroxy)chloroquine
-	Pharmacological inhibition of the kinin-kallikrein system in severe COVID-19 A proof-of-concept study
-	Aprepitant as a combinant with Dexamethasone reduces the inflammation via Neurokinin 1 Receptor Antagonism in severe to critical Covid-19 patients and potentiates respiratory recovery: A novel therapeutic approach
-	Time to negative PCR from symptom onset in COVID-19 patients on Hydroxychloroquine and Azithromycin - A real world experience
-	Telmisartan for treatment of Covid-19 patients: an open randomized clinical trial. Preliminary report
-	Beneficial effects of colchicine for moderate to severe COVID-19: an interim analysis of a randomized, double-blinded, placebo controlled clinical trial
33430799	Janus Kinase-Inhibitor and Type I Interferon Ability to Produce Favorable Clinical Outcomes in COVID-19 Patients: A Systematic Review and Meta-Analysis
34403297	Effectiveness of booster BCG vaccination in preventing Covid-19 infection
-	Immunogenicity and Safety of a SARS-CoV-2 Inactivated Vaccine in Healthy Adults Aged 18-59 years: Report of the Randomized, Double-blind, and Placebo-controlled Phase 2 Clinical Trial
-	Avoiding COVID-19 complications with diabetic patients could be achieved by multi-dose Bacillus Calmette–Guérin vaccine: A case study of beta cells regeneration by serendipity
-	First-in-Human Trial of a SARS CoV 2 Recombinant Spike Protein Nanoparticle Vaccine
33337933	Therapeutic effectiveness of interferon alpha 2b treatment for COVID-19 patient recovery
33210302	COVIDOSE: Low-dose tocilizumab in the treatment of Covid-19
-	Prophylaxis with tetracyclines in ARDS: Potential therapy for COVID-19-induced ARDS?
30318081	Effect and safety of combination of interferon alpha-2b and gamma or interferon alpha-2b for negativization of SARS-CoV-2 viral RNA
33547300	Efficacy and tolerability of bevacizumab 2 in patients with severe Covid -19
33835886	Use of a humanized anti-CD6 monoclonal antibody (itolizumab) in elderly patients with moderate COVID-19
-	Intravenous immunoglobulin (IVIG) significantly reduces respiratory morbidity in COVID-19 pneumonia: a prospective randomized trial
33289973	A Cluster-Randomized Trial of Hydroxychloroquine as Prevention of Covid-19 Transmission and Disease
-	Corticosteroid Use in Severely Hypoxemic COVID-19 Patients: An Observational Cohort Analysis of Dosing Patterns and Outcomes in the Early Phase of the Pandemic
-	A meta-review of systematic reviews and an updated metaanalysis on the efficacy of chloroquine and hydroxychloroquine in treating COVID19 infection
-	Resveratrol and Copper for treatment of severe COVID-19: an observational study (RESCU 002)
32717066	Association between NSAIDs use and adverse clinical outcomes among adults hospitalised with COVID-19 in South Korea: A nationwide study
35453198	Effectiveness and Safety of Chloroquine or hydroxychloroquine as a mono-therapy or in combination with Azithromycin in the treatment of COVID-19 patients: Systematic Review and Meta-Analysis
-	COVID-19 Severity in Europe and the USA: Could the Seasonal Influenza Vaccination Play a Role?
-	Concurrent human antibody and TH1 type T-cell responses elicited by a COVID-19 RNA vaccine
-	Renin-Angiotensin-Aldosterone-System inhibitor use in patients with COVID-19 infection and prevention of serious events: a cohort study in commercially insured patients in the US
-	ISARIC Clinical Data Report 8 June 2020
-	Clinical and laboratory evaluation of patients with SARS-CoV-2 pneumonia treated with high-titer convalescent plasma: a prospective study
32960899	Second Week Methyl-Prednisolone Pulses Improve Prognosis In Patients With Severe Coronavirus Disease 2019 Pneumonia: An Observational Comparative Study Using Routine Care Data.
-	Observational Study of the Efficiency of Treatments in Patients Hospitalized with Covid-19 in Madrid
35685498	Adjunctive Corticosteroids for COVID-19: A Retrospective Cohort Study
34364870	Do low TB prevalence or lack of BCG Vaccination Contribute to Emergence Multisystem Inflammatory Syndrome?
-	Effects of Tocilizumab in Critically Ill Patients With COVID-19: A Quasi-Experimental Study
-	Effect of Hydroxychloroquine in Hospitalized Patients with COVID-19: Preliminary results from a multi-centre, randomized, controlled trial
-	Treatment response to hydroxychloroquine and antibiotics for mild to moderate COVID-19: a retrospective cohort study from South Korea
-	A Multicenter, randomized, open-label, controlled trial to evaluate the efficacy and tolerability of hydroxychloroquine and a retrospective study in adult patients with mild to moderate coronavirus disease 2019 (COVID-19)
33123544	Addition of Tocilizumab to standard of care reduces mortality in severe COVID-19: A systematic review and meta-analysis
-	Baricitinib as rescue therapy in a patient with COVID-19 with no complete response to sarilumab
-	Association between angiotensin-converting enzyme inhibitors and angiotensin II 2 receptor blockers use and the risk of infection and clinical outcome of COVID-19: a 3 comprehensive systematic review and meta-analysis
35083229	Mortality and use of angiotensin converting enzyme inhibitors in Covid 19 disease – a systematic review
32641296	Effect of Systemic Inflammatory Response to SARS-CoV-2 on Lopinavir and Hydroxychloroquine Plasma Concentrations
35126577	COVID-19 in Iran, a comprehensive investigation from exposure to treatment outcomes
33721102	Strong Correlation Between Prevalence of Severe Vitamin D Deficiency and Population Mortality Rate from COVID-19 in Europe
-	Doxycycline and Hydroxychloroquine as Treatment for High-Risk COVID-19 Patients: Experience from Case Series of 54 Patients in Long-Term Care Facilities
35905465	Hydroxychloroquine with or without azithromycin and in-hospital mortality or discharge in patients hospitalized for COVID-19 infection: a cohort study of 4,642 in-patients in France
34099745	Hydroxychloroquine and mortality risk of patients with COVID-19: a systematic review and meta-analysis of human comparative studies
32448345	Efficacy and Safety of Remdesivir for COVID-19 Treatment: An Analysis of Randomized, Double-Blind, Placebo-Controlled Trials
-	Real-world Experience with Favipiravir for Treatment of COVID-19 in Thailand: Results from a Multicenter Observational Study
33513195	Hydroxychloroquine has no effect on SARS-CoV-2 load in nasopharynx of patients with mild form of COVID-19
-	Early Hydroxychloroquine Is Associated with an Increase of Survival in COVID-19 Patients: An Observational Study
-	Azithromycin and Hydroxychloroquine Accelerate Recovery of Outpatients with Mild/Moderate COVID-19
35780813	Convalescent Plasma for COVID-19. A randomized clinical trial
32587983	First Clinical Use of Lenzilumab to Neutralize GM-CSF in Patients with Severe COVID-19 Pneumonia
-	Phase 1/2 Study to Describe the Safety and Immunogenicity of a COVID-19 RNA Vaccine Candidate (BNT162b1) in Adults 18 to 55 Years of Age: Interim Report
35814322	Chronic treatment with hydroxychloroquine and SARS-CoV-2 infection
-	ICON (Ivermectin in COvid Nineteen) study: Use of Ivermectin is Associated with Lower Mortality in Hospitalized Patients with COVID19
35838894	Influenza Vaccination and COVID19 Mortality in the USA
32577681	The Association Between the Rate of Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers Use and the Number of Covid-19 Confirmed Cases and Deaths in the United States: Geospatial Study
32587982	Renin-angiotensin system blockers and susceptibility to COVID-19: a multinational open science cohort study
-	Hospitalized COVID-19 patients treated with Convalescent Plasma in a mid-size city in the midwest
35287602	Prolonged low-dose methylprednisolone in patients with severe COVID-19 pneumonia
35721667	Tocilizumab for treatment of mechanically ventilated patients with COVID-19
34326020	Observational Study of Metformin and Risk of Mortality in Persons Hospitalized with Covid-19
32690491	Effect of Dexamethasone in Hospitalized Patients with COVID-19: Preliminary Report
34854415	Pre exposure Hydroxychloroquine Prophylaxis for COVID-19 in healthcare workers: a retrospective cohort
32566564	Effectiveness and safety of glucocorticoids to treat COVID-19: a rapid review and meta-analysis
35903922	Chloroquine, but not hydroxychlorquine, prolongs the QT interval in a primary care population.
33447849	Outcomes in Patients with Severe COVID-19 Disease Treated with Tocilizumab – A Case- Controlled Study.
35848412	Efficacy and safety of chloroquine or hydroxychloroquine in moderate type of COVID-19: a prospective open-label randomized controlled study.
35815763	Clozapine treatment and risk of COVID-19.
35139366	Effect of hydroxychloroquine on SARS-CoV-2 viral load in patients with COVID-19.
34837230	Efficacy and Safety of Lopinavir/Ritonavir for Treatment of COVID-19: A Systematic Review and Meta-Analysis.
33534047	GLUCOCOVID: A controlled trial of methylprednisolone in adults hospitalized with COVID-19 pneumonia.
35677110	Remdesivir Efficacy in Coronavirus Disease 2019 (COVID-19): A Systematic Review.
-	Compassionate Use of Tocilizumab in Severe SARS-CoV2 Pneumonia. When late administration is too late.
-	Explore the Possible Impact of BCG Vaccination Policy on the Morbidity, Mortality, and Recovery Rates due to COVID-19 Infection.
32617169	Hydroxychloroquine-Induced Stevens-Johnson Syndrome in COVID-19: A rare Case Report.
-	A 78-year Old Urothelial Cancer Patient with Faster Recovery from COVID-19: Potential Benefit from Adjuvant Active Immunotherapy.
35083229	Mortality and use of angiotensin converting enzyme inhibitors in Covid 19 disease – a systematic review.
35531306	Effect of tocilizumab in hospitalized patients with severe pneumonia COVID-19: a cohort study.
32960147	Therapeutic effectiveness of interferon-alpha 2b against COVID-19: the Cuban experience.
34597766	Effects of Tocilizumab on Mortality in Hospitalized Patients with COVID-19: A Multicenter Cohort Study.
32898149	Adverse outcomes and mortality in users of non-steroidal anti-inflammatory drugs tested positive for SARS-CoV-2: a danish nationwide cohort study.
32918792	Tocilizumab as a Therapeutic Agent for Critically Ill Patients Infected with SARS-CoV-2.
35868492	Association of Vitamin D Deficiency and Treatment with COVID-19 Incidence.
-	Tobaiqy M, Helmi N, Majrashi M, Majrashi M, Al-Dahery S, Mujallad A. COVID-19 therapeutics outcome: systematic review and data analysis. Research Square. 2020. Disponível em: https://doi.org/10.21203/rs.3.rs-33391/v1
33154723	Assessment of Hydroxychloroquine and Chloroquine Safety Profiles – A Systematic Review and Meta-Analysis.
-	Association of Renin-Angiotensin-Aldosterone System Inhibition with Risk of COVID-19, Inflammation Level, Severity and Death in Patients With COVID-19: A Rapid Systematic Review and Meta-Analysis.
35894609	Association Between ACEIs or ARBs Use and Clinical Outcomes in COVID-19 Patients: A Systematic Review and Meta-analysis.
-	A shred of evidence that BCG vaccine may protect against COVID-19: Comparing cohorts in Spain and Italy.
35205852	Tocilizumab is associated with reduced risk of ICU admission and mortality in patients with SARS-CoV-2 infection.
-	Association of Bacille Calmette-Guérin (BCG), Adult Pneumococcal and Adult Seasonal Influenza Vaccines with Covid-19 Adjusted Mortality Rates in Level 4 European countries.
-	Ozone therapy for patients with SARS-COV-2 pneumonia: a single-center prospective cohort study.
-	Efficacy and Safety of Leflunomide for Refractory COVID-19: An Open-label Controlled Study.
34308390	A SYSTEMATIC ANALYSIS OF THE TIME COURSE TO DEVELOP TREATMENTS FOR COVID-19.
-	Rapid systematic review on clinical evidence of chloroquine and hydroxychloroquine in COVID-19: critical assessment and recommendation for future clinical trials.
33230045	"Plasma concentration and safety of lopinavir/ritonavir in patients with Covid-19: a 2 retrospective cohort study"
33068263	Impact of glucocorticoid treatment in Sars-CoV-2 infection mortality: a retrospective controlled Cohort Study
34733538	Renin-angiotensin-aldosterone system inhibitors and mortality in patients with hypertension hospitalized for COVID19: systematic review &meta-analysis
32810285	Effect of various treatment modalities on the novel coronavirus (nCOV-2019) infection in humans: a systematic review & meta-analysis
35663303	Use of inhibitors of the renin angiotensin system and COVID-19 prognosis: a systematic review and meta-analysis
34859557	Hydroxychloroquine and Tocilizumab Therapy in COVID-19 Patients - An Observational Study
32763496	Comorbidities, clinical signs and symptoms, laboratory findings, imaging features, treatment strategies, and outcomes in adult and pediatric patients with COVID-19: A systematic review and meta-analysis
35665014	A Systematic Review and Meta-analysis of Therapeutic options against SARS-CoV-2
32731258	ChAdOx1 nCoV-19 vaccination prevents SARS-CoV-2 pneumonia in rhesus macaques
35905973	Cancer immunotherapy does not increase the risk of death by COVID-19 in melanoma patients
32993479	Nebulized in-line endotracheal dornase alfa and albuterol administered to mechanically 2 ventilated COVID-19 patients: A case series
-	Treatment Response to Hydroxychloroquine, Lopinavir–Ritonavir, and Antibiotics for Moderate COVID-19: A First Report on the Pharmacological Outcomes from South Korea
-	Hydroxychloroquine and azithromycin plus zinc vs hydroxychloroquine and azithromycin alone: outcomes in hospitalized COVID-19 patients
-	Off-Label Real World Experience Using Tocilizumab for Patients Hospitalized with COVID-19 Disease in a Regional Community Health System: A Case-Control Study
35667745	Sarilumab use in severe SARS-CoV-2 pneumonia
35832701	Hydroxychloroquine in COVID-19: A systematic review and meta-analysis
-	Improved survival outcome in SARs-CoV-2 (COVID-19) Acute Respiratory Distress Syndrome patients with Tocilizumab administration
32511566	Early Safety Indicators of COVID-19 Convalescent Plasma in 5,000 Patients
35878651	ACE-inhibitors and Angiotensin-2 Receptor Blockers are not associated with severe SARS-COVID19 infection in a multi-site UK acute Hospital Trust
34736537	Systematic Review and Meta-analysis of the Effectiveness and Safety of Hydroxychloroquine in COVID-19
35777878	Systematic benefit-risk assessment for the use of chloroquine or hydroxychloroquine as a treatment for COVID-19: Establishing a framework for rapid decision-making
35727463	Steroid-responsive encephalitis in Covid-19 disease
32383183	A comparison study of SARS-CoV-2 IgG antibody between male and female COVID-19 patients: a possible reason underlying different outcome between gender
35905790	The race to find a SARS-CoV-2 drug can only be won by a few chosen drugs: a systematic review of registers of clinical trials of drugs aimed at preventing or treating COVID-19
-	Does BCG protect against SARS-CoV-2 infection ?: elements of proof
-	COVID-19 Related Mortality: Is the BCG Vaccine Truly Effective?
-	Evidence Supports a Causal Model for Vitamin D in COVID-19 Outcomes
-	Incidence of COVID-19 in a cohort of adult and paediatric patients with rheumatic diseases treated with targeted biologic and synthetic disease-modifying anti-rheumatic drugs
33350752	Hydroxychloroquine is associated with slower viral clearance in clinical COVID-19 patients with mild to moderate disease: A retrospective study
32804086	Ocular toxicity and Hydroxychloroquine: A Rapid Meta-Analysis
35588019	Lopinavir-ritonavir alone or combined with arbidol in the treatment of 73 hospitalized patients with COVID-19: a pilot retrospective study
35512430	The effect of angiotensin converting enzyme inhibitors and angiotensin receptor blockers on death and severity of disease in patients with coronavirus disease 2019 (COVID-19): A meta-analysis
-	A systematic review of Anakinra, Tocilizumab, Sarilumab and Siltuximab for coronavirus-related infections
32566562	Intravenous Immunoglobulin of COVID-19 Effectiveness of Intravenous Immunoglobulin for Children with Severe COVID-19: A Rapid Review
32887691	The role of corticosteroids in the management of critically ill patients with coronavirus disease 2019 (COVID-19): A meta-analysis
35808662	Hydroxychloroquine for the management of COVID-19: Hope or Hype? A Systematic review of the current evidence
32511388	Enisamium is a small molecule inhibitor of the influenza A virus and SARS-CoV-2 RNA polymerases
33321203	A Computational Approach to Design Potential siRNA Molecules as a Prospective Tool for Silencing Nucleocapsid Phosphoprotein and Surface Glycoprotein Gene of SARS-CoV-2
32541865	Boceprevir, GC-376, and calpain inhibitors II, XII inhibit SARS-CoV-2 viral replication by targeting the viral main protease
33192569	Heparin therapy improving hypoxia in COVID-19 patients - a case series
35186959	A Randomized, Single-blind, Group sequential, Active-controlled Study to evaluate the clinical efficacy and safety of α-Lipoic acid for critically ill patients with coronavirus disease 2019（COVID-19).
-	Design an efficient multi-epitope peptide vaccine candidate against SARS-CoV-2: An in silico analysis
32838355	Outcomes of hydroxychloroquine usage in United States veterans hospitalized with COVID-19
35891232	Rapid development of an inactivated vaccine for SARS-CoV-2
32566561	Potential Effectiveness and Safety of Antiviral Agents in Children with Coronavirus Disease 2019: A Rapid Review and Meta-Analysis
35727463	Steroid-responsive severe encephalopathy in SARS-CoV-2 infection
32882638	Clinical benefit of remdesivir in rhesus macaques infected with SARS-CoV-2
32442105	The FDA-approved gold drug Auranofin inhibits novel coronavirus (SARS-COV-2) replication and attenuates inflammation in human cells
35799196	Clinical Efficacy of Intravenous Immunoglobulin Therapy in Critical Patients with COVID-19: A multicenter retrospective cohort study
35533972	Hydroxychloroquine in patients with COVID-19: an open-label, randomized, controlled trial
-	No evidence of clinical efficacy of hydroxychloroquine in patients hospitalized for COVID-19 infection with oxygen requirement: results of a study using routinely collected data to emulate a target trial
-	Currently available intravenous immunoglobulin (Gamunex®-C and Flebogamma® DIF) contains antibodies reacting against SARS-CoV-2 antigens
-	The IMPDH inhibitor merimepodib suppresses SARS-CoV-2 replication in vitro
-	Key to successful treatment of COVID-19: accurate identification of severe risks and early intervention of disease progression
-	Treatment with ACE-inhibitors is associated with less severe disease with SARS-Covid-19 infection in a multi-site UK acute Hospital Trust
-	The Use of Adjuvant Therapy in Preventing Progression to Severe Pneumonia in Patients with Coronavirus Disease 2019: A Multicenter Data Analysis
35597770	Interferon-α2b treatment for COVID-19
34539392	Favipiravir versus Arbidol for COVID-19: A Randomized Clinical
33437211	COVID-19 infection during pregnancy: A systematic review to summarize possible symptoms, treatments, and pregnancy outcomes
-	BCG protects against COVID-19? A word of caution
-	Convalescent Plasma to Treat COVID-19: Chinese Strategy and Experiences
35695453	Human monoclonal antibodies block the binding of SARS CoV 2 spike protein
-	Hydroxychloroquine (HCQ): an observational cohort study in primary and secondary prevention of pneumonia in an at-risk population
-	Safety of hydroxychloroquine, alone and in combination with azithromycin, in light of rapid wide-spread use for COVID-19: a multinational, network cohort and self-controlled case series study
-	Chloroquine diphosphate in two different dosages as adjunctive therapy of hospitalized patients with severe respiratory syndrome in the context of coronavirus (SARS-CoV-2) infection: Preliminary safety results of a randomized, double-blinded, phase IIb clinical trial (CloroCovid-19 Study)
-	Therapeutic Application of Chloroquine and Hydroxychloroquine in Clinical Trials for COVID-19: A systematic review
-	Differential COVID-19-attributable mortality and BCG vaccine use in countries
35495105	Association of BCG vaccination policy with prevalence and mortality of COVID-19
34075090	Targeting the catecholamine-cytokine axis to prevent SARS-CoV-2 cytokine storm syndrome
35874909	Efficacy of hydroxychloroquine in patients with COVID-19: results of a randomized clinical trial
33183178	Lack of Antiviral Activity of Darunavir against SARS-CoV-2
33180803	Repurposing Therapeutics for COVID-19: Rapid Prediction of Commercially available drugs through Machine Learning and Docking
34316558	Kamal MA, Helmi N. Therapeutic Management of COVID-19 Patients: A systematic review
-	Use of siltuximab in patients with COVID-19 pneumonia requiring ventilatory support
-	The QT Interval in Patients with SARS-CoV-2 Infection Treated with Hydroxychloroquine/Azithromycin
35786174	Interleukin-6 in COVID-19: A Systematic Review and Meta-Analysis
35875562	Clinical features, Diagnosis, and Treatment of COVID-19: A systematic review of case reports and case series
32658841	DEVELOPMENT OF A HYPERIMMUNE EQUINE SERUM THERAPY FOR COVID-19 IN ARGENTINA
32931734	A Single-Dose Intranasal ChAd Vaccine Protects Upper and Lower Respiratory Tracts against SARS-CoV-2
32933365	Optimization of hydroxychloroquine dosing scheme based on COVID-19 patients’ characteristics: a review of the literature and simulations
32903552	A Simple Bayesian Method for Evaluating Whether Data From Patients With Rheumatic Diseases Who Have Been Under Chronic Hydroxychloroquine Medication Since Before the COVID-19 Outbreak Can Speak to Hydroxychloroquine’s Prophylactic Effect Against Infection With SARS-CoV-2
34289385	A single dose of an adenovirus-vectored vaccine provides protection against SARS-CoV-2 challenge
32826924	An adenovirus-vectored COVID-19 vaccine confers protection from SARS-COV-2 challenge in rhesus macaques
35094366	A Thermostable mRNA Vaccine against COVID-19
32793398	Evaluation of the immunogenicity of prime-boost vaccination with the replication-deficient viral vectored COVID-19 vaccine candidate ChAdOx1 nCoV-19
32783919	A Single Immunization with Nucleoside-Modified mRNA Vaccines Elicits Strong Cellular and Humoral Immune Responses against SARS-CoV-2 in Mice
33469218	Single-shot Ad26 vaccine protects against SARS-CoV-2 in rhesus macaques
34449440	Evaluation of the mRNA-1273 Vaccine against SARS-CoV-2 in Nonhuman Primates
32404477	A noncompeting pair of human neutralizing antibodies block COVID-19 virus binding to its receptor ACE2
35746797	A human monoclonal antibody blocking SARS-CoV-2 infection
32312290	Salvage use of tissue plasminogen activator (tPA) in the setting of acute respiratory distress syndrome (ARDS) due to COVID-19 in the USA: a Markov decision analysis
32307268	Active constituents and mechanisms of Respiratory Detox Shot, a traditional Chinese medicine prescription, for COVID-19 control and prevention: Network-molecular docking-LC-MSE analysis
32113846	In silico screening of Chinese herbal medicines with the potential to directly inhibit 2019 novel coronavirus
32510523	Fast Identification of Possible Drug Treatment of Coronavirus Disease -19 (COVID-19) Through Computational Drug Repurposing Study
32065055	Potent binding of 2019 novel coronavirus spike protein by a SARS coronavirus-specific human monoclonal antibody
34802883	Lianhuaqingwen exerts anti-viral and anti-inflammatory activity against novel coronavirus (SARS-CoV-2)
32306822	Peptide-like and small-molecule inhibitors against Covid-19
35876061	Molecular docking and dynamics simulation of FDA approved drugs with the main protease from 2019 novel coronavirus
35740872	Potential covalent drugs targeting the main protease of the SARS-CoV-2 coronavirus
32311760	Inactivation of severe acute respiratory syndrome coronavirus 2 in plasma and platelet products using a riboflavin and ultraviolet light-based photochemical treatment
32294562	A search for medications to treat COVID-19 via in silico molecular docking models of the SARS-CoV-2 spike glycoprotein and 3CL protease
33880524	Anti-HCV, nucleotide inhibitors, repurposing against COVID-19
32283108	Remdesivir and SARS-CoV-2: Structural requirements at both nsp12 RdRp and nsp14 Exonuclease active-sites
32960061	Drug repurposing for coronavirus (COVID-19): in silico screening of known drugs against coronavirus 3CL hydrolase and protease enzymes
33154404	Analysis of therapeutic targets for SARS-CoV-2 and discovery of potential drugs by computational methods
32293875	Why are lopinavir and ritonavir effective against the newly emerged Coronavirus 2019?: Atomistic insights into the inhibitory mechanisms
32291351	Repurposing Didanosine as a Potential Treatment for COVID-19 Using Single-Cell RNA Sequencing Data
32238094	Identification of Chymotrypsin-like Protease Inhibitors of SARS-CoV-2 Via Integrated Computational Approach
32284326	Remdesivir is a direct-acting antiviral that inhibits RNA-dependent RNA polymerase from severe acute respiratory syndrome coronavirus 2 with high potency
32280433	Predicting commercially available antiviral drugs that may act on the novel coronavirus (SARS-CoV-2) through a drug-target interaction deep learning model
35794497	In silico studies on therapeutic agents for COVID-19: Drug repurposing approach
35789829	Virtual screening and repurposing of FDA approved drugs against COVID-19 main protease
-	Investigating the mechanism of Qing-Fei-Pai-Du-Tang for the treatment of Novel Coronavirus Pneumonia by network pharmacology
-	Repurposing of clinically approved drugs for treatment of coronavirus disease 2019 in a 2019-novel coronavirus (2019-nCoV) related coronavirus model
32253226	An orally bioavailable broad-spectrum antiviral inhibits SARS-CoV-2 in human airway epithelial cell cultures and multiple coronaviruses in mice
-	Targeting Novel Coronavirus 2019: A Systematic Drug Repurposing Approach to Identify Promising Inhibitors Against 3C-like Proteinase and 2'-O-Ribose Methyltransferase
32251767	Remdesivir, lopinavir, emetine, and homoharringtonine inhibit SARS-CoV-2 replication in vitro
32249203	Microneedle array delivered recombinant coronavirus vaccines: Immunogenicity and rapid translational development
32766547	A vaccine for SARS-CoV-2: goals and promises
35817805	Does vitamin D status impact mortality from SARS-CoV-2 infection?
32876256	Covid-19 treatment update: follow the scientific evidence
32292817	Coalition: Advocacy for prospective clinical trials to test the post-exposure potential of hydroxychloroquine against COVID-19
32292907	Standing out from the crowd in treating COVID-19
32281268	G6PD and chloroquine: selecting the treatment against SARS-CoV-2?
32267556	COVID-19: Important Therapy Considerations and Approaches in this Hour of Need
35630280	COVID-19 and drug-induced liver injury: a problem of plenty or a petty point?
-	Ongoing Living Update of COVID-19 Therapeutic Options: Summary of Evidence.
-	Ongoing Living Update of Potential COVID-19 Therapeutics: summary of rapid systematic reviews
-	DRAFT landscape of COVID-19 candidate vaccines – 03 November 2020
-	HCQ is effective for COVID-19 when used early: analysis of 118 studies
-	DRAFT landscape of COVID-19 candidate vaccines – 19 October 2020
-	Ongoing Living Update of Potential COVID-19 Therapeutics: summary of rapid systematic reviews
-	DRAFT landscape of COVID-19 candidate vaccines – 02 October 2020
-	Ongoing Living Update of Potential COVID-19 Therapeutics: summary of rapid systematic reviews
-	DRAFT landscape of COVID-19 candidate vaccines – 28 September 2020
-	DRAFT landscape of COVID-19 candidate vaccines – 21 September 2020
-	DRAFT landscape of COVID-19 candidate vaccines – 23 September 2020
-	DRAFT landscape of COVID-19 candidate vaccines – 17 September 2020
-	DRAFT landscape of COVID-19 candidate vaccines – 9 September 2020
-	DRAFT landscape of COVID-19 candidate vaccines – 8 September 2020
-	DRAFT landscape of COVID-19 candidate vaccines – 28 August 2020
-	DRAFT landscape of COVID-19 candidate vaccines – 25 August 2020
33877121	Tocilizumab en infección por COVID-19
-	Remdesivir en pacientes con COVID-19
-	DRAFT landscape of COVID-19 candidate vaccines – 20 August 2020
-	INTERFERON PARA PROFILAXIA E TRATAMENTO DE COVID-19. Revisão sistemática rápida
-	Uso de dexametasona en pacientes internados con COVID-19
-	Lopinavir-Ritonavir para infecção por SARS-CoV-2 (Covid-19). Revisão sistemática rápida.
-	Hidroxicloroquina e cloroquina para Covid-19. Revisão sistemática de ensaios clínicos randomizados
-	REPORTE BREVE Nº 30 USO DE ANAKINRA PARA EL TRATAMIENTO DE PACIENTES CON EL DIAGNOSTICO DE COVID-19, 2020.  SEGURO SOCIAL DE SALUD - ESSALUD INSTITUTO DE EVALUACION DE TECNOLOGIAS EN SALUD E INVESTIGACIÓN
-	Uso de dexametasona en pacientes internados con COVID-19 - Informe de Evaluación de Tecnología Sanitaria
-	DRAFT landscape of COVID-19 candidate vaccines – 10 August 2020
-	Drug vignettes: Remdesivir
-	Drug vignettes: Interferons
-	DRAFT landscape of COVID-19 candidate vaccines – 31 July 2020
-	DRAFT landscape of COVID-19 candidate vaccines – 27 July 2020
-	DRAFT landscape of COVID-19 candidate vaccines – 21 July 2020
-	DRAFT landscape of COVID-19 candidate vaccines – 15 July 2020
-	DRAFT landscape of COVID-19 candidate vaccines – 13 July 2020
-	Eficácia da Ivermectina para o Tratamento da Covid-19. Revisão sistemática rápida
32542211	Emergence of institutional antithrombotic protocols for coronavirus 2019
-	DRAFT landscape of COVID-19 candidate vaccines – 06 July 2020
-	Associação hidroxicloroquina/ cloroquina e azitromicina para Covid-19
-	Tocilizumabe para infecção por SARS-CoV-2 (COVID-19) Revisão sistemática rápida
-	Corticoides para infecção por SARS-CoV-2 (Covid-19) Revisão sistemática rápida.
-	DRAFT landscape of COVID-19 candidate vaccines – 24 June 2020
-	DRAFT landscape of COVID-19 candidate vaccines – 22 June 2020.
-	DRAFT landscape of COVID-19 candidate vaccines – 18 June 2020.
35894360	Targeted Update: Safety and efficacy of hydroxychloroquine or chloroquine for treatment of COVID-19
-	Uso de plasma de pacientes recuperados no tratamento de COVID-19. Revisão sistemática rápida.
-	Heparina para Covid-19. Revisão sistemática rápida.
-	Eficácia, segurança e prognóstico associados ao uso de Inibidores da Enzima Conversora de Angiotensina (IECA) e Bloqueadores do Receptor de Angiotensina 2 (BRA) para COVID-19. Revisão sistemática rápida.
-	DRAFT landscape of COVID-19 candidate vaccines - 16 June 2020
-	DRAFT landscape of COVID-19 candidate vaccines - 9 June 2020
-	Nitazoxanida no tratamento de covid-19. Revisão sistemática rápida.
-	Tocilizumabe para infecção por SARS-CoV-2 (COVID-19) Revisão sistemática rápida.
-	Remdesivir para infecção por SARS-CoV-2 (COVID-19). Revisão sistemática.
-	Hidroxicloroquina e cloroquina para Covid-19. Revisão sistemática rápida
-	Ongoing Living Update of Potential COVID-19 Therapeutics: summary of rapid systematic reviews. Rapid Review, 8 May 2020
33323376	DRAFT landscape of COVID-19 candidate vaccines - 15 May 2020
-	Corticoides para infecção por SARS-CoV-2 (Covid-19) Revisão sistemática rápida
-	Associação hidroxicloroquina/cloroquina e azitromicina para Covid-19.
-	Uso de Tocilizumab para el tratamiento de pacientes con COVID-19. Reporte breve n° 01.
-	Uso de Oseltamivir para el tratamiento de pacientes con COVID-19. Reporte breve n° 01.
-	Uso de atazanavir para el tratamiento de pacientes con diagnóstico de COVID-19. Reporte breve n° 02.
-	Uso de AINES en pacientes con diagnóstico de COVID-19. Reporte breve n° 013.
34586598	Draft landscape of COVID 19 candidate vaccines - 11 May 2020
-	COVID-19 Informal consultation on the dose of chloroquine and hydroxychloroquine for the SOLIDARITY Clinical Trial
33323376	DRAFT landscape of COVID-19 candidate vaccines - 5 May 2020
35894360	What is the evidence for using macrolide antibiotics to treat COVID-19?
-	Drug vignettes: Tocilizumab
-	Heparinas para infecção por SARS-CoV-2 (COVID-19). Revisão sistemática rápida
-	"Remdesivir parainfecção por SARS-CoV-2 (COVID-19). Revisão sistemática"
35905496	Vitamin D: A rapid review of the evidence for treatment or prevention in COVID-19
35905796	A rapid review of the evidence for treatment or prevention in COVID-19
-	DRAFT landscape of COVID-19 candidate vaccines - 20 April 2020
-	Ongoing Living Update of Potential COVID-19 Therapeutics: summary of rapid systematic reviews
-	Infectious Diseases Society of America Guidelines on the Treatment and Management of Patients with COVID-19
-	DRAFT landscape of COVID-19 candidate vaccines - 23 April 2020
-	Nitazoxanida para tratamento de COVID-19: Revisão Sistemática Rápida
-	Atazanavir para COVID-19. Revisão sistemática rápida
-	Uso de plasma de pacientes recuperados no tratamento de COVID-19. Revisão sistemática rápida
-	Inibidores da janus associated kinases para COVID-19.
-	Antagonistas do receptor da endotelina para o tratamento de pacientes com COVID-19
-	Antagonistas do receptor da ivermectina para o tratamento de pacientes com COVID-19
-	DRAFT landscape of COVID-19 candidate vaccines – 4 April 2020
35506263	Remdesivir for severe covid-19: a clinical practice guideline
32667444	Guidelines for the pharmacological treatment of COVID-19. The task force/consensus guideline of the Brazilian Association of Intensive Care Medicine, the Brazilian Society of Infectious Diseases and the Brazilian Society of Pulmonology and Tisiology
33565225	Interim Guidelines on Antiviral Therapy for COVID-19
32955785	Risk of metformin in type 2 diabetes patients with COVID-19: a preliminary retrospective report
35029324	Tocilizumab for severe COVID-19 in solid organ transplant recipients: a matched case-control study
32882767	Use of Darunavir-Cobicistat as a Treatment Option for Critically Ill Patients with SARS-CoV-2 Infection
32888840	Experience of the use of hydroxychloroquine on patients with COVID-19: A perspective on viral load and cytokine kinetics
-	Towards evidence-based Emergency medicine: best BETs from the Manchester Royal Infirmary. BET 2: Hydroxychloroquine in the treatment of COVID-19
-	"Use of Darunavir-Cobicistat as a Treatment Optionfor Critically Ill Patients with SARS-CoV-2 Infection"
35829692	A novel approach to managing COVID-19 patients
32848743	Preliminary Experience With Low Molecular Weight Heparin Strategy in COVID-19 Patients
33665766	Chronic therapeutic anticoagulation is associated with decreased thrombotic complications in SARS‐CoV‐2 infection
35692410	Metformin use is associated with reduced mortality rate from coronavirus disease 2019 (COVID-19)
32828896	A comprehensive strategy for the early treatment of COVID-19 with azithromycin/hydroxychloroquine and/or corticosteroids: results of a retrospective observational study in the French overseas department of Reunion Island
35903614	Corticosteroid Therapy in COVID-19 Disease
32767527	Susceptibility to COVID-19 in patients treated with antimalarials: a population based study in Emilia-Romagna, Northern Italy
32305587	Can post-exposure prophylaxis for COVID-19 be considered as an outbreak response strategy in long-term care hospitals? International Journal of Antimicrobial Agents
35192051	"Effect of Systemic Glucocorticoids on Mortality or Mechanical Ventilation in Patients With COVID-19"
32795898	Oxygen-ozone (O2-O3) immunoceutical therapy for patients with COVID-19. Preliminary evidence reported.
35754519	Risk of QT Interval Prolongation Associated With Use of Hydroxychloroquine With or Without Concomitant Azithromycin Among Hospitalized Patients Testing Positive for Coronavirus Disease 2019 (COVID-19)
32347963	An independent appraisal and re-analysis of hydroxychloroquine treatment trial for COVID-19
35905123	Lopinavir/ritonavir did not shorten the duration of SARS CoV-2 shedding in patients with mild pneumonia in Taiwan
35367460	Mortality of COVID-19 with preadmission metformin use in patients with diabetes: a meta-analysis
32874012	Renin-angiotensin system blockers and outcomes during hydroxychloroquine treatment in patients hospitalized for COVID-19 pneumonia
33443121	Renin-angiotensin system inhibitors improve the clinical outcomes of COVID-19 patients with hypertension
35174897	Therapeutic plasma exchange in patients with COVID-19 pneumonia in intensive care unit: a retrospective study
34631752	Efficacy of tocilizumab treatment in severely ill COVID-19 patients
-	"Argatroban for therapeutic anticoagulation for heparin resistanceassociated with Covid-19 infection"
-	“Toxic erythema” and eosinophilia associated to tocilizumab therapy in a COVID-19 patient
-	Drug-induced vasculitis in a patient with COVID-19
-	Favourable outcome of Coronavirus-19 in a 1-year-old girl with acute myeloid leukaemia and severe treatment-induced immunosuppression
32369612	IL-6 blockade treatment for severe COVID-19 in two patients with multiple myeloma
35776051	A retrospective cohort study of methylprednisolone therapy in severe patients with COVID-19 pneumonia
32333918	Baricitinib therapy in COVID-19: A pilot study on safety and clinical impact
32307653	CD147 as a Target for COVID-19 Treatment: Suggested Effects of Azithromycin and Stem Cell Engagement
35085462	Off-label Use of Tocilizumab in Patients with SARS-CoV-2 Infection
34091065	Attention should be paid to venous thromboembolism prophylaxis in the management of COVID-19
35885517	Safety of hydroxychloroquine for treatment or prevention of SARS‐CoV‐2 infection: A rapid systematic review and meta‐analysis of randomized clinical trials.
-	L’hydroxy-chloroquine pour traiter les patients infectes du ´COVID-19: quelques lec¸ons d’an-thropologie medicale et d’histoire de la m ´ edecine
35904477	Amiodarone in the COVID‑19 Era: Treatment for Symptomatic Patients Only, or Drug to Prevent Infection?
35313385	Adverse events associated with nafamostat mesylate and favipiravir treatment in COVID-19 patients
35572594	An Inactivated Virus Candidate Vaccine to Prevent COVID-19
32728733	No higher risk of respiratory symptoms in Italian rheumatological patients under IL-6R-inhibitor therapy in SARS-CoV-2 pandemic
35899637	The use of dexamethasone in the treatment of COVID-19
32835233	Anakinra in COVID-19: important considerations for clinical trials
32745524	Critical COVID-19 disease, homeostasis, and the “surprise” of effective glucocorticoid therapy
32492105	A Randomized Trial of Convalescent Plasma for COVID-19—Potentially Hopeful Signals
32612616	Potential Treatments for COVID-19 Related Cytokine Storm - Beyond Corticosteroids
-	Effectiveness of Hydroxychloroquine in COVID-19 disease: A done and dusted situation?
32871238	Vitamin D for COVID-19: a case to answer?
32628248	Practical considerations in prevention and treatment of venous thromboembolism in hospitalized patients with COVID-19
35885517	Hydroxychloroquine and Azithromycin as Treatments for COVID-19
-	Rituximab: a safe therapeutic option during the COVID-19 pandemic? Journal of Dermatological Treatment. 22 de julho de 2020
32683322	Hypercoagulable state in COVID-19 with diabetes mellitus and obesity: Is therapeutic-dose or higher-dose anticoagulant thromboprophylaxis necessary?
32698247	The effect of BCG vaccine in the era of COVID-19 pandemic
35905790	How should we treat pregnant women infected with SARS-CoV-2?
35905562	Anakinra for patients with COVID-19
32647045	Hydroxychloroquine and COVID-19: critiquing the impact of disease public profile on policy and clinical decision-making
32654907	Bacillus Calmette–Guérin vaccine, antimalarial, age and gender relation to COVID-19 spread and mortality
32646469	Angiotensin II treatment in COVID-19 patients: more risk than benefit? A single-center experience
-	Is Hydroxychloroquine a possible post-exposure prophylaxis drug to limit the transmission to health care workers exposed to COVID19?
-	Ivermectin and Novel Coronavirus Disease (COVID-19): Keeping Rigor in Times of Urgency
-	Ivermectin and COVID-19: a report in Antiviral Research, widespread interest, an FDA warning, two letters to the editor and the authors' responses
-	New international guidance on quality, safety and efﬁcacy of DNA vaccines
32632377	COVID-19 and the rush for self-medication and self-dosing with ivermectin: A word of caution
33987331	Rapid advice guidelines for management of children with COVID-19
33316396	No evidence of clinical benefits of early treatment of COVID-19 patients with hydroxychloroquine and azithromycin
35545850	Ivermectin: potential candidate for the treatment of Covid 19
-	BCG is a Good Immunotherapeutic Agent for Viral and Autoimmune Diseases: Is it a New Weapon against Coronavirus (COVID-19)?
-	Does zinc improve symptoms of viral upper respiratory tract infection? Evidence-Based Pract
33818952	Accelerating Development of SARS-CoV-2 Vaccines — The Role for Controlled Human Infection Models
35039009	Ensuring Uptake of Vaccines against SARS-CoV-2
32582439	Can early treatment of patients with risk factors contribute to managing the COVID-19 pandemic?
32601063	Covid-19: Oxford team begins vaccine trials in Brazil and South Africa to determine efficacy
35870803	Adrenal Insufficiency and Glucocorticoid Use During the COVID-19 Pandemic.
32546603	COVID-19 in patients with rheumatological diseases treated with anti-TNF.
35632465	Amplifying RNA Vaccine Development.
34011413	Hydroxychloroquine for covid-19: the end of the line?
35896965	Monoclonal Antibodies for Prevention and Treatment of COVID-19.
35904406	Convalescent Plasma and COVID-19.
35906015	COVID-19 vaccines for all?
34955389	Can existing live vaccines prevent COVID-19?
32505245	COVID-19 vaccine development pipeline gears up.
32759267	Treat 2019 novel coronavirus (COVID-19) with IL-6 inhibitor: Are we already that far?
32462717	COVID-19: Consider IL6 receptor antagonist for the therapy of cytokine storm syndrome in SARS-CoV-2 infected patients.
32451259	Hydroxychloroquine as antiviral prophylaxis for exposed caregivers to Covid-19: An urgent appraisal is needed
-	Dermatologic manifestations of hydroxychloroquine therapy: a closer look at the nails
32313848	Precision Medicine in COVID-19: IL-1β a Potential Target
35874956	SARS-CoV-2 and the Use of Chloroquine as an Antiviral Treatment
35645195	Hydroxychloroquine and azithromycin as potential treatments for COVID-19
21592343	Drug vignettes: Azithromycin
-	A recommendation for the use of chloroquine, hydroxychloroquine, primaquine or tafenoquine for prophylaxis againts the 2019 novel coronavirus (COVD-19) with note to the ophthalmic considerations
35845955	Covid‐19 and drug therapy, what we learned
-	The FDA has authorised remdesivir for use in COVID-19 patients: but there’s no good evidence it reduces mortality
32360697	Metformin in COVID-19: A possible role beyond diabetes
35897341	NSAIDs in patients with viral infections, including Covid-19: Victims or perpetrators?
35505633	Emergency Use Authorization of remdesivir by the US Food and Drug Administration
35187603	Can melatonin reduce the severity of COVID-19 pandemic?
35862378	Headache medication and the COVID-19 pandemic
35644101	COVID-19 therapeutic options for patients with kidney disease
32305501	The Potential Role of Th17 Immune Responses in Coronavirus Immunopathology and Vaccine-induced Immune Enhancement
32233753	Coronavirus Disease 2019 (COVID‐19): Do Angiotensin‐Converting Enzyme Inhibitors/Angiotensin Receptor Blockers Have a Biphasic Effect?
32306288	Chloroquine for SARS-CoV-2: Implications of Its Unique Pharmacokinetic and Safety Properties
35885036	Angiotensin Receptor Blockers and 2019-nCoV
35784344	Challenges of Convalescent Plasma Therapy on COVID-19
-	Response to recent commentaries regarding the involvement of angiotensin-converting enzyme 2 (ACE2) and reninangiotensin system blockers in SARS-CoV-2 infections
32304577	Thromboembolic risk and anticoagulant therapy in COVID-19 patients: Emerging evidence and call for action
-	Inaccurate conclusions by Tang and colleagues
32543708	Generalized pustular figurate erythema: A newly delineated severe cutaneous drug reaction linked with hydroxychloroquine
32267301	Driving forces for COVID-19 clinical trials using chloroquine: the need to choose the right research questions and outcomes
32440985	Switch from oral anticoagulants to parenteral heparin in SARS-CoV-2 hospitalized patients
32295789	Role of immunosuppressive therapy in rheumatic diseases concurrent with covid-19
-	Finding Effective Treatments for COVID-19: Scientific Integrity and Public Confidence in a Time of Crisis
32296994	The double burden of disease of COVID-19 in cardiovascular patients: overlapping conditions could lead to overlapping treatments
32295811	EMA advice on renin-angiotensin system medicines during covid-19 pandemic
32272196	"Any possible role of phosphodiesterase type 5 inhibitors in the treatment of severe COVID19 infections? A lesson from urology"
-	"Reply to ""Anticoagulant treatment is associated with decreased mortality in severe coronavirus disease 2019 patients with coagulopathy"
35905562	Could IL-17 represent a new therapeutic target for the treatment and/or management of COVID-19-related respiratory syndrome?
-	Insights from immuno-oncology: the Society for Immunotherapy of Cancer Statement on access to IL-6-targeting therapies for COVID-19
33157292	Potential of Heparin and Nafamostat Combination Therapy for COVID-19
35758352	Amiodarone as a possible therapy for coronavirus infection
-	Ivermectin as a potential COVID-19 treatment from the pharmacokinetic point of view
35905828	Target Virus or Target Ourselves for COVID-19 Drugs Discovery?-Lessons learned from anti-influenzas virus therapies
32296817	Importance of inclusion of pregnant and breastfeeding women in COVID-19 therapeutic trials
32292529	Highlights of traditional Chinese medicine frontline expert advice in the China national guideline for COVID-19
-	Why tocilizumab could be an efective treatment for severe COVID-19?
35528817	Coronavirus Vaccines: Light at the End of the Tunnel
32296012	Potential benefits of precise corticosteroids therapy for severe 2019-nCoV pneumonia
34584656	Hydroxychloroquine prophylaxis for COVID-19 contacts in India
35903922	Chloroquine or hydroxychloroquine for prophylaxis of COVID-19
32283815	Mesenchymal Stromal Cell Secretome for Severe COVID-19 Infections: Premises for the Therapeutic Use
32304640	Hydroxychloroquine in the management of critically ill patients with COVID-19: the need for an evidence base
-	Is There a Role for Tissue Plasminogen Activator (tPA) as a Novel Treatment for Refractory COVID-19 Associated Acute Respiratory Distress Syndrome (ARDS)?
32922463	Thalidomide against Coronavirus Disease 2019 (COVID-19): A Medicine with a Thousand Faces
33528827	Pharmaceutical are of chloroquine phosphate in elderly patients with coronavirus pneumonia (COVID-19)
35902414	Drug Evaluation during the Covid-19 Pandemic
35906084	Hydroxychloroquine and ivermectin: a synergistic combination for COVID-19 chemoprophylaxis and/or treatment?
35894360	Chloroquine and hydroxychloroquine in covid-19.
35359967	Type 1 interferons as a potential treatment against COVID-19
33984571	Recommendations for coronavirus infection in rheumatic diseases treated with biologic therapy
35462191	Therapeutic Potential for Tetracyclines in the Treatment of COVID-19
33482680	Considerations for statin therapy in patients with COVID-19
32278373	Regulators split on antimalarials for COVID-19
35891289	SARS-CoV-2 Vaccines: Status Report
32302703	Considerations for Drug Interactions on QTc in Exploratory COVID-19 (Coronavirus Disease 2019) Treatment
32255489	Towards Optimization of Hydroxychloroquine Dosing in Intensive Care Unit COVID-19 Patients
-	Comunicado a la opinión pública uso de Hidroxicloroquina / Public opinion on the use of Hydroxychloroquine
32249257	Macrolide treatment for COVID-19: Will this be the way forward?
32239799	The versatile heparin in COVID-19. Journal of thrombosis and haemostasis
33361100	Early use of nitazoxanide in mild Covid-19 disease: randomised, placebo-controlled trial.
35891421	Transfusion reactions associated with COVID-19 convalescent plasma therapy for SARS-CoV-2.
33446136	Hydroxychloroquine in the treatment of outpatients with mildly symptomatic COVID-19: a multi-center observational study.
-	Corticosteroid treatment has no efect on hospital mortality in COVID‐19 patients.
33440088	Interim Results of a Phase 1–2a Trial of Ad26.COV2.S Covid-19 Vaccine.
35287602	The use of methylprednisolone in COVID-19 patients: A propensity score matched retrospective cohort study.
33434674	Efficacy Evaluation of Intravenous Immunoglobulin in Non-severe Patients with COVID-19: A Retrospective Cohort Study Based on Propensity Score Matching.
33374333	Convalescent Plasma Transfusion for the Treatment of COVID-19—Experience from Poland: A Multicenter Study.
33416918	Impact of oral anticoagulation on clinical outcomes of COVID‐19: a nationwide cohort study of hospitalized patients in Germany.
35726121	Cardiovascular Comorbidities and Pharmacological Treatments of COVID-19 Patients Not Requiring Hospitalization.
35531306	Matched cohort study on the efficacy of tocilizumab in patients with COVID-19.
34625144	Therapeutic plasma exchange for coronavirus disease-2019 triggered cytokine release syndrome
33078604	A single center cohort of 40 severe COVID-19 patients who were treated with convalescent plasma.
35598856	Remdesivir for the treatment of COVID-19: A systematic review and meta-analysis of randomized controlled trials.
33393643	Clinical outcome, viral response and safety profile of chloroquine in COVID-19 patients—initial experience.
33391531	Treatment of severe acute respiratory syndrome (SARS), Middle East respiratory syndrome (MERS), and coronavirus disease 2019 (COVID-19): a systematic review of in vitro, in vivo, and clinical trials.
35727348	Early corticosteroids are associated with lower mortality in critically ill patients with COVID-19: a cohort study.
35773886	The Role of Vitamin C as Adjuvant Therapy in COVID-19.
33422263	Continuation versus discontinuation of renin–angiotensin system inhibitors in patients admitted to hospital with COVID-19: a prospective, randomised, open-label trial.
33412395	Combination therapy of IFNβ1 with lopinavir–ritonavir, increases oxygenation, survival and discharging of sever COVID-19 infected inpatients.
33356606	Association of ACEI/ARB, inflammatory cytokines, and antiviral drugs with liver dysfunction in patients with hypertension and COVID-19.
34407339	Early High-Titer Plasma Therapy to Prevent Severe Covid-19 in Older Adults.
34227081	Umbilical cord mesenchymal stem cells for COVID-19 acute respiratory distress syndrome: A double-blind, phase 1/2a, randomized controlled trial.
33402839	Systematic Review on the Therapeutic Options for COVID-19: Clinical Evidence of Drug Efficacy and Implications.
33402859	Early Experience With Methylprednisolone on SARS-CoV-2 Infection in the African American Population, a Retrospective Analysis.
33402523	Beneficial Effects of Intermediate Dosage of Anticoagulation Treatment on the Prognosis of Hospitalized COVID-19 Patients: The ETHRA Study.
32623470	Long-term ACE Inhibitor/ARB Use Is Associated With Severe Renal Dysfunction and Acute Kidney Injury in Patients With Severe COVID-19: Results From a Referral Center Cohort in the Northeast of France.
-	Efectividad de los glucocorticoides en pacientes hospitalizados por neumonía grave por SARS-CoV-2.
33390341	Impact of prior statin use on clinical outcomes in COVID-19 patients: data from tertiary referral hospitals during COVID-19 pandemic in Italy.
35793346	Low vitamin D status is associated with coronavirus disease 2019 outcomes: A systematic review and meta-analysis
35898377	Association of metformin with mortality or ARDS in patients with COVID-19 and type 2 diabetes: a retrospective cohort study.
35784292	Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine.
33392485	Safety and immunogenicity of INO-4800 DNA vaccine against SARS-CoV-2: A preliminary report of an open-label, Phase 1 clinical trial.
34568488	Statins and clinical outcomes with COVID-19: Meta-analyses of observational studies.
33388006	Clinical outcomes after early ambulatory multidrug therapy for high-risk SARS-CoV-2 (COVID-19) infection.
33647553	Comparing ICU Admission Rates of Mild/Moderate COVID-19 Patients Treated with Hydroxychloroquine, Favipiravir, and Hydroxychloroquine plus Favipiravir.
34600589	Tocilizumab in the Management of COVID-19: A Preliminary Report.
34557260	No clinical benefit in mortality associated with hydroxychloroquine treatment in patients with COVID-19.
-	Risk Factors Associated With In-Hospital Mortality in a US National Sample of Patients With COVID-19.
34084113	Safety and Efficacy of Convalescent Plasma for Severe COVID‐19: Interim Report of a Multicenter Phase II Study from Saudi Arabia.
35816896	Effects of Tocilizumab in COVID-19 patients: a cohort study.
35899636	A Neutralizing Monoclonal Antibody for Hospitalized Patients with Covid-19.
33354849	Tetracyclines in COVID-19 patients quarantined at home: Literature evidence supporting Real-World Data from a Multicenter Observational Study Targeting Inflammatory & Infectious Dermatoses.
33354678	Effects of Inhaled Epoprostenol and Prone Positioning in Intubated Coronavirus Disease 2019 Patients With Refractory Hypoxemia.
33342929	Efficacy of early hydroxychloroquine treatment in preventing COVID-19 pneumonia aggravation, the experience from Shanghai
-	Early Clinical Outcomes with Tocilizumab for Severe Covid-19: A Two-Center Retrospective Study.
33063447	QTc prolongation among hydroxychloroquine sulphate-treated COVID-19 patients: An observational study.
33344594	Effect of methylprednisolone in severe and critical COVID-19: Analysis of 102 cases.
35630429	Corticosteroid therapy in critically ill patients with COVID‑19: a multicenter, retrospective study.
35624081	Renin-angiotensin system blockers, risk of SARS-CoV-2 infection and outcomes from CoViD-19: systematic review and meta-analysis.
35892438	A systematic review and meta‑analysis on chloroquine and hydroxychloroquine as monotherapy or combined with azithromycin in COVID‑19 treatment
33338232	Sofosbuvir and daclatasvir for the treatment of COVID-19 outpatients: a double-blind, randomized controlled trial.
35631607	Convalescent plasma may be a possible treatment for COVID-19: A systematic review.
33332778	REGN-COV2, a Neutralizing Antibody Cocktail, in Outpatients with Covid-19.
33333252	Tocilizumab in the Treatment of Critical COVID-19 Pneumonia: A Retrospective Cohort Study of Mechanically Ventilated Patients.
33330530	Thromboprofilaxys With Fondaparinux vs. Enoxaparin in Hospitalized COVID-19 Patients: A Multicenter Italian Observational Study.
33326457	Glucocorticoids with low-dose anti-IL1 anakinra rescue in severe non-ICU COVID-19 infection: A cohort study.
32407459	Risk Factors for Severe Disease and Efficacy of Treatment in Patients Infected With COVID-19: A Systematic Review, Meta-Analysis, and Meta-Regression Analysis.
33323550	Safety and efficacy of convalescent plasma therapy in severely and critically ill patients with COVID-19: A systematic review with meta-analysis.
-	Low 25-Hydroxyvitamin D Levels on Admission to the Intensive Care Unit May Predispose COVID-19 Pneumonia Patients to a Higher 28-Day Mortality Risk: A Pilot Study on a Greek ICU Cohort.
33318314	Coagulation dysfunction in ICU patients with coronavirus disease 2019 in Wuhan, China: A retrospective observational study of 75 fatal cases.
-	Study of the Efficacy and Safety of Topical Ivermectin + Iota-Carrageenan in the Prophylaxis against COVID-19 in Health Personnel.
33289973	Hydroxychloroquine as Postexposure Prophylaxis to Prevent Severe Acute Respiratory Syndrome Coronavirus 2 Infection. A Randomized Trial.
34020215	Effect of Arbidol (Umifenovir) on COVID-19: a randomized controlled trial.
35321649	Impact of renin–angiotensin system inhibitors use on mortality in severe COVID-19 patients with hypertension: a retrospective observational study.
-	Efficacy and safety of transfusing plasma from COVID-19 survivors to COVID-19 victims with severe illness. A double-blinded controlled preliminary study.
33084232	A systematic review and meta-analysis of the use of renin-angiotensin system drugs and COVID-19 clinical outcomes: What is the evidence so far?
-	Ivermectin as Pre-exposure Prophylaxis for COVID-19 among Healthcare Providers in a Selected Tertiary Hospital in Dhaka – An Observational Study.
-	Ivermectin use associated with reduced duration of COVID-19 febrile illness in a community setting.
-	Celebrex Adjuvant Therapy on Coronavirus Disease 2019: An Experimental Study.
33317261	COVID-19 and Acute Respiratory Distress Syndrome. Impact of corticosteroid treatment and predictors of poor outcome.
-	Blockage of interleukin‑1β with canakinumab in patients ith Covid‑19.
34979235	Corticosteroid use in COVID‑19 patients: a systematic review and meta‑analysis on clinical outcomes.
35904437	Angiotensin-Converting Enzyme Inhibitors or Angiotensin Receptor Blockers Use and COVID-19 Infection Among 824,650 Patients with Hypertension from a US integrated Healthcare System.
33307734	Therapeutic dosing of low-molecular-weight heparin may decrease mortality in patients with severe COVID-19 infection.
-	Incidencia de la COVID-19 en pacientes en tratamiento crónico con hidroxicloroquina
33310766	Inactivated trivalent influenza vaccination is associated with lower mortality among patients with COVID-19 in Brazil.
33316235	Corticosteroid therapy is associated with improved outcome in critically ill COVID-19 patients with hyperinflammatory phenotype.
-	Effect of hydroxychloroquine, azithromycin and lopinavir/ritonavir on the QT corrected interval in patients with COVID-19.
33298897	Antihypertensive drugs are associated with reduced fatal outcomes and improved clinical characteristics in elderly COVID-19 patients.
-	Sars-Cov-2 Associated Coagulopathy and Thromboembolism Prophylaxis in Children: a Single Centre Observational Study.
33348222	Safety and efficacy of hydroxychloroquine in 152 outpatients with confirmed COVID-19: A pilot observational study.
34760747	The Role of Hydroxychloroquine in COVID-19 Treatment: A Systematic Review and Meta-Analysis.
33283773	Systematic review and meta-analysis of effectiveness and safety of favipiravir in the management of novel coronavirus (COVID-19) patients.
33322317	High-Dose Cholecalciferol Booster Therapy is Associated with a Reduced Risk of Mortality in Patients with COVID-19: A Cross-Sectional Multi-Centre Observational Study.
35443520	Baricitinib plus Remdesivir for Hospitalized Adults with Covid-19.
33316402	Effect of hydroxychloroquine pre-exposure on infection with SARS-CoV-2 in rheumatic disease patients: A population-based cohort study
-	Evaluating the Efficacy and Safety of the Existing Repurposed Pharmacological Agents for Treating COVID-19: A Meta-analysis and Systemic Review of Clinical Trials.
-	First Report of Tocilizumab Use in a Cohort of Latin American Patients Hospitalized for Severe COVID-19 Pneumonia.
33301514	Efficacy and harms of remdesivir for the treatment of COVID-19: A systematic review and meta-analysis.
-	Corticosteroids in patients hospitalised for COVID-19 pneumonia who require oxygen: observational comparative study using routine care data.
35153098	Association between seasonal flu vaccination and COVID-19 among healthcare workers.
35583911	Anakinra treatment in critically ill COVID‑19 patients: a prospective cohort study.
35888056	Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine.
35088108	Repurposed Tocilizumab in Patients with Severe COVID-19.
33298370	Corticosteroids for Patients With Coronavirus Disease 2019 (COVID-19) With Different Disease Severity: A meta-Analysis of Randomized Clinical Trials.
33296027	Effect of early oseltamivir on outpatients without hypoxia with suspected COVID-19.
35680347	Efficacy and safety of hydroxychloroquine in healthcare professionals with mild SARS-CoV-2 infection: prospective, non-randomized trial.
33275094	Mortality in tocilizumab-treated patients with COVID-19: a systematic review and meta-analysis.
35841979	The dual role of anti-viral therapy in the treatment of Coronavirus disease 2019.
33291194	Investigation of QT Prolongation with Hydroxychloroquine and Azithromycin for the Treatment of COVID‐19.
33497876	Severe COVID-19 pneumonia in Piacenza, Italy – a cohort study of the first pandemic wave.
33330541	Association of Statin Use With the In-Hospital Outcomes of 2019-Coronavirus Disease Patients: A Retrospective Study.
33646835	Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK.
32954492	The role of methylprednisolone on preventing disease progression for hospitalized patients with severe COVID-19.
33621948	COVID-19 Convalescent Plasma Treatment of Moderate and Severe Cases of SARS-CoV-2 Infection: A Multicenter Interventional Study.
33278747	Pentoxifylline decreases serum LDH levels and increases lymphocyte count in COVID-19 patients: Results from an external pilot study.
35400159	Association between statin use and outcomes in patients with coronavirus disease 2019 (COVID-19): a nationwide cohort study.
33278503	Low-dose Whole-lung Irradiation for COVID-19 Pneumonia: Final Results of a Pilot Study.
33276252	Association of inhaled and systemic corticosteroid use with Coronavirus Disease 2019 (COVID-19) test positivity in patients with chronic pulmonary diseases.
35905935	Viral clearance after early corticosteroid treatment in patients with moderate or severe covid‑19.
33282889	Increasing Age, the Existence of Comorbidities, and Corticosteroid Treatment in Combination With Antiviral Therapy Prolongs the Recovery of SARS-COV-2-Infected Patients, Measured as the Conversion From Positive to Negative rtPCR: A 239 Patients’ Retrospective Study.
33784966	Hydroxychloroquine/Azithromycin treatment, QT interval and ventricular arrhythmias in hospitalized patients with COVID‐19.
-	Adjunctive favipiravir for severe COVID-19: a retrospective observational study of the first 41 patients in Thailand.
-	An open-label, randomized trial of the combination of IFN-k plus TFF2 with standard care in the treatment of patients with moderate COVID-19.
33274479	Cyclosporine A plus low‐dose steroid treatment in COVID‐19 improves clinical outcomes in patients with moderate to severe disease. A pilot study.
33262415	A systematic review of corticosteroid treatment for noncritically ill patients with COVID‑19.
35680172	Metformin and risk of mortality in patients hospitalised with COVID-19: a retrospective cohort analysis.
-	Synergistic Effect of Quercetin and Vitamin C Against COVID-19: Is A Possible Guard for Front liners?
33259916	Hydroxychloroquine lung pharmacokinetics in critically ill patients infected with COVID-19.
33264276	A Retrospective Study on the Effects of Convalescent Plasma Therapy in 24 Patients Diagnosed with COVID-19 Pneumonia in February and March 2020 at 2 Centers in Wuhan, China.
34803159	INFLUENCE OF TOCILIZUMAB ON THE OUTCOME OF PATIENTS WITH COVID-19. RETROSPECTIVE OBSERVATIONAL STUDY.
33200081	Preventive Efficacy of Tenofovir/Emtricitabine Against Severe Acute Respiratory Syndrome Coronavirus 2 Among Pre-Exposure Prophylaxis Users.
33278625	A five day course of ivermectin for the treatment of COVID-19 may reduce the duration of illness.
35895276	Efficacy of Remdesivir in Covid-19 Patients
-	Association between renin-angiotensin-aldosterone system inhibitor use and covid-19 hospitalization and death: a 1,4 million patient nation-wide registry analysis.
35695334	Systematic review on current antiviral therapy in COVID-19 pandemic.
33251016	Assessment of schistosomiasis endemicity and preventive treatment on coronavirus disease 2019 outcomes in Africa.
33259913	A COVID-19 Prophylaxis? Lower incidence associated with prophylactic administration of Ivermectin.
33252992	Rapid review of suspected adverse drug events due to remdesivir in the WHO database
35620541	Treatment of COVID-19 patients with the anti-CD6 antibody itolizumab.
33217362	Safety, tolerability, and immunogenicity of an inactivated SARS-CoV-2 vaccine in healthy adults aged 18–59 years: a randomised, double-blind, placebo-controlled, phase 1/2 clinical trial.
35839363	Insulin Treatment Is Associated with Increased Mortality in Patients with COVID-19 and Type 2 Diabetes.
33250495	Comparison of clinical and laboratory features and treatment options of 237 symptomatic and asymptomatic children infected with SARS-CoV-2 in the early phase of the COVID-19 pandemic in Turkey.
-	Tocilizumab and COVID-19: A Meta-Analysis of 2120 Patients with Severe Disease 1 and Implications for Clinical Trial Methodologies.
33256382	Mortality reduction in 46 patients with severe COVID-19 treated with hyperimmune plasma. A proof-of-concept, single-arm, multicenter trial.
34889863	Renin-angiotensin system antagonists are associated with lower mortality in hypertensive patients with COVID-19.
34613881	A Case–Control Study of the 2019 Influenza Vaccine and Incidence of COVID-19 Among Healthcare Workers.
33251522	Predictors of Mortality and Effect of Drug Therapies in Mechanically Ventilated Patients With Coronavirus Disease 2019: A Multicenter Cohort Study.
32702098	Continued In-Hospital Angiotensin-Converting Enzyme Inhibitor and Angiotensin II Receptor Blocker Use in Hypertensive COVID-19 Patients Is Associated With Positive Clinical Outcome.
33241872	Tocilizumab administration is associated with reduction in biomarkers of coronavirus disease 2019 (COVID-19) infection.
33238596	Soluble Receptor for Advanced Glycation End Products and Its Forms in COVID-19 Patients with and without Diabetes Mellitus: A Pilot Study on Their Role as Disease Biomarkers.
35219601	Corticosteroids treatment in severe patients with COVID-19: a propensity score matching study.
35893672	The effectiveness of early anticoagulant treatment in Covid-19 patients.
33247380	Do Zinc Supplements Enhance the Clinical Efficacy of Hydroxychloroquine?: a Randomized, Multicenter Trial
33244512	Safety and Efficacy of Apixaban For Therapeutic Anticoagulation in Critically Ill ICU Patients with Severe COVID-19 Respiratory Disease.
33236114	Serum 25(OH)D Level on Hospital Admission Associated With COVID-19 Stage and Mortality.
34740598	Effects of Recent Use of Renin-Angiotensin System Inhibitors on Mortality of Patients With Coronavirus Disease 2019.
33235888	Antivirals With Adjunctive Corticosteroids Prevent Clinical Progression of Early Coronavirus 2019 Pneumonia: A Retrospective Cohort Study.
33231487	Association of Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Blockers With Severity of COVID-19: A Multicenter, Prospective Study.
-	Prescribing practices of lopinavir/ritonavir, hydroxychloroquine and azithromycin during the COVID-19 epidemic crisis and pharmaceutical interventions in a French teaching hospital.
35404846	Treatment of SARS-cov-2 pneumonia with favipiravir: Early results from the Ege University cohort, Turkey.
35761219	A Randomized Trial of Convalescent Plasma in Covid-19 Severe Pneumonia.
34661247	Evidence for treatment with estradiol for women with SARS-CoV-2 infection.
33624299	A Cluster-Randomized Trial of Hydroxychloroquine for Prevention of Covid-19.
-	The effect of anticoagulation on clinical outcomes in novel Coronavirus (COVID-19) pneumonia in a U.S. cohort.
33232277	Estimating the release of inflammatory factors and use of glucocorticoid therapy for COVID-19 patients with comorbidities.
-	Efficacy of therapeutic plasma exchange in the treatment of penn class 3 and 4 cytokine release syndrome complicating COVID-19.
33231925	Assessment of COVID-19 Treatment containing both Hydroxychloroquine and Azithromycin: A Natural Clinical Trial.
33225306	Intravenous Immunoglobulin Plus Methylprednisolone Mitigate Respiratory Morbidity in Coronavirus Disease 2019
33227231	Therapeutic potential of ivermectin as add-on treatment in COVID 19: A systematic review and meta-analysis.
35502801	A Propensity-Matched Cohort Study of Tocilizumab in Patients With Coronavirus Disease 2019.
33186991	Anticoagulation in COVID-19: Effect of Enoxaparin, Heparin, and Apixaban on Mortality
-	linical Characteristics and Outcomes of 905 COVID-19 Patients Admitted to Imam Khomeini Hospital Complex in the Capital City of Tehran, Iran.
32965359	The effects of favipiravir on hematological parameters of covıd-19 patients.
33216906	The effect of IL-6 inhibitors on mortality among hospitalized COVID-19 patients: a multicenter study.
35894609	Renin–angiotensin system inhibitors and mortality in patients with COVID‐19.
33219551	High-Dose Methylprednisolone in Nonintubated Patients with Severe COVID-19 Pneumonia.
35874909	Randomized double-blinded placebo-controlled trial of hydroxychloroquine with or without azithromycin for virologic cure of non-severe Covid-19.
35885517	Safety of hydroxychloroquine and darunavir or lopinavir in COVID-19 infection.
33219294	Adverse impact of renin–angiotensin system blockade on the clinical course in hospitalized patients with severe COVID‐19: a retrospective cohort study.
33217033	"Comparison of Infection Risks and Clinical Outcomes in Patients with and without SARS-CoV-2 Lung Infection under Renin-Angiotensin-Aldosterone-System Blockade - Systematic Review and Meta-Analysis."
33613703	Non-steroidal anti-inflammatory drugs and susceptibility to COVID-19.
33187772	Vitamin D 25OH deficiency in COVID-19 patients admitted to a tertiary referral hospital.
33400157	Anakinra combined with methylprednisolone in patients with severe COVID-19 pneumonia and hyperinflammation: an observational cohort study.
33210547	Risk factors of mortality and contribution of treatment in patients infected with COVID-19: a retrospective propensity score matched study.
33211672	BCG vaccination history associates with decreased SARS-CoV-2 seroprevalence across a diverse cohort of healthcare workers.
33753759	Role of low-molecular weight heparin in hospitalized patients with SARS-CoV-2 pneumonia: a prospective observational study.
35551297	Lack of efficacy of standard doses of ivermectin in severe COVID-19 patients
33208294	The effect of thymosin α1 on mortality of critical COVID-19 patients: A multicenter retrospective study.
33292350	An anti-CD6 monoclonal antibody (itolizumab) reduces circulating IL-6 in severe COVID-19 elderly patients.
33209988	Comparative analysis between the use of renin–angiotensin system antagonists and clinical outcomes of hospitalized patients with COVID-19 respiratory infection.
-	Safety and immunogenicity of ChAdOx1 nCoV-19 vaccine administered in a prime-boost regimen in young and old adults(COV002): a single-blind, randomised, controlled, phase 2/3 trial.
35845297	Remdesivir Use in Patients Requiring Mechanical Ventilation due to COVID-19.
33205469	Safety and feasibility of umbilical cord mesenchymal stem cells in patients with COVID-19 pneumonia: A pilot study.
33217362	Safety, tolerability, and immunogenicity of an inactivated SARS-CoV-2 vaccine in healthy adults aged 18–59 years
33601033	Efficacy and Safety of Favipiravir, an Oral RNA-Dependent RNA Polymerase Inhibitor, in Mild-to-Moderate COVID-19: A Randomized, Comparative, Open-Label, Multicenter, Phase 3 Clinical Trial.
33204210	Chloroquine, hydroxychloroquine, and COVID-19: systematic review and narrative synthesis of efficacy and safety.
33191600	Renin–angiotensin system inhibition and risk of infection and mortality in COVID-19: a systematic review and meta-analysis.
33195334	IL-6 Inhibition in Critically Ill COVID-19 Patients Is Associated With Increased Secondary Infections.
34837230	Efficacy and safety of lopinavir/ritonavir in the treatment of COVID-19: A systematic review.
33200828	Tocilizumab in hospitalized patients with COVID-19: Clinical outcomes, inflammatory marker kinetics, and safety.
35443522	Comparison of efficacy of dexamethasone and methylprednisolone in moderate to severe covid 19 disease.
33185785	Low molecular weight heparin in COVID-19 patients prevents delirium and shortens hospitalization.
35775296	Clinical characteristics and fatal outcomes of hypertension in patients with severe COVID-19.
33415131	Comorbidities, Cardiovascular Therapies, and COVID-19 Mortality: A Nationwide, Italian Observational Study (ItaliCO).
33190637	Mortality and other adverse outcomes in patients with type 2 diabetes mellitus admitted for COVID-19 in association with glucose-lowering drugs: a nationwide cohort study.
32907890	Elevated D-dimers and lack of anticoagulation predict PE in severe COVID-19 patients.
33194450	The efficacy of IL-6 inhibitor Tocilizumab in reducing severe COVID-19 mortality: a systematic review.
34534511	A randomized clinical trial of the efficacy and safety of interferon β-1a in treatment of severe COVID-19.
33189888	Effectiveness and safety of intravenous tocilizumab to treat COVID-19-associated hyperinflammatory syndrome: Covizumab-6 observational cohort.
35577631	Randomized, double-blinded and placebo-controlled phase II trial of an inactivated SARS-CoV-2 vaccine in healthy adults.
35905032	Prophylactic or therapeutic doses of heparins for COVID‐19 infection? A retrospective study.
33217576	Anakinra in hospitalized patients with severe COVID-19 pneumonia requiring oxygen therapy: results of a prospective, open-label, interventional study.
33214093	Evaluating the effects of Intravenous Immunoglobulin (IVIg) on the management of severe COVID-19 cases: A randomized controlled trial.
-	Utility of Ivermectin and Doxycycline combination for the treatment of SARS- CoV-2.
-	Prevalence of Diabetes, Management and Outcomes among Covid-19 Adult Patients Admitted in a Specialized Tertiary Hospital in Riyadh
33188624	Tocilizumab for Severe Worsening COVID-19 Pneumonia: a Propensity Score Analysis.
33184146	Short term, high-dose vitamin D supplementation for COVID-19 disease: a randomised, placebo-controlled, study (SHADE study).
33165755	Mortality risk assessment in Spain and Italy, insights of the HOPE COVID‐19 registry.
33704501	Vitamin D Deficiency Is Inversely Associated with COVID-19 Incidence and Disease Severity in Chinese People.
-	Safety and efficacy of Artemisinin-Piperaquine for treatment of COVID-19: an open-label, non-randomized, and controlled trial.
-	Comparison between Prophylactic versus Therapeutic Doses of Low-Molecular-Weight Heparin in Severely Ill Coronavirus Disease 2019 Patients in Relation to Disease Progression and Outcome.
33016549	Letter: severe COVID‐19 infection and biologic therapies—a cohort study of 7808 patients in France.
33153629	GM-CSF Neutralization With Lenzilumab in Severe COVID-19 Pneumonia: A Case-Control Study, Mayo Clinic Proceedings
33045398	Clinical characteristics in 545 patients with severe asthma on biological treatment during the COVID-19 outbreak.
-	Cloroquina y sus derivados en el manejo de la COVID-19: una revisión sistemática exploratoria
33117850	Remdesivir Use Compared With Supportive Care in Hospitalized Patients With Severe COVID-19: A Single-Center Experience
-	The efect of tocilizumab on cytokine release syndrome in COVID‐19 patients.
33181454	The effect of favipiravir on QTc interval in patients hospitalized with coronavirus disease 2019.
33181328	Randomized Controlled Open Label Trial on the Use of Favipiravir Combined with Inhaled Interferon beta-1b in Hospitalized Patients with Moderate to Severe COVID-19 Pneumonia.
33180097	Fluvoxamine vs Placebo and Clinical Deterioration in Outpatients With Symptomatic COVID-19 A Randomized Clinical Trial.
33169088	Tocilizumab in the treatment of rapidly evolving COVID-19 pneumonia and multifaceted critical illness: A retrospective case series.
33189161	Safety and efficacy of inhaled nebulised interferon beta-1a (SNG001) for treatment of SARS-CoV-2 infection: a randomised, double-blind, placebo-controlled, phase 2 trial.
33168337	Lack of association of antihypertensive drugs with the risk and severity of COVID-19: A meta-analysis.
33172477	Corticosteroid therapy for coronavirus disease 2019‑related acute respiratory distress syndrome: a cohort study with propensity score analysis.
33173853	Eculizumab as an emergency treatment for adult patients with severe COVID-19 in the intensive care unit: A proof-of-concept study.
32965360	Impact of antihypertensive agents on clinical course and in-hospital mortality: analysis of 169 hypertensive patients hospitalized for COVID-19.
33849612	CXCL10 could drive longer duration of mechanical ventilation during COVID-19 ARDS.
-	Significantly decreased mortality in a large cohort of COVID-19 patients transfused early with convalescent plasma containing high titer anti-SARS-CoV-2 spike protein IgG.
-	Hydroxychloroquine as pre-exposure prophylaxis against COVID-19 in health-care workers: A single-center experience.
33163696	Is BCG associated with reduced incidence of COVID-19? A meta-regression of global data from 160 countries.
33157287	Therapeutic Plasma Exchange followed by Convalescent Plasma transfusion in critical COVID-19- an exploratory study.
35692410	Is there an association between metformin use and clinical outcomes in diabetes patients with COVID-19?
33162299	Interleukin-6 receptor blockade with subcutaneous tocilizumab improves coagulation activity in patients with COVID-19.
33154498	Cardiac adverse events associated with chloroquine and hydroxychloroquine exposure in 20 years of drug safety surveillance reports.
34975139	Therapeutic Management of Coronavirus Disease 2019 (COVID-19): A Systematic Review and Treatment Algorithm.
-	Positive association between COVID-19 deaths and influenza vaccination rates in elderly people worldwide.
35745684	The Cardiac Toxicity of Chloroquine or Hydroxychloroquine in COVID-19 Patients: A Systematic Review and Meta-regression Analysis.
33121991	Remdesivir: A potential game-changer or just a myth? A systematic review and meta-analysis.
34199134	Effect of Hydroxychloroquine on Clinical Status at 14 Days in Hospitalized Patients With COVID-19.
-	QTc interval prolongation and life-threatening arrhythmias during hospitalization in patients with COVID-19. Results from a multi-center prospective registry.
33161002	Pulmonary vascular improvement in severe COVID-19 patients treated with tocilizumab.
-	Asociación entre el tratamiento esteroideo a dosis alta, la función respiratoria y el tiempo hasta el alta en pacientes con COVID-19: Estudio de cohortes.
33121070	The Association between Influenza Vaccination and the Risk of SARS-CoV-2 Infection, Severe Illness, and Death: A Systematic Review of the Literature.
33772933	Frequency of Long QT in Patients with SARS-CoV-2 Infection Treated with Hydroxychloroquine: A Meta-analysis.
33992168	Tocilizumab Use in COVID-19 Cytokine-release Syndrome: Retrospective Study of Two Centers.
33111329	Outcome of patients hospitalized for COVID-19 and exposure to angiotensin-converting enzyme inhibitors and angiotensin-receptor blockers in France: results of the ACE-CoV study.
32965364	Investigation of the frequency of COVID-19 in patients treated with intravesical BCG.
33790785	Impact of Hydroxychloroquine on Mortality in Hospitalized Patients with COVID-19: Systematic Review and Meta-Analysis.
35891168	Protection against SARS‐CoV‐2 by BCG vaccination is not supported by epidemiological analyses
33138935	COVID-19 In-Hospital Mortality and Use of Renin-Angiotensin System Blockers in Geriatrics Patients.
35511939	Ibuprofen and NSAID Use in COVID-19 Infected Patients Is Not Associated with Worse Outcomes:  Prospective Cohort Study.
35143744	Outcomes of COVID-19 Hospitalized Patients Previously Treated with Renin-Angiotensin System Inhibitors.
33166179	Hydroxychloroquine vs. Azithromycin for Hospitalized Patients with COVID-19 (HAHPS): Results of a Randomized, Active Comparator Trial.
35755851	Tocilizumab use in patients with moderate to severe COVID-19: A retrospective cohort study
33758946	Efficacy and safety of remdesivir in hospitalized Covid‐19 patients: Systematic review and meta‐analysis including network meta‐analysis
-	Clinical predictors of donor antibody titer and correlation with recipient antibody response in a COVID-19 convalescent plasma clinical trial
33534080	Blood ozonization in patients with mild to moderate COVID‑19 pneumonia: a single centre experience
33123774	Possible association of vitamin D status with lung involvement and outcome in patients with COVID-19: a retrospective study
33232684	Metformin is associated with Decreased 30-day Mortality among Nursing Home Residents Infected with SARS-CoV2
33132915	Effect of Triple Combination Therapy With Lopinavir-Ritonavir, Azithromycin, and Hydroxychloroquine on QT Interval and Arrhythmic Risk in Hospitalized COVID-19 Patients
33111169	No benefit of hydroxychloroquine on SARS-CoV-2 viral load reduction in non-critical hospitalized patients with COVID-19
34956474	Phase 3 Trial of Coronavir (Favipiravir) in Patients with Mild to Moderate COVID-19
-	Effect of Statin Therapy on SARS-CoV-2 Infection-Related Mortality in Hospitalized Patients
-	Statin Use and In-Hospital Mortality in Diabetics with COVID-19
-	Zinc and vitamin A deficiency predisposes to the need for intubation and ICU admission in patients with COVID-19. An observational study
33114246	Inhaled Corticosteroids and COVID-19 Risk and Mortality: A Nationwide Cohort Study
35606884	Impact of Corticosteroids in COVID-19 Outcomes: Systematic Review and Meta-Analysis
35899637	Corticosteroid treatment in severe COVID-19 patients with acute respiratory distress syndrome
-	A Case Control Study to Evaluate the Impact of Colchicine on Patients Admitted to the Hospital with Moderate to Severe COVID-19 Infection
33138935	COVID-19 In-Hospital Mortality and Use of Renin-Angiotensin System Blockers in Geriatrics Patients
-	Influenza Vaccination and Risk of SARS-CoV-2 Infection in a Cohort of HealthWorkers
33322317	VITAMIN D TREATMENT IS ASSOCIATED WITH REDUCED RISK OF MORTALITY IN PATIENTS WITH COVID-19: A CROSS-SECTIONAL MULTI-CENTRE OBSERVATIONAL STUDY
-	Seroprevalence of COVID-19 amongst health care workers in a tertiary care hospital of a metropolitan city from India
34674735	Tocilizumab for patients with COVID-19 pneumonia. The single-arm TOCIVID-19 prospective trial
35859991	The Use of Therapeutic-Dose Anticoagulation and Its Effect on Mortality in Patients With COVID-19: A Systematic Review
33704468	Sofosbuvir/daclatasvir regimens for the treatment of COVID-19: an individual patient data meta-analysis
33111980	OZONE AS ADJUVANT SUPPORT IN THE TREATMENT OF COVID-19: A PRELIMINARY REPORT OF PROBIOZOVID TRIAL
33127507	Comparison of antiviral effect for mild-to-moderate COVID-19 cases between lopinavir/ritonavir versus hydroxychloroquine: A nationwide propensity score-matched cohort study
33090501	Comparative Effectiveness of Lopinavir/Ritonavir-Based Regimens in COVID-19
33079180	Clinical Characteristics and Outcomes of COVID-19 Patients Receiving Compassionate Use Leronlimab
33079200	The Effect of Prior ACEI/ARB Treatment on COVID-19 Susceptibility and Outcome: A Systematic Review and Meta-Analysis
33095513	The Use of Renin–Angiotensin–Aldosterone System (RAAS) Inhibitors is Associated with a Lower Risk of Mortality in Hypertensive COVID-19 Patients: A Systematic Review and Meta-analysis
33137493	Risk of Hospitalization for Covid-19 Outpatients Treated with Various Drug Regimens in Brazil: Comparative Analysis
33122096	COVID-19 outpatients – early risk-stratified treatment with zinc plus low dose hydroxychloroquine and azithromycin a retrospective case series study
33003964	Safely Administering Potential QTc Prolonging Therapy Across a Large Healthcare System in the COVID-19 Era
35488828	Corticosteroids on the Management of Coronavirus Disease 2019 (COVID-19): A Systemic Review and Meta-Analysis
33103063	Corticosteroids in COVID-19: Is it Rational? A Systematic Review and Meta-Analysis.
-	Corticosteroids for COVID-19 patients requiring oxygen support? Yes, but not for everyone: Effect of corticosteroids on mortality and Intensive Care Unit admission in patients with COVID-19 according to patients' oxygen requirements.
33093359	Aspirin Use is Associated with Decreased Mechanical Ventilation, ICU Admission, and In-Hospital Mortality in Hospitalized Patients with COVID-19
35727429	SARS-CoV-2 Neutralizing Antibody LY-CoV555 in Outpatients with Covid-19
34364979	Vitamin D and survival in COVID-19 patients: A quasi-experimental study
33078138	Clinical characteristics and outcomes among hospitalized adults with severe COVID-19 admitted to a tertiary medical center and receiving antiviral, antimalarials, glucocorticoids, or immunomodulation with tocilizumab or cyclosporine: A retrospective observational study (COQUIMA cohort)
33035673	Beneficial Effect of Corticosteroids in Preventing Mortality in Patients Receiving Tocilizumab to Treat Severe COVID-19 Illness
35100583	Effect of Tocilizumab in Hospitalized Patients with Severe COVID-19 Pneumonia: A Case-Control Cohort Study
33075713	Subcutaneous tocilizumab in adults with severe and critical COVID-19: A prospective open-label uncontrolled multicenter trial
33080002	Association Between Early Treatment With Tocilizumab and Mortality Among Critically Ill Patients With COVID-19
35677110	Efficacy and safety of tocilizumab in COVID-19 patients
35657993	Efficacy of Tocilizumab in Patients Hospitalized with Covid-19
35891407	Effect of Tocilizumab vs Usual Care in Adults Hospitalized With COVID-19 and Moderate or Severe Pneumonia: A Randomized Clinical Trial
33051695	Tocilizumab for treating COVID-19: a systemic review and meta-analysis of retrospective studies
35433719	Use of Tocilizumab in COVID-19: A Systematic Review and Meta-Analysis of Current Evidence
33043484	Association of Anticoagulation Dose and Survival in Hospitalized COVID-19 Patients: A Retrospective Propensity Score Weighted Analysis
33039120	Association of hypertension and antihypertensive agents and the severity of COVID-19 pneumonia. A monocentric French prospective study
35799196	Clinical efficacy of intravenous immunoglobulin therapy in critical ill patients with COVID-19
33058086	Safety and Effectiveness of Hydroxychloroquine and Azithromycin Combination Therapy for Treatment of Hospitalized Patients with COVID-19: A Propensity-Matched Study
33075525	Hydroxychloroquine Safety Outcome within Approved Therapeutic Protocol for COVID-19 Outpatients
-	QTc prolongation among hydroxychloroquine sulfate-treated COVID-19 patients: An observational study
33082342	A pragmatic randomized controlled trial reports lack of efficacy of hydroxychloroquine on coronavirus disease 2019 viral kinetics
33765902	The Outcome of Hydroxychloroquine in Patients Treated for COVID-19: Systematic Review and Meta-Analysis
35504528	Statin use is associated with lower disease severity in COVID‑19 infection
34565246	High versus standard doses of corticosteroids in severe COVID-19: a retrospective cohort study
35569351	No harm from angiotensin-converting enzyme inhibitors or angiotensin receptor inhibitors in patients with COVID-19. Results of a prospective study on a hospital-based cohort
33069281	Safety and immunogenicity of an inactivated SARS-CoV-2 vaccine, BBIBP-CorV: a randomised, double-blind, placebo-controlled, phase 1/2 trial
33039952	Cohort study to evaluate effect of vitamin D, magnesium, and vitamin B12 in combination on severe outcome progression in older patients with coronavirus (COVID-19)
34956474	Efficacy of umifenovir in the treatment of mild and moderate COVID-19 patients
33033405	Preemptive interleukin‐6 blockade in patients with COVID‐19
33649979	Thromboprophylaxis with enoxaparin is associated with a lower death rate in patients hospitalized with SARS-CoV-2 infection. A cohort study.
35512728	Remdesivir for the Treatment of Covid-19 — Final Report
35904406	Convalescent plasma for patients with severe COVID-19
35838929	Convalescent plasma or hyperimmune immunoglobulin for people with COVID-19: a living systematic review (Review)
33031085	Nitazoxanide against COVID-19 in three explorative scenarios
-	Case Series of 100 COVID-19 Positive Patients Treated with Combination of Ivermectin and Doxycycline
-	Use of Ivermectin is Associated with Lower Mortality in Hospitalized Patients with COVID-19 (ICON study)
-	Effectiveness of Ivermectin in SARS-CoV-2/COVID-19 Patients
33054978	Triple therapy with hydroxychloroquine, azithromycin, and ciclesonide for COVID-19 pneumonia
33044019	Hydroxychloroquine in hospitalized COVID‐19 patients: Real world experience assessing mortality
35872684	Effect of Hydroxychloroquine in Hospitalized Patients with Covid-19
32977363	Anti-androgens may protect against severe COVID-19 outcomes: results from a prospective cohort study of 77 hospitalized men
33053279	Safety and Immunogenicity of Two RNA-Based Covid-19 Vaccine Candidates
33015643	Anti-C5a antibody IFX-1 (vilobelimab) treatment versus best supportive care for patients with severe COVID-19 (PANAMO): an exploratory, open-label, phase 2 randomised controlled trial
33002613	Tocilizumab Therapy of COVID-19: A Comparison of Subcutaneous and Intravenous Therapies
32993751	Efficacy of tocilizumab in patients with COVID-19 ARDS undergoing noninvasive ventilation
-	IL-6 serum levels predict severity and response to Tocilizumab in COVID-19: na observational study
-	Tocilizumab combined with favipiravir in the treatment of COVID-19: A multicenter trial in a small sample size
33027192	Fondaparinux Use in Patients With COVID-19: A Preliminary Multicenter Real-World Experience
32987902	Venous Thrombo-Embolism in Hospitalized SARS-CoV-2 Patients Treated with Three Different Anticoagulation Protocols: Prospective Observational Study
33022834	Anticoagulation outcomes in hospitalized Covid‐19 patients: A systematic review and meta‐analysis of case‐control and cohort studies
35864037	Prophylactic anticoagulants for patients hospitalised with COVID-19
33002611	Effect of convalescent blood products for patients with severe acute respiratory infections of viral etiology: a systematic review and meta-analysis
35904406	Convalescent plasma therapy in patients with COVID-19.
32927129	Is oseltamivir suitable for fighting against COVID-19: In silico assessment,in vitro and retrospective study
33008327	Subcutaneous injection of IFN alpha-2b for COVID-19: an observational study
33395331	Lopinavir–ritonavir in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
33006442	Influence of blood pressure control and application of renin-angiotensin-aldosterone system inhibitors on the outcomes in COVID-19 patients with hypertension
35904437	Angiotensin-Converting Enzyme Inhibitors or Angiotensin Ii Receptor Blockers and Prognosis of Hypertensive Patients Hospitalized With Covid-19
35881908	RAAS inhibitors are not associated with mortality in COVID-19 patients: findings from an observational multicenter study in Italy and a meta-analysis of 19 studies
33020690	Comparing the impact of Hydroxychloroquine based regimens and standard treatment on COVID-19 patient outcomes: A retrospective cohort study
-	Hydroxychloroquine Use on Healthcare Workers Exposed to COVID-19 -A Pandemic Hospital Experience
33042552	Hydroxychloroquine is effective, and consistently so used early, for Covid-19: A systematic review
34801741	Low-to-moderate dose corticosteroids treatment in hospitalized adults with COVID-19
33015160	Effects of Short-Term Low-Dose Glucocorticoids for Patients with Mild COVID-19
34975140	Association of corticosteroids use and outcomes in COVID-19 patients: A systematic review and meta-analysis
33009770	Clinical Characteristics and Outcomes of Patients Hospitalized for COVID-19 in Africa: Early Insights from the Democratic Republic of the Congo
32941512	SARS-CoV-2 positivity rates associated with circulating 25-hydroxyvitamin D levels
-	Positive association between COVID-19 deaths and influenza vaccination rates in elderly people worldwide
34044428	COVID-19 vaccine BNT162b1 elicits human antibody and TH1 T-cell responses
-	Serum levels of Vitamin C and Vitamin D in a cohort of critically ill COVID-19 patients of a North American Community Hospital Intensive Care Unit in May 2020. A Pilot Study
32953967	COVID-19 therapies and their impact on QT interval prolongation: A multicentre retrospective study on 196 patients
33790785	Evaluation of current medical approaches for COVID-19: a systematic review and meta-analysis
32995704	Therapeutic Anticoagulation Delays Death in COVID-19 Patients: Cross-Sectional Analysis of a Prospective Cohort
32640479	Venous thromboembolism in COVID-19: systematic review of reported risks and current guidelines
35501097	Anticoagulant treatment is associated with decreased mortality in severe coronavirus disease 2019 patients with coagulopathy
32977137	Therapeutic versus prophylactic anticoagulation for severe COVID-19: A randomized phase II clinical trial (HESACOVID)
32994187	Sitagliptin Treatment at the Time of Hospitalization Was Associated With Reduced Mortality in Patients With Type 2 Diabetes and COVID-19: A Multicenter, Case-Control, Retrospective, Observational Study
-	Comparative effectiveness and safety of ribavirin plus interferon-alpha, lopinavir/ritonavir plus interferon-alpha and ribavirin plus lopinavir/ritonavir plus interferon-alpha in patients with mild to moderate novel coronavirus pneumonia: results of a randomized, open-labeled prospective study
34629660	Ivermectin treatment may improve the prognosis of patients with COVID-19
-	Outcome of ivermectin treated mild to moderate COVID-19 cases: a single-centre, open-label, randomised controlled study
-	An open-label, randomized trial of the combination of IFN-k plus TFF2 with standard care in the treatment of patients with moderate COVID-19
32980434	The role of anti-hypertensive treatment, comorbidities and early introduction of LMWH in the setting of COVID-19: A retrospective, observational study in Northern Italy
32910274	Renin-Angiotensin System Inhibitors and COVID-19: a Systematic Review and Meta-Analysis. Evidence for Significant Geographical Disparities
35570298	Ibuprofen use and clinical outcomes in COVID-19 patients
35904716	Early Hydroxychloroquine but not Chloroquine use reduces ICU admission in COVID-19 patients
32956782	Assessing QT interval in COVID-19 patients: Safety of Hydroxychloroquine-azithromycin combination regimen
35788169	The association of treatment with hydroxychloroquine and hospital mortality in COVID-19 patients
32971536	Arrhythmic safety of hydroxychloroquine in COVID-19 patients from different clinical settings
33134417	Treating Covid-19 With Hydroxychloroquine (TEACH): A Multicenter, Double-Blind, Randomized Controlled Trial in Hospitalized Patients
34781981	Efficacy and Safety of Hydroxychloroquine vs Placebo for Pre-exposure SARS-CoV-2 Prophylaxis Among Health Care Workers A Randomized Clinical Trial
34245622	Favipiravir versus other antiviral or standard of care for COVID-19 treatment: a rapid systematic review and meta-analysis
32446698	Famotidine Use Is Associated With Improved Clinical Outcomes in Hospitalized COVID-19 Patients: A Propensity Score Matched Retrospective Cohort Study
35663537	Risk of COVID-19-related death among patients with chronic obstructive pulmonary disease or asthma prescribed inhaled corticosteroids: an observational cohort study using the OpenSAFELY platform
35219601	Efficacy of corticosteroid treatment for hospitalized patients with severe COVID-19: a multicenter study
-	Effect of Corticosteroid Therapy on the Duration of SARS-CoV-2 Clearance in Patients with Mild COVID-19: A Retrospective Cohort Study.
35786174	Efficacy and Safety of Corticosteroid Treatment in Patients With COVID-19: A Systematic Review and Meta-Analysis
33976439	Clinical characteristics, treatment regimen and duration of hospitalization among COVID-19 patients in Ghana: a retrospective cohort study
-	Vitamin D sufficiency, a serum 25hydroxyvitamin D at least 30 ng/mL reduced risk for adverse clinical outcomes in patients with COVID-19 infection
35763290	Safety and Immunogenicity of SARS-CoV-2 mRNA-1273 Vaccine in Older Adults
35391642	Could Vitamins Help in the Fight Against COVID-19?
32950003	Impact of interleukin-6 blockade with tocilizumab on SARS-CoV-2 viral kinetics and antibody responses in patients with COVID-19: A prospective cohort study
-	"Tocilizumab ameliorates the hypoxia in COVID-19 moderate patients withbilateral pulmonary lesions: a randomized, controlled, open-label, multicenter trial"
32964913	Decreased mortality in COVID-19 patients treated with Tocilizumab: a rapid systematic review and meta-analysis of observational studies
32932930	Repurposing Immunomodulatory Therapies against Coronavirus Disease 2019 (COVID-19) in the Era of Cardiac Vigilance: A Systematic Review
35904406	Convalescent Plasma for the Treatment of Patients with Severe Coronavirus Disease 2019
32964918	Double-blind, randomized, placebo-controlled trial with N-acetylcysteine for treatment of severe acute respiratory syndrome caused by COVID-19
32943404	Intravenous methylprednisolone pulse as a treatment for hospitalised severe COVID-19 patients: results from a randomised controlled clinical trial
-	Treatment of COVID-19 Patients with Prolonged Post-Symptomatic Viral Shedding with Leflunomide -- a Single-Center, Randomized, Controlled Clinical Trial
33546734	Impact of Treatment with Renin-Angiotensin System Inhibitors on Clinical Outcomes in Hypertensive Patients Hospitalized with COVID-19
32953968	Implications of myocardial injury in Mexican hospitalized patients with coronavirus disease 2019 (COVID-19)
-	Hydroxychloroquine and Interferons for the Prophylaxis and Early Treatment of Covid-19-Current Clinical Advances
32984847	Long-term hydroxychloroquine use in patients with rheumatic conditions and development of SARS-CoV-2 infection: a retrospective cohort study
35903826	Glucocorticoid therapy does not delay viral clearance in COVID-19 patients.
32958718	A prospective, randomized, open-label trial of early versus late favipiravir in hospitalized patients with COVID-19
32936949	Antimicrobial mouthwashes (gargling) and nasal sprays administered to patients with suspected or confirmed COVID-19 infection to improve patient outcomes and to protect healthcare workers treating them (Review)
35905957	Use of antimicrobial mouthwashes (gargling) and nasal sprays by healthcare workers to protect them when treating patients with suspected or confirmed COVID-19 infection
32386514	Interventions for treatment of COVID-19: a protocol for a living systematic review with network meta-analysis including individual patient data (The LIVING Project)
-	Palliative Care Utilization Among Patients With COVID-19 in an Underserved Population: A Single-Center Retrospective Study
-	Clinical characteristics of 276 hospitalized patients with coronavirus disease 2019 in Zengdu District, Hubei Province: a singlecenter descriptive study
32911042	Analysis of the predictive factors for critical illness of COVID-19 during treatment - Relationship between serum zinc level and critical illness of COVID-19
-	Impact of Vitamin D Deﬁciency on COVID-19—A Prospective Analysis from the CovILD Registry
35893907	Vitamin D Deficiency and Outcome of COVID-19 Patients
32923016	Efficacy and safety of triazavirin therapy for coronavirus disease 2019: A pilot randomized controlled trial
33950993	Observational study on off-label use of tocilizumab in patients with severe COVID-19
35657993	Efficacy of Tocilizumab in COVID-19: A Systematic review and Meta-Analysis
32920504	A low dose heparinized saline protocol is associated with improved duration of arterial line patency in critically ill COVID-19 patients
32910179	Effect of Recombinant Human Granulocyte Colony–Stimulating Factor for Patients With Coronavirus Disease 2019 (COVID-19) and Lymphopenia
34137799	Convalescent plasma treatment of severe COVID-19: a propensity score–matched control study
32923991	Compassionate use of convalescent plasma for treatment of moderate and severe pneumonia in COVID-19 patients and association with IgG antibody levels in donated plasma
-	Mortality Risk Factors among Hospitalized COVID-19 Patients in a Major Referral Center in Iran
32903258	Efficacy of corticosteroids in non-intensive care unit patients with COVID-19 pneumonia from the New York Metropolitan region
35878897	The effect of antivirals on COVID-19: a systematic review
-	Terapia medicamentosa para infecções por coronavírus em humanos: revisão sistemática rápida.
32921965	Biological, Molecular and Pharmacological Characteristics of Chloroquine, Hydroxychloroquine, Convalescent Plasma, and Remdesivir for COVID-19 Pandemic: A Comparative Analysis
32930657	Zinc sulfate in combination with a zinc ionophore may improve outcomes in hospitalized COVID-19 patients
-	Utilidad y seguridad de la automonitorizacion electrocardiográfica durante el tratamiento con hidroxicloroquina y azitromicina en pacientes con COVID-19
33299775	Hydroxychloroquine and Azithromycin as a Treatment of COVID-19: Electrocardiogram Variability
34932789	Effect of combination therapy of hydroxychloroquine and azithromycin on mortality in COVID‐19 patients
-	Hydroxychloroquine in COVID-19: The Study Points to Premature Decisions on Efficacy While Bells Ringing for Safety
32922409	Treatment of COVID-19 With Conestat Alfa, a Regulator of the Complement, Contact Activation and Kallikrein-Kinin System
32937800	Colchicine to Weather the Cytokine Storm in Hospitalized Patients with COVID-19
32933039	The Efficacy of the Mineralcorticoid Receptor Antagonist Canrenone in COVID-19 Patients
32926439	Clinical characteristics of 132 healthcare workers cases with COVID-19: a retrospective study from a single center in Wuhan, China
32923613	Mandated Bacillus Calmette-Guérin (BCG) vaccination predicts flattened curves for the spread of COVID-19
35495105	Correlation between immunity from BCG and the morbidity and mortality of COVID-19
32789505	Effect of an Inactivated Vaccine Against SARS-CoV-2 on Safety and Immunogenicity Outcomes - Interim Analysis of 2 Randomized Clinical Trials
32903131	Systematic review of the antiviral properties of TRIM56: a potential therapeutic intervention for COVID-19
32838235	Early use of low dose tocilizumab in patients with COVID-19: A retrospective cohort study with a complete follow-up
34987916	Outcome of COVID-19 patients with use of Tocilizumab: A single center experience
32889241	Promising effects of tocilizumab in COVID-19: A non-controlled, prospective clinical trial
32897543	Analysis of the prophylactic effect of thymosin drugs on COVID‐19 for 435 medical staff: A hospital‐based retrospective study
34013969	Convalescent Plasma Therapy and Its Effects On COVID-19 Patient Outcomes: A Systematic Review of Current Literature
35613761	Lopinavir/ritonavir for the treatment of SARS, MERS and COVID-19: a systematic review
35904437	Angiotensin converting enzyme inhibitors do not increase the risk of poor outcomes in COVID-19 disease. A multi-centre observational study
32802142	COVID-19: age, Interleukin-6, C-reactive protein, and lymphocytes as key clues from a multicentre retrospective study
-	The Association of Renin-AngiotensinAldosterone System Inhibitors With Outcomes Among a Predominantly Ethnic Minority Patient Population Hospitalized With COVID-19: The Bronx Experience
34322403	No benefit of hydroxychloroquine in COVID-19: Results of Systematic Review and Meta-Analysis of Randomized Controlled Trials
35905000	Hydroxychloroquine use and progression or prognosis of COVID-19: a systematic review and meta-analysis
35832701	A Meta-Analysis on the Effects of Hydroxychloroquine on COVID-19
35620807	Characteristics and outcomes of admitted patients infected with SARS-CoV-2 in Uganda
32817375	Hydroxychloroquine use in COVID-19: is the risk of cardiovascular toxicity justified?
32896750	Immunomodulatory-based therapy as a potential promising treatment strategy against severe COVID-19 patients: A systematic review
32881007	Are the steroids a blanket solution for COVID‐19? a systematic review and meta‐analysis
33172477	Systemic corticosteroids and mortality in severe and critical COVID-19 patients in Wuhan, China
32880102	Efficacy Evaluation of Early, Low-Dose, Short-Term Corticosteroids in Adults Hospitalized with Non-Severe COVID-19 Pneumonia: A Retrospective Cohort Study
-	Agentes potencialmente terapéuticos contra el SARS-COV-2: revisión rápida de la evidencia
35537738	Chloroquine and Hydroxychloroquine for the Treatment of COVID-19: a Systematic Review and Meta-analysis
35871071	Chloroquine and Hydroxychloroquine in treatment of COVID-19 Disease
32983936	Effect of bromhexine on clinical outcomes and mortality in COVID-19 patients: A randomized clinical trial
32881359	Bromhexine Hydrochloride Tablets for the Treatment of Moderate COVID-19: An Open-label Randomized Controlled Pilot Study
-	Azithromycin in addition to standard of care versus standard of care alone in the treatment of patients admitted to the hospital with severe COVID-19 in Brazil (COALITION II): a randomised clinical trial
35884195	Observational study of azithromycin in hospitalized patients with COVID-19
32881340	The potential of low molecular weight heparin to mitigate cytokine storm in severe COVID-19 patients: a retrospective cohort study
32892540	The Impact of the “Low Molecular Weight Heparin” Administration on the Clinical Course of the COVID-19 Disease
32885463	Empiric therapeutic anticoagulation and mortality in critically ill patients with respiratory failure from SARS-CoV-2: A retrospective cohort study
32896291	Safety and immunogenicity of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine in two formulations: two open, non-randomised phase 1/2 studies from Russia
32860431	Evaluation of seventeen patients with COVID-19 pneumonia treated with anakinra according to HScore, SOFA, MuLBSTA and Brescia-COVID respiratory severity scale (BCRSS) scoring systems
-	"Prolongation of QT interval due tohydroxychloroquine overdose used inCOVID-19 treatment"
33154656	Corticosteroid Use in the Treatment of COVID-19: A Multicenter Retrospective Study in Hunan, China
32844224	Hydroxychloroquine and azithromycin tolerance in haemodialysis patients during COVID-19 infection
32835086	Effect of oral L-Glutamine supplementation on Covid-19 treatment
35892391	Impact of Azithromycin and/or Hydroxychloroquine on Hospital Mortality in COVID-19
32871242	Dual-Histamine Receptor Blockade with Cetirizine - Famotidine Reduces Pulmonary Symptoms in COVID-19 Patients
35321338	Metformin Is Associated with Higher Incidence of Acidosis, but Not Mortality, in Individuals with COVID-19 and Pre-existing Type 2 Diabetes
32857301	Comparing outcomes of hospitalized patients with moderate and severe COVID-19 following treatment with hydroxychloroquine plus atazanavir/ritonavir
32865701	Patients with Prolonged Positivity of SARS-CoV-2 RNA Benefit from Convalescent Plasma Therapy: A Retrospective Study
35884886	Tocilizumab use in COVID -19 associated pneumonia
32735965	Antecedent Immunosuppressive Therapy for Immune-Mediated Inflammatory Diseases in the Setting of a COVID-19 Outbreak
32853675	Predictive factors for cardiac conduction abnormalities with hydroxychloroquine-containing combinations for COVID-19
32860964	Treatment with tocilizumab or corticosteroids for COVID-19 patients with hyperinflammatory state: a multicentre cohort study (SAM-COVID-19)
32852721	Renin–Angiotensin–Aldosterone System Inhibitors and Risk of Death in Patients Hospitalised with COVID-19: A Retrospective Italian Cohort Study of 43,000 Patients
32843231	High dose subcutaneous Anakinra to treat acute respiratory distress syndrome secondary to cytokine storm syndrome among severely ill COVID-19 patients
32850921	Ruxolitinib Rapidly Reduces Acute Respiratory Distress Syndrome in COVID-19 Disease. Analysis of Data Collection From RESPIRE Protocol
-	Effects of Short-Term Hydroxychloroquine Plus Moxifloxacin Therapy on Corrected QT Interval and Tp-e Interval in Patients With COVID-19
-	A clinical pilot study on the safety and efficacy of aerosol inhalation treatment of IFN-k plus TFF2 in patients with moderate COVID-19
32876697	Effect of Hydrocortisone on Mortality and Organ Support in Patients With Severe COVID-19 - The REMAP-CAP COVID-19 Corticosteroid Domain Randomized Clinical Trial,
35780813	Effect of Hydrocortisone on 21-Day Mortality or Respiratory Support Among Critically Ill Patients With COVID-19 A Randomized Clinical Trial
-	Effect of Calcifediol Treatment and best Available Therapy versus best Available Therapy on Intensive Care Unit Admission and Mortality Among Patients Hospitalized for COVID-19: A Pilot Randomized Clinical study
33648568	Effect of Dexamethasone on Days Alive and Ventilator-Free in Patients With Moderate or Severe Acute Respiratory Distress Syndrome and COVID-19 The CoDEX Randomized Clinical Trial
35842684	Treatment of severe COVID-19 with human umbilical cord mesenchymal stem cells
33850184	Interferon β-1b in treatment of severe COVID-19: A randomized clinical trial
35765103	Human umbilical cord-derived mesenchymal stem cell therapy in patients with COVID-19: a phase 1 clinical trial
33762954	Safety and Effectiveness of Azithromycin in Patients with COVID-19: an open-label randomized trial
34122093	Association Between Administration of Systemic Corticosteroids and Mortality Among Critically Ill Patients With COVID-19: A Meta-analysis
34728441	Zinc for the prevention and treatment of SARS-CoV-2 and other acute viral respiratory infections: a rapid review
32849448	Directly Acting Antivirals for COVID-19: Where Do We Stand?
35892438	Effect of hydroxychloroquine with or without azithromycin on the mortality of COVID-19 patients: a systematic review and meta-analysis
35832701	Safety and Efficacy of Hydroxychloroquine in COVID-19: A Systematic Review and Meta-Analysis
35898725	The effect of quercetin on the prevention or treatment of COVID-19 and other respiratory tract infections in humans: A rapid review
33264556	Effect of remdesivir on patients with COVID-19: A network meta-analysis of randomized control trials
32842505	The Association between Influenza and Pneumococcal Vaccinations and SARS-Cov-2 Infection: Data from the EPICOVID19 Web-Based Survey
33951374	Phase 1–2 Trial of a SARS-CoV-2 Recombinant Spike Protein Nanoparticle Vaccine
35026500	Azithromycin: The First Broad-spectrum Therapeutic
35889352	Clinical efficacy of antivirals against novel coronavirus (COVID-19): A review
32839815	COVID-19 and Antimalarial Drugs: Harms Outweigh Benefits
35899572	Glucocorticoids improve severe or critical COVID-19 by activating ACE2 and reducing IL-6 levels
32820236	Renin–angiotensin system inhibitors and the severity of coronavirus disease 2019 in Kanagawa, Japan: a retrospective cohort study
35318127	Angiotensin Converting Enzyme Inhibitor and Angiotensin II Receptor Blocker Use Among Outpatients Diagnosed With COVID-19
-	Efficacy and Safety of Anti-malarial Drugs (Chloroquine and Hydroxy-Chloroquine) in Treatment of COVID-19 Infection: A Systematic Review and Meta-Analysis. view and Meta-Analysis
33768612	QT interval and arrhythmic safety of hydroxychloroquine monotherapy in coronavirus disease 2019
32839534	Association between renin-angiotensin-aldosterone system inhibitor treatment, neutrophil-lymphocyte ratio, D-Dimer and clinical severity of COVID-19 in hospitalized patients: a multicenter, observational study
32814839	Compassionate use of JAK1/2 inhibitor ruxolitinib for severe COVID-19: a prospective observational study
32829051	Effect of a Previous History of Antiretroviral Treatment on Clinical Picture of Patients with Co-infection of SARS-CoV-2 and HIV: A Preliminary Study
32733907	Challenges in the Management of SARS-CoV2 Infection: The Role of Oral Bacteriotherapy as Complementary Therapeutic Strategy to Avoid the Progression of COVID-19
32859477	Use of hydroxychloroquine in hospitalised COVID-19 patients is associated with reduced mortality: Findings from the observational multicentre Italian CORIST study
32785086	Prior Routine Use of Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) and Important Outcomes in Hospitalised Patients with COVID-19
35658110	Is there any potential management against COVID-19? A systematic review and meta-analysis
-	Hydroxychloroquine is protective to the heart, not Harmful: A systematic review.
-	Antiviral Activity of Ivermectin Against SARS-CoV-2: An Old-Fashioned Dog with a New Trick—A Literature Review
-	"Application of methylene blue -vitamin C –N-acetyl cysteine for treatment of critically ill COVID-19 patients, report of a phase-I clinicaltrial"
35906055	Case studies of SARS-CoV-2 treated with favipiravir among patients in critical or severe condition
-	Effectiveness of remdesivir in patients with COVID-19 under mechanical ventilation in an Italian ICU
-	Pattern of SARS-CoV-2 infection among dependant elderly residents living in retirement homes in Marseille, France, March-June 2020
-	Low-dose Hydroxychloroquine Therapy and Mortality in Hospitalized Patients with COVID-19: A Nationwide Observational Study of 8075 Participants
35871071	Hydroxychloroquine in the Treatment of COVID-19: A Multicenter Randomized Controlled Study
-	Remdesivir is Effective for Moderately Severe Patients: A Re-Analysis of the First Double-Blind, Placebo-Controlled, Randomized Trial on Remdesivir for Treatment of Severe COVID-19 Patients Conducted in Wuhan City
32830286	Effect of Renin-Angiotensin-Aldosterone System Inhibitors in Patients with COVID-19: a Systematic Review and Meta-analysis of 28,872 Patients
35547540	Steroids in COVID-19: An overview
33596800	A Review on Remdesivir: A Possible Promising Agent for the Treatment of COVID-19
33886388	Potential therapeutic application of mesenchymal stem cell-derived exosomes in SARS-CoV-2 pneumonia
35764545	The impact of sofosbuvir/daclatasvir or ribavirin in patients with severe COVID-19
32827987	The effect of 5-day course of hydroxychloroquine and azithromycin combination on QT interval in non-ICU COVID19(+) patients
32820807	Empiric Antibacterial Therapy and Community-onset Bacterial Co-infection in Patients Hospitalized with COVID-19: A Multi-Hospital Cohort Study
35818662	Tocilizumab and steroid treatment in patients with COVID-19 pneumonia
32821939	Effect of Remdesivir vs Standard Care on Clinical Status at 11 Days in Patients With Moderate COVID-19 A Randomized Clinical Trial
33585508	Remdesivir and its antiviral activity against COVID-19: A systematic review
-	Fatal COVID-19 in an MS patient on natalizumab: A case report
32796765	Targeting Endothelial Dysfunction in Eight Extreme-Critically Ill Patients with COVID-19 Using the Anti-Adrenomedullin Antibody Adrecizumab (HAM8101)
32855629	Finding the Best Antiviral Regimen for COVID-19: A Double-Center Retrospective Cohort Study of 207 Cases in Hunan, China
32805623	Anti Xa activity after high dose LMWH thrombosis prophylaxis in covid 19 patients at the intensive care unit
32812025	Evaluation of the efficacy of sofosbuvir plus daclatasvir in combination with ribavirin for hospitalized COVID-19 patients with moderate disease compared with standard care: a single-centre, randomized controlled trial
35904769	Sofosbuvir and daclatasvir compared with standard of care in the treatment of patients admitted to hospital with moderate or severe coronavirus infection (COVID-19): a randomized controlled trial
-	The use of non-steroidal anti-inflammatory drugs (NSAIDs) in patients with COVID-19. Scientific brief
35904132	COVID-19 and multisystem inflammatory syndrome in children and adolescents
32881350	Tocilizumab for severe COVID‐19 pneumonia: case series of 5 Australian patients
35458497	Safety of intermediate dose of low molecular weight heparin in COVID-19 patients
34735523	Impact of Famotidine Use on Clinical Outcomes of Hospitalized COVID-19 Patients
32809969	Baricitinib restrains the immune dysregulation in severe COVID-19 patients
32810285	Efficacy of various treatment modalities for nCOV‐2019: a systematic review and meta‐analysis
-	Recent Updates Published About Favipiravir in COVID-19
-	Oral Corticosteroid Relieves Post-COVID-19 Anosmia in a 35-Year-Old Patient
34050953	Intravenous Immunoglobulin and Favipiravir treatment for A Kidney Transplant Patient with Severe Covid-19 Pneumonia
-	Neumonía por COVID-19 y uso de tocilizumab
32789604	Heparin-induced thrombocytopenia in COVID-19 patients with severe acute respiratory distress syndrome requiring extracorporeal membrane oxygenation: two case reports
35165651	A case report of a pregnant woman infected with coronavirus disease 2019 pneumonia
32775845	Steroids: A Therapeutic Option for COVID-19 Pneumonia Patients With ESRD?
35893672	Severe arterial thromboembolism in patients with Covid- 19
32802622	Clinical Outcomes of Early Treatment With Doxycycline for 89 High-Risk COVID-19 Patients in Long-Term Care Facilities in New York
-	Successful treatment of 28 patients with coronavirus disease 2019 at a medical center in Taiwan
32809882	Lopinavir-ritonavir Treatment for COVID-19 Infection in Intensive Care Unit: Risk of Bradycardia
32795143	"Corticosteroid prevents COVID-19 progressionwithin its therapeutic window: a multicenter, proof-of-concept, observational study"
32807002	Mortality and Pre-Hospitalization use of Renin-Angiotensin System Inhibitors in Hypertensive COVID-19 Patients
35453248	Hydroxychloroquine for treatment of non-severe COVID-19 patients
32738257	Systematic review of the role of renin-angiotensin system inhibitors in late studies on Covid-19: a new challenge overcome?
32983928	The application of corticosteroids in COVID-19: A two-edged sword
-	Uncontrolled mass use of hydroxychloroquine
32796809	Short-term corticosteroid therapy for early exacerbation of COVID-19 pneumonia: a case report
35842293	Impact of Tocilizumab on mortality and/or invasive mechanical ventilation requirement in a cohort of 206 COVID-19 patients
33208294	Thymosin α1 therapy in critically ill patients with COVID-19: A multicenter retrospective cohort study
32979572	Tocilizumab among patients with COVID-19 in the intensive care unit: a multicentre observational study
-	Comparison of Viral Clearance between Ivermectin with Doxycycline and Hydroxychloroquine with Azithromycin in COVID-19 Patients
35882451	Auxora versus standard of care for the treatment of severe or critical COVID-19 pneumonia: results from a randomized controlled trial
34045812	Hydroxychloroquine and Coronavirus Disease 2019: A Systematic Review of a Scientific Failure
-	Outcomes and biomarker analyses among patients with COVID-19 treated with interleukin 6 (IL-6) receptor antagonist sarilumab at a single institution in Italy
32793725	Tocilizumab exerts anti-inflammatory activity in six critically ill COVID-19 patients: a retrospective analysis
35628892	Three Cases of Pediatric Multisystem Inflammatory Syndrome Associated with COVID-19 Due to SARS-CoV-2
32790733	Hydroxychloroquine and tocilizumab therapy in COVID-19 patients—An observational study
-	Agentes terapéuticos utilizados en 238 pacientes hospitalizados por COVID-19 y su relación con la mortalidad
-	Methylprednisolone as Adjunctive Therapy for Patients Hospitalized With COVID-19 (Metcovid): A Randomised, Double-Blind, Phase IIb, Placebo-Controlled Trial
35771353	Phase 1/2 study of COVID-19 RNA vaccine BNT162b1 in adults
32782662	Risk of QTc prolongation with Chloroquine/Hyroxychloroquine and Azithromycin treatment for COVID-19: Quantification and precautions for a busy clinician
32821381	Chloroquine and hydroxychloroquine as a repurposed agent against COVID-19: a narrative review
-	"Prolonged QT Interval in a PatientWith Coronavirus Disease-2019: Beyond Hydroxychloroquine and Azithromycin"
-	Cardiovascular Considerations of Experimental Hydroxychloroquine Therapy on Patients Diagnosed With COVID-19: A Case Series Review
32789513	Outcomes Associated With Use of a Kinin B2 Receptor Antagonist Among Patients With COVID-19
-	Análisis de la relación entre los inhibidores del sistema renina-angiotensina y la evolución de pacientes hospitalizados por infección respiratoria COVID-19
32790075	Late Onset Infectious Complications and Safety of Tocilizumab in the Management of COVID-19
32784192	Efficacy of hydroxychloroquine and tocilizumab in patients with COVID-19: A single-center retrospective chart review
32789505	Effect of an Inactivated Vaccine Against SARS-CoV-2 on Safety and Immunogenicity Outcomes: Interim Analysis of 2 Randomized Clinical
-	Towards evidence-based emergency medicine: best BETs from the Manchester Royal Infirmary
35905855	Chloroquine or Hydroxychloroquine for Management of Coronavirus Disease 2019: Friend or Foe?
-	Argatroban therapy for heparin-induced thrombocytopenia in a patient with coronavirus disease 2019
-	Thrombolysis and use of argatroban for the treatment of massive pulmonary embolism following anticoagulation failure in a patient with COVID-19
35844322	Plasma exchange in critically ill COVID-19 patients
32777745	Mild clinical manifestations of SARS-CoV-2 related pneumonia in two patients with multiple sclerosis under treatment with ocrelizumab
34401329	QTc prolongation during antiviral therapy in two COVID-19 patients
32786041	Evaluation of retinotoxicity of COVID-19 treatment: hydroxychloroquine and lopinavir/ritonavir
-	Impact of implementation of an individualised thromboprophylaxis protocol T in critically ill ICU patients with COVID-19: A longitudinal controlled before-after study
33683065	Effects of Hydroxychloroquine on Covid-19 in Intensive Care Unit Patients: Preliminary Results
32779705	SARS-CoV-2 Neutralizing Antibody Titers in Convalescent Plasma and Recipients in New Mexico: An Open Treatment Study in COVID-19 Patients
35120577	Vitamin D deficiency as a predictor of poor prognosis in patients with acute  respiratory failure due to COVID-19
35904406	Convalescent Plasma Therapy on Patients with Severe or Life-Threatening COVID-19: A Metadata Analysis
32780229	Safety of hydroxychloroquine in COVID-19 and other diseases: a systematic review and meta-analysis of 53 randomized trials
34265436	Hydroxychloroquine in COVID-19: An updated systematic review with meta-analysis
32776534	Early administration of lopinavir/ritonavir plus hydroxychloroquine does not alter the clinical course of SARSCoV-2 infection: a retrospective cohort study
32795424	Treatment of COVID-19 Patients with Convalescent Plasma Reveals a Signal of Significantly Decreased Mortality
32776298	Hydroxychloroquine versus lopinavir/ritonavir in severe COVID-19 patients - Results from a real-life patient cohort
34208017	TREATMENT WITH HYDROXYCHLOROQUINE IN PATIENTS WITH COVID-19. EXPERIENCE OF A NEUROLOGY DEPARTMENT
-	Favipiravir y/o umifenovir en infección por COVID-19
-	Documento de Evaluación de Tecnologías Sanitarias – Informe de Respuesta Rápida: Ivermectina para COVID-19
32776573	Convalescent plasma a clutch at straws in COVID-19 management! A systematic review and meta-analysis
-	Potential new treatment strategies for COVID‐19: is there a role for bromhexine as add‐on therapy?
34854327	Drug repurposing of nitazoxanide: can it be an effective therapy for COVID-19?
32744917	Antibody-based immunotherapeutics and use of convalescent plasma to counter COVID-19: advances and prospects
32645632	Baricitinib, a drug with potential effect to prevent SARS-COV-2 from entering target cells and control cytokine storm induced by COVID-19
32801640	Antiviral Agent Therapy Optimization in Special Populations of COVID-19 Patients
32725351	Successful recovery of recurrence of positive SARS-CoV-2 RNA in COVID-19 patient with systemic lupus erythematosus: a case report and review
35352636	COVID-19 in Liver Transplant Patients: Report of 2 Cases and Review of the Literature
35860245	Clinical study using mesenchymal stem cells for the treatment of patients with severe COVID-19
-	Corticoides sistémicos en COVID-19
34695571	Stem cell therapy for Covid‐19: possibilities and challenges
32838181	Effect of Rectal Ozone (O3) in Severe COVID-19 Pneumonia: Preliminary Results
32756149	Clinical remission of a critically ill COVID-19 patient treated by human umbilical cord mesenchymal stem cells
35836734	Clinical Experience with Use of Remdesivir in the Treatment of Severe Acute Respiratory Syndrome Coronavirus 2: a Case Series
32770691	Lessons learned from early compassionate use of convalescent plasma on critically ill patients with Covid-19
32767353	Morning vs. evening administration of antiviral therapy in COVID-19 patients. A preliminary retrospective study in Ferrara, Italy
35817743	Corticosteroid therapy for patients with severe novel Coronavirus disease 2019
32641762	BCG vaccination policy and preventive chloroquine usage: do they have an impact on COVID-19 pandemic?
32757497	Early Hydroxychloroquine Administration for Rapid Severe Acute Respiratory Syndrome Coronavirus 2 Eradication
35777750	Tocilizumab for treatment of patients with severe COVID–19: A retrospective cohort study
32768701	Low-Dose Subcutaneous Tocilizumab to Prevent Disease Progression in Patients with Moderate COVID-19 Pneumonia and Hyperinflammation
35904574	Early Identification of COVID-19 Cytokine Storm and Treatment with Anakinra or Tocilizumab
32770240	AVIFAVIR for Treatment of Patients with Moderate COVID-19: Interim Results of a Phase II/III Multicenter Randomized Clinical Trial
32758689	SARS-CoV-2 Clearance in COVID-19 Patients with Novaferon Treatment: A Randomized, Open-label, Parallel Group Trial
32757246	Association of angiotensin converting enzyme inhibitors and angiotensin II receptor blockers with risk of COVID-19, inflammation level, severity, and death in patients with COVID-19: A rapid systematic review and meta-analysis
32744592	Searching for COVID-19 treatments: First, do no harm
35905562	The role of remdesivir in COVID -19 infection
-	Therapeutic response to corticosteroids in a critically ill patient with COVID-19
33681293	A severe COVID-19 despite ongoing treatment with Lopinavir-Ritonavir
-	Persistence of rT-PCR-SARS-CoV-2 infection and delayed serological response, as a possible effect of rituximab according to the hypothesis of Schulze-Koops et al
33043142	The effects of renin–angiotensin system inhibitors (RASI) in coronavirus disease (COVID-19) with hypertension: A retrospective,single-center trial
35902857	Venous thromboembolism in critically ill COVID-19 patients receiving prophylactic or therapeutic anticoagulation: a systematic review
32754408	The Potential Vaccine Component for COVID-19: A Comprehensive Review of Global Vaccine Development Efforts
35432769	Cytokine Storm in COVID-19: The Current Evidence and Treatment Strategies
32426090	COVID-19, asthma, and biologic therapies: What we need to know
-	Abordaje terapéutico del SARS-CoV-2 (COVID-19) mediante células mesenquimales de médula ósea alogénica expandidas. Conceptos a propósito de un primer caso en España
34908881	Hydroxychloroquine and chloroquine: a potential and controversial treatment for COVID‑19
35901463	COVID-19 in pediatric patients: A case series
32766266	Administration of Immunoglobulins in SARS-CoV-2-Positive Patient Is Associated With Fast Clinical and Radiological Healing: Case Report
34530744	Clinical outcomes of COVID‑19 in Wuhan, China: a large cohort study
32736197	The characteristics and outcomes of 681 severe cases with COVID-19 in China.
-	Treatment of COVID-19 Patients at a Medical College Hospital in Bangladesh
32765274	No Statistically Apparent Difference in Antiviral Effectiveness Observed Among Ribavirin Plus Interferon-Alpha, Lopinavir/Ritonavir Plus Interferon-Alpha, and Ribavirin Plus Lopinavir/Ritonavir Plus Interferon-Alpha in Patients With Mild to Moderate Coronavirus Disease 2019: Results of a Randomized, Open-Labeled Prospective Study
32747157	A cytokine super cyclone in COVID-19 patients with risk factors: the therapeutic potential of BCG immunization
32760407	High-Dose Intravenous Immunoglobulins in the Treatment of Severe Acute Viral Pneumonia: The Known Mechanisms and Clinical Effects
-	Multisystem Inflammatory Syndrome With Complete Kawasaki Disease Features Associated With SARS-CoV-2 Infection in a Young Adult. A Case Report
-	Prolonged asymptomatic SARS-CoV-2 infection in a child receiving immunosuppressive therapy
-	Interferon-α2b spray inhalation did not shorten vírus shedding time of SARS-CoV-2 in hospitalized patients: a preliminary matched case-control study
32750201	Corticosteroid, oseltamivir, and delayed admission are independent risk factors for prolonged viral shedding in patients with Coronavirus Disease 2019
34115801	Impact of medical care including anti-infective agents use on the prognosis of COVID-19 hospitalized patients over time
-	Antiviral agents, glucocorticoids, antibiotics, and intravenous immunoglobulin usage in 1142 patients with coronavirus disease 2019: a systematic review and meta-analysis
32750438	The immune system as a target for therapy of SARS-CoV-2: A systematic review of the current immunotherapies for COVID-19
32644027	Tocilizumab for COVID-19: a real ‘miracle drug’?
32753141	Acute QT Interval Modifications During Hydroxychloroquine-Azithromycin Treatment in the Context of COVID-19 Infection
32727996	Acute Gouty Arthritis During Favipiravir Treatment for Coronavirus Disease 2019: A Case Report
35024375	Use of the IL-6R Antagonist Tocilizumab in Hospitalized COVID-19 Patients
32728438	Safety and potential efficacy of cyclooxygenase-2 inhibitors in coronavirus disease  2019
-	A retrospective evaluation on the efficacy of Lopinavir/ritonavir and chloroquine to treat non-severe COVID-19 patients
32744399	Tocilizumab shortens time on mechanical ventilation and length of hospital stay in patients with severe COVID-19: a retrospective cohort study
35115385	Antirheumatic Disease Therapies for the Treatment of COVID‐19: A Systematic Review and Meta‐analysis
-	Tratamiento farmacológico en tiempos de incertidumbre: uso de la hidroxicloroquina/cloroquina en el tratamiento de COVID-19
35084705	Efficacy of Corticosteroids in Patients with SARS, MERS and COVID-19: A Systematic Review and Meta-Analysis
32735768	Anti-Inflammatory Properties of Drugs Used to Control COVID-19 and their Effects on the Renin-Angiotensin System and Angiotensin-Converting Enzyme-2
32733775	Ascorbate as Prophylaxis and Therapy for COVID-19—Update From Shanghai and U.S. Medical Institutions
-	Effect of favipiravir and an anti- inflammatory strategy for COVID-19
32734502	Anakinra for the Treatment of COVID-19-Associated Pericarditis: A Case Report
-	COVID-19 in a Patient With Rheumatoid Arthritis During Tocilizumab Treatment
-	Rapid and Impressive Response to a Combined Treatment with Single-Dose Tocilizumab  and NIV in a Patient with COVID-19 Pneumonia/ARDS
34398044	Clinical efficacy of glucocorticoid on the treatment of patients with COVID-19 pneumonia: A single-center experience
-	Association between treatment with colchicine and improved survival in a single-centre cohort of adult hospitalised patients with COVID-19 pneumonia and acute respiratory distress syndrome
32725762	COVID‐19 in Patients with Inflammatory Arthritis: A Prospective Study on the Effects of Comorbidities and DMARDs on Clinical Outcomes
32720702	The Association of Interleukin-6 value, Interleukin inhibitors and Outcomes of Patients with COVID-19 in New York City
33153994	Risk of severe COVID-19 disease with ACE inhibitors and angiotensin receptor blockers: cohort study including 8.3 million people
35878897	Drug treatments for covid-19: living systematic review and network meta-analysis.
35606884	Mortality in COVID-19 patients with acute respiratory distress syndrome and corticosteroids use: a systematic review and meta-analysis
35812521	BCG vaccination early in life does not improve COVID-19 outcome of elderly populations, based on nationally reported data
-	Tratamento precoce para COVID-19 baseado em evidência científica.
33210457	Remdesivir: A beacon of hope from Ebola virus disease to COVID-19
33308661	Brief Review of Chloroquine and Hydroxychloroquine Toxicity and Management
35373125	Liver injury in remdesivir-treated COVID-19 patients
35870265	Hepatic disorders with the use of remdesivir for coronavirus 2019 (COVID-19)
32721528	Early administration of Interleukin-6 inhibitors for patients with severe Covid-19 disease is associated with decreased intubation, reduced mortality, and increased discharge
35674525	Appropriate use of Tocilizumab in COVID-19 Infection
35905790	Vitamin D high doses supplementation could represent a promising alternative to prevent or treat COVID-19 infection
32700555	Hydroxychloroquine in COVID-19 Therapy: Protection Versus Proarrhythmia
-	Heart-Kidney Transplanted patient affected by COVID-19 pneumonia treated with tocilizumab on top of immunosuppressive maintenance therapy
35860939	Heparin-Induced Thrombocytopenia in COVID-19
-	Interacciones medicamentosas potenciales en pacientes COVID 19 en tratamiento con lopinavir/ritonavir
34162596	Historically controlled comparison of glucocorticoids with or without tocilizumab versus supportive care only in patients with COVID-19-associated cytokine storm syndrome: results of the CHIC study
32713677	Interleukin-6 receptor blocking with intravenous tocilizumab in COVID-19 severe acute respiratory distress syndrome: A retrospective case-control survival analysis of 128 patients
35299062	Safety and efficacy of tocilizumab in the treatment of severe acute respiratory syndrome coronavirus-2 pneumonia: A retrospective cohort study
-	Outcome of Non-Critical COVID-19 Patients with Early Hospitalization and Early Antiviral Treatment Outside the ICU.
32719766	Clinical Use of Short-Course and Low-Dose Corticosteroids in Patients With Non-severe COVID-19 During Pneumonia Progression
33521304	Tocilizumab plus glucocorticoids in severe and critically COVID-19 patients. A single center experience
35897803	COVID-19: Mechanisms of Vaccination and Immunity
33357185	Hydroxychloroquine and azithromycin combination could be lethal to covid-19 patients
35896292	Neurological Disorders Identified during Treatment of a SARS-CoV-2 Infection
32715804	ADRS due to COVID-19 in midterm pregnancy: successful management with plasma transfusion and corticosteroids
33673818	Tocilizumab improves survival in patients with persistent hypoxia in severe COVID-19 pneumonia
34570886	Medication utilization in patients in New York hospitals during the COVID-19 pandemic
32707096	Retrospective Multicenter Cohort Study Shows Early Interferon Therapy Is Associated with Favorable Clinical Responses in COVID-19 Patients
35657993	Tocilizumab for severe COVID-19: a systematic review and meta-analysis
-	Vacunas para SARS-CoV-2, diferentes estrategias de los desarrollos en curso
35713132	Remdesivir—Bringing Hope for COVID-19 Treatment
-	Therapeutic blockade of inflammation in severe COVID-19 infection with intravenous n-acetylcysteine
32715376	Successful treatment of two Japanese ESRD cases with severe COVID‐19 pneumonia
32711297	COVID-19 and multiple sclerosis: a description of two cases on alemtuzumab
32680535	Infliximab against severe COVID-19-induced cytokine storm syndrome with organ failure – a cautionary case series
32514354	High‐dose, short‐term corticosteroids for ARDS caused by COVID ‐19: a case series
32709838	Unusual Early Recovery of a Critical COVID-19 Patient After Administration of Intravenous Vitamin C
35536525	An infant with coronavirus disease 2019 in China: A case report
35475016	High doses of hydroxychloroquine do not affect viral clearance in patients with SARS-CoV-2 infection
33746047	Utilization of COVID-19 treatments and clinical outcomes among patients with cancer: A COVID-19 and Cancer Consortium (CCC19) cohort study
35046626	Ribavirin Therapy For Severe COVID-19: A Retrospective Cohort Study
34282406	Remdesivir for Severe COVID-19 versus a Cohort Receiving Standard of Care
32674818	The Effects of ARBs, ACEis, and Statins on Clinical Outcomes of COVID-19 Infection Among Nursing Home Residents
32706087	A systematic review on the efficacy and safety of IL-6 modulatory drugs in the treatment of COVID-19 patients
34228347	Rationale and evidence on the use of tocilizumab in COVID-19: a systematic review
32758899	BCG vaccination and COVID-19: Much ado about nothing?
32702153	Management of immunosuppression in kidney transplant recipients with COVID-19 pneumonia: A summary of 41 confirmed cases reported worldwide
-	Therapeutic Plasma Exchange: a potential management strategy for critically III COVID-19 patients. 2020
-	Prolonged viral shedding in a lymphoma patient with COVID-19 infection receiving convalescent plasma
-	Persistent COVID-19 in an Immunocompromised Patient Temporarily Responsive to Two Courses of Remdesivir Therapy
32550258	As the COVID-19 pandemic drags on, where have all the STEMIs gone?
32701969	Safety, tolerability, and clinical outcomes of hydroxychloroquine for hospitalized patients with coronavirus 2019 disease
32690352	Experience with tocilizumab in severe COVID-19 pneumonia after 80 days of follow-up: A retrospective cohort study
32684169	Neuromuscular blocking agents (NMBA) for COVID-19 acute respiratory distress syndrome: a multicenter observational study
32868435	Early IL-1 receptor blockade in severe inflammatory respiratory failure complicating COVID-19
32700398	Low plasma 25(OH) vitamin D level is associated with increased risk of COVID-19 infection: an Israeli population-based study
-	A Small-Scale Medication of Leflunomide as a Treatment of COVID-19 in an Open-Label Blank-Controlled Clinical Trial
-	Recommendations on antithrombotic treatment during the COVID-19 pandemic. Position statement of the Working Group on Cardiovascular Thrombosis of the Spanish Society of Cardiology
32682575	Targeting Cytokine Storm to Manage Patients with COVID-19: A Mini- Review
32696429	Azithromycin in COVID‑19 Patients: Pharmacological Mechanism, Clinical Evidence and Prescribing Guidelines
32696570	Tocilizumab therapy in individuals with COVID-19 infection and hyperinflammatory state
-	A Case of COVID-19 in a Patient with Asymptomatic Hemoglobin D Thalassemia and Glucose-6-Phosphate Dehydrogenase Deficiency
-	Successful remission induction therapy with gilteritinib in a patient with de novo FLT3‐mutated acute myeloid leukaemia and severe COVID‐19
-	The Combined Use of Tocilizumab and Hemoadsorption in a Patient with SARS-COV-2-19-Associated Pneumonia: A Case Report
-	High-dose chemotherapy in a patient with coronavirus disease (COVID-19)
32697931	Detection of anti-heparin-PF4 complex antibodies in COVID-19 patients on heparin therapy
35873716	Administration of umbilical cord mesenchymal stem cells in patients with severe COVID-19 pneumonia
-	Tocilizumab for patients with severe COVID-19: a retrospective, multi-centre study
35905465	Hydroxychloroquine with or without Azithromycin in Mild-to-Moderate COVID-19.
35905562	Use of remdesivir for patients with Covid-19: a review article
32837030	Novel Stem Cells and Nucleic Acid-Based Vaccine Trials Against Viral Outbreak: A Systematic Evaluation During COVID-2019 Pandemic
34220503	Hydroxychloroquine for COVID-19: What is Our Current State of Knowledge?
32685874	Anticoagulation, immortality, and observations of COVID-19
33279832	Pros and cons for use of statins in people with coronavirus disease-19 (COVID-19)
32522226	Low molecular weight heparins in COVID-19 patients: beware of augmented renal clearance!
32585589	Immune-related pneumonitis with nivolumab and ipilimumab during the coronavirus disease 2019 (COVID-19) pandemic
32649228	Low- dose systemic steroids, an emerging therapeutic option for COVID-19 related urticaria
32584421	Combined IL-6 and JAK-STAT inhibition therapy in COVID-19 related sHLH, potential game changer
32652563	Remdesivir during induction chemotherapy for newly diagnosed paediatric acute lymphoblastic leukaemia with concomitant SARS-CoV-2 infection
32835274	Acute cor pulmonale in COVID-19-related ARDS: improvement with almitrine infusion
-	Differential Diagnosis and Clinical Management of a Case of COVID-19 in a Patient With Stage III Lung Cancer Treated With Radio-chemotherapy and Durvalumab
-	"Effectiveness of Tocilizumab in a COVID-19 Patientwith Cytokine Release Syndrome"
-	SARS-CoV-2 infection in a psoriatic arthritis patient treated with IL-17 inhibitor
32685369	Early use of tocilizumab in respiratory failure associated with acute COVID -19 pneumonia in recipients with solid organ transplantation
32675436	Tailoring steroids in the treatment of COVID-19 pneumonia assisted by CT scans: Three case reports
35577652	Heparin-induced thrombocytopenia with thrombosis in COVID-19 adult respiratory distress syndrome.
32628001	A possible benefit from therapeutic anticoagulation in COVID-19: the Dolo hospital experience in Veneto, Italy
35892438	Effects on QT interval of hydroxychloroquine associated with ritonavir/darunavir or azithromycin in patients with SARS-CoV-2 infection
32692874	The hazard of (sub)therapeutic doses of anticoagulants in non‐critically ill patients with Covid‐19: the Padua province experience
32561148	Treatment Considerations for COVID-19: A Critical Review of the Evidence (or Lack Thereof)
32687267	Chloroquine and hydroxychloroquine for the prevention and therapy of COVID-19: new hopes and old cardiovascular concerns
-	The potential role of IL-6 in monitoring severe case of coronavirus disease 2019
-	Severe COVID-19 in a patient with chronic graft-versus-host disease after hematopoietic stem cell transplant successfully treated with ruxolitinib
-	Safety and Efficacy of Amiodarone in a Patient With COVID-19
32563271	Case Report: A COVID-19 Patient Presenting with Mild Rhabdomyolysis
35577652	Heparin‐induced Thrombocytopenia with Thrombosis in COVID‐19 Adult Respiratory Distress Syndrome
32379903	Outcome of a patient with refractory Hodgkin lymphoma on pembrolizumab, infected with SARS-CoV-2
34611072	The Role of Interleukin-6 Inhibitors in the Treatment of COVID-19 Infections: A Case Series
32692462	Abnormal laboratory findings and plasma concentration monitoring of lopinavir and ritonavir in COVID-19
34285519	Clinical characteristics and treatment of critically ill patients with COVID-19 in Hebei
32594787	COVID-19 in pemphigus vulgaris patients with previous rituximab therapy: A tele-medicine experience
35502801	Use of tocilizumab in kidney transplant recipients with COVID-19
32621881	Incidence of arrhythmias and electrocardiographic abnormalities in symptomatic pediatric patients with pcr positive SARS-Cov-2 infection including drug induced changes in the corrected qt interval (QTc) (2020)
-	Efficacy of ACEIs/ARBs versus CCBs on the progression of COVID-19 patients with hypertension in Wuhan: A hospital-based retrospective cohort study
35423847	Remdesivir for the Treatment of Covid-19 - Preliminary Report
35158480	Negative SARS-CoV-2 antibody testing following COVID-19 infection in Two MS patients treated with ocrelizumab
32493739	Kawasaki-like multisystem inflammatory syndrome in children during the covid-19 pandemic in Paris, France: prospective observational study
32683974	Gastrointestinal Perforation After Treatment With Tocilizumab: An Unexpected Consequence of COVID-19 Pandemic
-	Successful Treatment of Severe COVID-19 Pneumonia With Clazakizumab in a Heart Transplant Recipient: A Case Report
32574337	Case Report: Clinical Treatment of the First Critical Patient With Coronavirus Disease (COVID-19) in Liaocheng, Shandong Province
32686633	QT Interval Evaluation Associated With Use of Hydroxychloroquine with Combined Use of Azithromycin Among Hospitalized Children Positive for COVID-19
32687645	Clinical outcomes and adverse events in patients hospitalised with COVID‐19, treated with off‐label hydroxychloroquine and azithromycin
32683212	Update I. A systematic review on the efficacy and safety of chloroquine/hydroxychloroquine for COVID-19
35660738	Immunogenicity and safety of a recombinant adenovirus type-5-vectored COVID-19 vaccine in healthy adults aged 18 years or older: a randomised, double-blind, placebo-controlled, phase 2 trial
32678017	A synergistic role of convalescent plasma and mesenchymal stem cells in the treatment of severely ill COVID-19 patients: a clinical case report
-	Vitamin D Sufficiency Reduced Risk for Morbidity and Mortality in COVID-19 Patients
35899342	COVID-19 in two infants in China
32682360	The use of hydroxychloroquine plus azithromycin and early hospital admission are beneficial in Covid-19 patients: Turkey experience with real-life data
34228774	A critical evaluation of glucocorticoids in the management of severe COVID19
35568573	The cardiovascular effects of treatment with hydroxychloroquine and azithromycin
32682342	A pandemic center's experience of managing pregnant women with COVID-19 infection in Turkey: A prospective cohort study
33920093	Dexamethasone in Hospitalized Patients with Covid-19 — Preliminary Report
-	Effet bénéfique de l'association hydroxychloroquine/azithromycine dans le traitement des patients âgés atteints de la COVID-19: résultats d'une étude observationnelle
-	Mild COVID‐19 infection in an NMO patient treated with tocilizumab: a confrmation of anti‐IL‐6 protective role?
-	Systematic analysis of COVID-19 infection and symptoms in a systemic lupus erythematosus population: correlation with disease characteristics, hydroxychloroquine use and immunosuppressive treatments
32674929	Reply to Gautret et al: hydroxychloroquine sulfate and azithromycin for COVID-19: what is the evidence and what are the risks?
35050225	Risk of severe COVID-19 in hypertensive patients treated with renin-angiotensin-aldosterone system inhibitors
32702298	Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trial
-	Clinical course of COVID-19 in a series of patients with chronic arthritis treated with immunosuppressive targeted therapies
32670785	Successful recovery from COVID-19 pneumonia after receiving baricitinib, tocilizumab, and remdesivir. A case report: Review of treatments and clinical role of computed tomography analysis
32668103	Case 24-2020: A 44-Year-Old Woman with Chest Pain, Dyspnea, and Shock
35797144	Cardiac Dysfunction and Shock in Pediatric Patients With COVID-19
-	COVID-19 in a patient with active tuberculosis: A rare case-report
-	Multiple Acute Ischemic Strokes in a COVID-19 Patient: a Case Report
35093528	Tocilizumab for the treatment of adult patients with severe COVID‐19 pneumonia: a single‐center cohort study
32673060	Hydroxychloroquine in Nonhospitalized Adults With Early COVID-19: A Randomized Trial
35262569	Hydroxychloroquine for Early Treatment of Adults with Mild Covid-19: A Randomized-Controlled Trial
34534511	Efficacy and safety of interferon β-1a in treatment of severe COVID-19: A randomized clinical trial
32855991	Antiviral Activity and Safety of Darunavir/Cobicistat for Treatment of COVID-19
32667699	Systematic Review and Meta-analysis of Effectiveness of Treatment Options Against SARS-CoV-2 infection
32837093	COVID-19 Vaccines: A Race Against Time in the Middle of Death and Devastation!
32636754	A Snapshot of the Global Race for Vaccines Targeting SARS-CoV-2 and the COVID-19 Pandemic
34798306	Corticosteroid administration for viral pneumonia: COVID-19 and beyond
32616467	Mesenchymal stem cells in the fight against viruses: Face to face with the invisible enemy
32758889	Rethinking interleukin-6 blockade for treatment of COVID-19
35872668	Severe coronavirus infection in pregnancy: challenging cases report
32633594	Could anti‐hypertensive drug therapy affect the clinical prognosis of hypertensive patients with COVID‐19 infection? Data from centers of southern Italy
32958511	Interleukin-6 receptor blockade with subcutaneous tocilizumab in severe COVID-19 pneumonia and hyperinflammation: a case–control study
32633865	A retrospective review of memantine use and COVID-19-associated mortality from a national database
-	Atorvastatin associated with decreased hazard for death in COVID-19 patients admitted to an ICU: a retrospective cohort study
-	The Use of IV vitamin C for patients with COVID-19: a single center observational study
-	Characteristics, predictors and outcomes among 99 patients hospitalised with COVID-19 in a tertiary care centre in Switzerland: an observational analysis
34374713	The hypercoagulable state in COVID-19: Incidence, pathophysiology, and management
35636275	COVID-19 in 7 multiple sclerosis patients in treatment with ANTI-CD20 therapies
32650356	Covid-19: A systemic disease treated with a wide-ranging approach: A case report
35873181	A Case of COVID-19 with Acute Myocardial Infarction and Cardiogenic Shock
32654163	First case of DRESS syndrome caused by hydroxychloroquine with a positive patch test
32766535	Subcutaneous tocilizumab treatment in patients with severe COVID-19-related cytokine release syndrome: An observational cohort study
35894609	Association Between Renin-Angiotensin-Aldosterone System Inhibitors and COVID-19
32654555	Clinical Features of COVID-19 in Patients With Essential Hypertension and the Impacts of Renin-angiotensin-aldosterone System Inhibitors on the Prognosis of COVID-19 Patients
35900642	Treatment with proton pump inhibitors increases the risk of secondary infections and ARDS in hospitalized patients with COVID-19: coincidence or underestimated risk factor?
35403380	A Randomized, Open‐label, Controlled Clinical Trial of Azivudine Tablets in the Treatment of Mild and Common COVID‐19, A Pilot Study
32619884	Could anti-CD20 therapy jeopardise the efficacy of a SARS-CoV-2 vaccine?
35455301	An mRNA Vaccine against SARS-CoV-2 — Preliminary Report
32612804	Emerging and experimental treatments for COVID-19 and drug interactions with psychotropic agents
32627127	Clinical guidance for navigating the QTc-prolonging and arrhythmogenic potential of pharmacotherapy during the COVID-19 pandemic
33692615	Pros and cons of corticosteroid therapy for COVID-19 patients
-	Coronavirus disease 2019 rash in a psoriatic patient treated with Secukinumab: is there a role for Interleukin 17?
34649563	Clinical characteristics and management of a liver transplanted patient admitted with SARS-CoV-2 infection
32656044	Pulse Therapy With Corticosteroids and Intravenous Immunoglobulin in the Management of Severe Tocilizumab-Resistant COVID-19: A Report of Three Clinical Cases
32550127	Management of the first severe case of COVID-19 in the small islands of Maldives
32628137	Association between chronic ACE inhibitor exposure and decreased odds of severe disease in patients with COVID-19
32641191	Bacillus Calmette–Guérin vaccination and clinical characteristics and outcomes of COVID-19 in Rhode Island, United States: a cohort study
32653015	Comparison of hydroxychloroquine, lopinavir/ritonavir, and standard of care in critically ill patients with SARS-CoV-2 pneumonia: an opportunistic retrospective analysis
35905043	QT prolongation in adiverse, urban population of COVID-19 patients treated with hydroxychloroquine, chloroquine, or azithromycin
35024360	The risk of QTc-interval prolongation in COVID-19 patients treated with chloroquine
-	Hydroxychloroquine and Azithromycin as a Treatment of COVID-19: Results of an 1 Open-Label Non-Randomized Clinical Trial: Response to David Spencer (Elsevier)
32650355	Antirheumatic drugs for COVID-19 treatment based on the phases of the disease: Current concept
32651941	That Escalated Quickly: Remdesivir's Place in Therapy for COVID-19
35031265	An adult with Kawasaki-like multisystem inflammatory syndrome associated with COVID-19
33214651	Iloprost for COVID-19-related vasculopathy
-	Portal vein thrombosis in a patient with COVID-19
35891168	BCG vaccine protection from severe coronavirus disease 2019 (COVID-19)
32652164	SAFETY AND EFFICACY OF ANTI-IL6-RECEPTOR TOCILIZUMAB USE IN SEVERE AND CRITICAL PATIENTS AFFECTED BY CORONAVIRUS DISEASE 2019: A COMPARATIVE ANALYSIS
32646770	Clinical characteristics and predictors of survival in adults with coronavirus disease 2019 receiving tocilizumab
-	Evaluation of safety, efficacy, tolerability, and treatment-related outcomes of type I interferons for human coronaviruses (HCoVs) infection in clinical practice: An updated critical systematic review and meta-analysi
35904406	Convalescent plasma or hyperimmune immunoglobulin for people with COVID-19: a living  systematic review
35296091	Potential adjuvants for the development of a SARS-CoV-2 vaccine based on experimental results from similar coronaviruses
35432612	Role of vitamin D in preventing of COVID-19 infection, progression and severity
34686643	Lithium Toxicity in Two Coronavirus Disease 2019 (COVID-19) Patients
32644205	Clinical exacerbation of SARS-CoV2 infection after fingolimod withdrawal
32601378	COVID-19 among fit patients with CLL treated with venetoclax-based combinations
32632355	Efficacy and safety of tocilizumab in critically ill adults with COVID-19 infection in Bahrain: A report of 5 cases
32653054	Intensive care admissions of children with paediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2 (PIMS-TS) in the UK: a multicentre observational study
-	Coronavirus disease 2019 (COVID‑19) in a patient with ankylosing spondylitis treated with secukinumab: a case‑based review
32637086	Severe refractory COVID-19 patients responding to convalescent plasma
32620409	Life-saving effect of convalescent plasma treatment in covid-19 disease: Clinical trial from eastern Anatolia
32644254	Early use of tocilizumab in the prevention of adult respiratory failure in SARS-CoV-2 infections and the utilization of interleukin-6 levels in the management
35894360	Treating COVID-19 with Chloroquine
34733538	The use of renin angiotensin system inhibitor on mortality in patients with coronavirus disease 2019 (COVID-19): A systematic review and meta-analysis
35832701	Hydroxychloroquine safety: A meta-analysis of randomized controlled trials
35858382	SARS-CoV-2: Virology, epidemiology, immunology and vaccine development
35477027	Update on use of chloroquine/hydroxychloroquine to treat coronavirus disease 2019 (COVID-19)
32485970	A Review on SARS-CoV-2 Virology, Pathophysiology, Animal Models, and Anti-Viral Interventions
32582221	Could Coronavirus Disease 2019 (COVID-19) Render Natural Immunity to Re-infections? A Spotlight on the Therapeutic Pipeline
32638884	Primum non nocere _ Are chloroquine and hydroxychloroquine safe prophylactic/treatment options for SARS-CoV-2 (covid-19)?
34986000	No evidence of rapid antiviral clearance or clinical benefit with the combination of hydroxychloroquine and azithromycin in patients with severe COVID-19 infection
-	Convalescent Plasma Therapy: Helpful Treatment of COVID-19 in a Kidney Transplant Recipient presenting with serve clinical manifestation and complex complications
-	Coronavirus disease 2019 (COVID-19) pneumonia in a hemodialysis patient: A case report
-	First case of convalescent plasma transfusion in a child with COVID-19-associated severe aplastic anemia
32635353	Treatment of severe COVID-19 with tocilizumab mitigates cytokine storm and averts mechanical ventilation during acute respiratory distress: a case report and literature review
-	Prolonged presence of SARS-CoV-2 in a COVID-19 case with rheumatoid arthritis taking iguratimod treated with ciclesonide
-	Association between angiotensin blockade and COVID-19 severity in Hong Kong
32564905	Protective role of chronic treatment with direct oral anticoagulants in elderly patients affected by interstitial pneumonia in COVID-19 era
32621202	Use of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers in context of COVID-19 outbreak: a retrospective analysis
32860325	Incidence of Deep Vein Thrombosis among non-ICU Patients Hospitalized for COVID-19 Despite Pharmacological Thromboprophylaxis
-	Clinical course, severity and mortality in a cohort of patients with COVID-19 with rheumatic diseases
32634589	Potential effective treatment for COVID-19: systematic review and meta-analysis of the severe infectious disease with convalescent plasma therapy
32629768	Role of Lopinavir/Ritonavir in the Treatment of Covid-19: A Review of Current Evidence, Guideline Recommendations, and Perspectives
35854384	Obstetric Management of COVID-19 in Pregnant Women
32633162	Successful Treatment of Covid-19 Associated Cytokine Release Syndrome with Colchicine. A Case Report and Review of Literature
32593961	Is serological response to SARS-CoV-2 preserved in MS patients on ocrelizumab treatment? A case report
32627442	Convalescent Plasma Therapy in Coronavirus Disease 2019: a Case Report and Suggestions to Overcome Obstacles
34130113	Mortality and the use of antithrombotic therapies among nursing home residents with COVID ‐19
32617806	Successful use of tPA for thrombolysis in COVID related ARDS: a case series
32566579	Clinical characteristics of 16 patients with COVID-19 infection outside of Wuhan, China: a retrospective, single-center study
35906045	Healthcare workers & SARS-CoV-2 infection in India: A case-control investigation in the time of COVID-19
32574789	Predictive factors of mortality in patients treated with tocilizumab for acute respiratory distress syndrome related to coronavirus disease 2019 (COVID-19)
32623080	An Observational Cohort Study of Hydroxychloroquine and Azithromycin for COVID-19: (Can’t Get No) Satisfaction
34879491	Corticosteroid therapy for patients with CoVID-19 pneumonia: a before-after study
32531955	Prospects of Replication-Deficient Adenovirus Based Vaccine Development against SARS-CoV-2
32574268	Fighting the Host Reaction to SARS-COv-2 in Critically Ill Patients: The Possible Contribution of Off-Label Drugs
32622993	Prophylactic (hydroxy)chloroquine in COVID-19: potential relevance for cardiac arrhythmia risk
32629149	Janus sword actions of chloroquine and hydroxychloroquine against COVID-19
34388532	Repositioning chloroquine as antiviral prophylaxis against COVID-19: potential and challenges.
32617244	A Case of COVID-19 Infection With Delayed Thromboembolic Complication on Warfarin
32619760	Associations of clinical characteristics and treatment regimens with viral RNA shedding duration in patients with COVID-19
32626630	Serious adverse events associated with hydroxychloroquine amidst COVID-19 pandemic: case series and literature review
32838309	COVID-19 in patients with rheumatic disease in Hubei province, China: a multicentre retrospective observational study
32632417	Incidence and clinical profiles of COVID-19 pneumonia in pregnant women: A single-centre cohort study from Spain
32610873	Characteristics, treatment outcomes and role of hydroxychloroquine among 522 COVID-19 hospitalized patients in Jaipur City: an epidemio-clinical study
34044300	Assessing the risk of seizures with chloroquine or hydroxychloroquine therapy for COVID-19 in persons with epilepsy
35788169	Psychiatric adverse events with hydroxychloroquine during COVID-19 pandemic
35881908	RAAS inhibitors do not increase the risk of COVID-19
-	Tocilizumab and Remdesivir in a Pregnant Patient With Coronavirus Disease 2019 (COVID-19)
32619764	Case reports study of the first five patients COVID-19 treated with remdesivir in France
32620147	Nafamostat mesylate treatment in combination with favipiravir for patients critically ill with Covid-19: a case series
32368755	A Recovered Case of COVID-19 Myocarditis and ARDS Treated With Corticosteroids, Tocilizumab, and Experimental AT-001
32411770	Clinical characteristics of 60 discharged cases of 2019 novel coronavirus-infected pneumonia in Taizhou, China
32621621	Lopinavir/ritonavir is associated with pneumonia resolution in COVID-19 patients with influenza coinfection: a retrospective matched-pair cohort study
32816702	Interleukin-6 blockade with sarilumab in severe COVID-19 pneumonia with systemic hyperinflammation: an open-label cohort study
35531426	Treatment with Hydroxychloroquine, Azithromycin, and Combination in Patients Hospitalized with COVID-19
35848641	Hydroxychloroquine as Prophylaxis or Treatment for COVID-19: What Does the Evidence Say?
32526079	Current status of mesenchymal stem cell therapy for immune/inflammatory lung disorders: Gleaning insights for possible use in COVID-19
35794900	Massive Pulmonary Thromboembolism in Patients with COVID-19
32609083	COVID-19 in Patient with Sarcoidosis Receiving Long-Term Hydroxychloroquine Treatment, France, 2020
-	Treatment and preliminary outcomes of 150 acute care patients with COVID-19 in a rural health system in the Dakotas
35857159	Effects of Hydroxychloroquine Treatment on QT Interval
35904437	Treatment with ACE inhibitors or ARBs and risk of severe/lethal COVID-19: a meta-analysis
35707401	Use of Baricitinib in Patients with Moderate and Severe COVID-19
-	Cutaneous side effects of hydroxychloroquine in health care workers in a COVID referral hospital - implications for clinical practice
-	Severe COVID-19 Infection While on Long Standing Therapy with Hydroxychloroquine
35756668	Imatinib for COVID-19: A case report
-	Drug-induced liver injury in a COVID-19 patient: potential interaction of remdesivir with Pglycoprotein inhibitors
-	Severe COVID-19 infection in a patient with multiple sclerosis treated with fingolimod
32603010	Belatacept, kidney transplantation and COVID-19: successful management of the first reported case within the United Kingdom
-	Tratamiento y evolucion del sindrome de tormenta de citoquinas asociados a infeccion por SARS-CoV-2 en pacientes octogenários
32569491	Is the use of ACE inb/ARBs associated with higher in-hospital mortality in Covid-19 pneumonia patients?
-	Impact of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers on COVID-19 in a western population. CARDIOVID registry
-	Role of corticosteroid in the management of COVID-19: A systemic review and a clinician’s perspective.
32533071	Ivermectin: a systematic review from antiviral effects to COVID-19 complementary regimen
33635229	Coronavirus disease-19 and rheumatological disorders: A narrative review
32529517	Venous Thromboembolism in COVID-19: Towards an Ideal Approach to Thromboprophylaxis, Screening, and Treatment
32585765	A Case of Successful Treatment of Severe COVID-19 Pneumonia with Favipiravir and Tocilizumab in Post-kidney Transplant Recipient
32602262	Use of anakinra to prevent mechanical ventilation in severe COVID‐19: a case series
-	Can hydroxychloroquine be useful in the prevention of COVID-19? An Italian survey in dermatological and rheumatological patients already under treatment
32603493	Methylprednisolone added to tocilizumab reduces mortality in SARS‐CoV‐2 pneumonia: an observational study
35892438	Association of Hydroxychloroquine with QTc Interval in Patients
32579195	Effect of Colchicine vs Standard Care on Cardiac and Inflammatory Biomarkers and Clinical Outcomes in Patients Hospitalized With Coronavirus Disease 2019: The GRECCO-19 Randomized Clinical Trial
32603531	Febuxostat therapy in outpatients with suspected COVID-19: A clinical trial
35886565	Nanotechnology for COVID-19: Therapeutics and Vaccine Research
34063964	Available Evidence and Ongoing Clinical Trials of Remdesivir: Could It Be a Promising Therapeutic Option for COVID-19?
32588163	Auxiliary role of mesenchymal stem cells as regenerative medicine soldiers to attenuate inflammatory processes of severe acute respiratory infections caused by COVID-19
32584474	A brief review of interplay between vitamin D and angiotensin-converting enzyme 2: Implications for a potential treatment for COVID-19
33521301	Pneumococcal superinfection in COVID-19 patients: a series of 5 cases
-	Successful treatment of chronic myelomonocytic leukaemia with hydroxycarbamide in a patient presenting with acute hypoxic respiratory failure due to COVID‐19 pneumonia
35642468	Multisystem Inflammatory Syndrome in U.S. Children and Adolescents
32594619	Prior treatment with immunosuppressants among COVID‐19 inpatients at one hospital in Spain
35815299	Multisystem Inflammatory Syndrome in Children in New York State
35811982	In-Hospital Use of Statins Is Associated with a Reduced Risk of Mortality among Individuals with COVID-19
-	Incidence of severe COVID-19 in a Spanish cohort of 1037 patients with rheumatic diseases treated with biologics and JAK-inhibitors.
34012395	TB infection and BCG vaccination: are we protected from COVID-19?
32584431	Colchicin Treatment of Covid-19 Presenting With Cutaneous Rash and Myopericarditis
32558945	A case series of COVID‐19 patients with chronic hepatitis B virus infection
-	Favorable COVID-19 course despite significant comorbidities in a ruxolitinib-treated patient with primary myelofibrosis
32593183	Ruxolitinib for Tocilizumab-Refractory Severe COVID-19 Infection
32584416	Amelioration of COVID-19 related cytokine storm syndrome: Parallels to chimeric antigen receptor-T cell cytokine release syndrome
-	A case of erythema multiforme major in a patient with COVID 19: The role of corticosteroid treatment
32593180	Convalescent plasma for persisting Covid-19 following therapeutic lymphocyte depletion: a report of rapid recovery
34722046	A case of Covid-19 patient with acute limb ischemia and heparin resistance
32593867	Outcomes of 3,737 COVID-19 patients treated with hydroxychloroquine/azithromycin and other regimens in Marseille, France: A retrospective analysis
32588427	QT interval prolongation under hydroxychloroquine/ azithromycin association for inpatients with SARS-CoV-2 lower respiratory tract infection
32574312	Clinical Implications of Chloroquine and Hydroxychloroquine Ototoxicity for COVID-19 Treatment: A Mini-Review
33088574	Clinical Efficacy of Chloroquine derivatives in COVID-19 Infection: Comparative meta-analysis between the Big data and the real world
32578156	Lopinavir-Ritonavir in the Treatment of COVID-19: A Dynamic Systematic Benefit-Risk Assessment
35295732	Short-Term Dexamethasone in Sars-CoV-2 Patients
34385593	Ruxolitinib for the treatment of SARS-CoV-2 induced acute respiratory distress syndrome (ARDS)
34337913	Compassionate Use of Tocilizumab for Treatment of SARS-CoV-2 Pneumonia
-	Anakinra, una alternativa potencial en el tratamiento de la infección respiratoria grave por SARS-CoV-2 refractaria a tocilizumab
33120400	Infusion of convalescent plasma is associated with clinical improvement in critically ill patients with COVID-19: a pilot study
32562159	The clinical value of two combination regimens in the Management of Patients Suffering from Covid-19 pneumonia: a single centered, retrospective, observational study
35777750	Tocilizumab in patients with severe COVID-19: a retrospective cohort study
32581810	Combination of Ruxolitinib and Eculizumab for Treatment of Severe SARS-CoV-2-Related Acute Respiratory Distress Syndrome: A Controlled Study
35749386	SARS-CoV-2 infection and stem cells: Interaction and intervention.
32568411	Tocilizumab’s efficacy in COVID-19 patients is determined by the presence of cytokine storm.
32568376	Successful treatment of severe COVID-19 with subcutaneous anakinra as a sole treatment. Rheumatology.
-	Complicated coronavirus disease 2019 (COVID-19) in a psoriatic patient treated with ixekizumab.
-	Coronavirus disease 2019: favorable outcome in an immunosuppressed patient with multiple sclerosis
35367528	Rapid radiological improvement of COVID-19 pneumonia after treatment with tocilizumab
32557694	Clinical features and the treatment of children with COVID-19: A case series from Wenzhou, China
32562070	A complex COVID-19 case with rheumatoid arthritis treated with tocilizumab
32550090	Bradycardia in Patients With COVID-19: A Calm Before the Storm?
35906025	Systemic or biologic treatment in psoriasis patients does not increase the risk of a severe form of COVID-19
-	Improved Clinical Symptoms and Mortality on Severe/Critical COVID-19 Patients Utilizing Convalescent Plasma Transfusion
35550376	BCG Vaccination in infancy does not protect against COVID‐19. Evidence from a natural experiment in Sweden
32563675	Investigational therapies for the treatment of COVID-19: updates from ongoing clinical trials.
32560646	Non-optimal effectiveness of convalescent plasma transfusion and hydroxychloroquine in treating COVID-19: a case report.
32565309	Effect of combination antiviral therapy on hematological profiles in 151 adults hospitalized with severe coronavirus disease 2019.
32557648	Vaccine development and therapeutic design for 2019‐ncov/SARS‐cov‐2: challenges and chances.
35126885	A Comprehensive Review on Tocilizumab in COVID-19 Acute Respiratory Distress Syndrome.
-	Coagulopathy, thromboembolic complications and the use of heparin in COVID-19 Pneumonia,
35657109	Tocilizumab treatment for Cytokine Release Syndrome in hospitalized COVID-19 patients: survival and clinical outcomes.
32838307	COVID-19 in patients with rheumatic diseases in northern Italy : a single-centre observational and case – control study.
-	Compassionate use of hydroxychloroquine in clinical practice for patients with mild to severe Covid-19 in a French university hospital.
35864917	Association of Angiotensin-Converting Enzyme Inhibitor or Angiotensin Receptor Blocker Use With COVID-19 Diagnosis and Mortality.
32556875	Antithrombotic Therapies in COVID-19 Disease: a Systematic Review.
32562480	Systematic review of registered trials of Hydroxychloroquine prophylaxis for COVID-19 health-care workers at the first third of 2020.
35904710	Vaccines and Therapies in Development for SARS-CoV-2 Infections
35499460	Anticoagulation Options for Coronavirus Disease 2019 (COVID-19)-Induced Coagulopathy.
35892311	Clinical use of Convalescent Plasma in the COVID-19 pandemic
35863730	Clinical characteristics, diagnosis, and treatment of COVID-19: A case report.
-	A child with a severe multi-system inflammatory syndrome following an asymptomatic COVID-19 infection: a novel management for a new disease?
-	COVID-19 in a young man with hypertension: A case study of missed opportunities in intensive progression.
32546029	Case report: use of lenzilumab and tocilizumab for the treatment of coronavirus disease 2019.
-	COVID-19 in a patient with severe asthma treated with Omalizumab.
32542893	Acute generalized exanthematous pustulosis induced by empiric hydroxychloroquine for presumed COVID-19
-	Use of amantadine in a patient with SARS‐Cov‐2.
32779755	Hydroxychloroquine treatment in COVID‐19: a descriptive observational analysis of 30 cases from a single center in Wuhan, China.
35011938	Tocilizumab in patients with severe COVID-19: a single-center observational analysis.
-	"Clinical characteristics of 17 patients with COVID-19and systemic autoimmune diseases: aretrospective study."
32536150	Lopinavir-ritonavir versus hydroxychloroquine for viral clearance and clinical improvement in patients with mild to moderate coronavirus disease 2019.
34451835	Baricitinib: A review of pharmacology, safety and emerging clinical experience in COVID-19.
32581514	Characteristics of COVID-19 Clinical Trials in China Based on the Registration Data on ChiCTR and ClinicalTrials.gov.
35852269	Inhaled nitric oxide treatment in spontaneously breathing COVID-19 patients.
32544570	Five severe COVID-19 pneumonia patients treated with triple combination therapy with lopinavir/ritonavir, hydroxychloroquine, and interferon β-1b.
-	Withdrawing mycophenolate mofetil in treating a young kidney transplant recipient with COVID-19.
32835256	GM-CSF blockade with mavrilimumab in severe COVID-19 pneumonia and systemic hyperinflammation: a single-centre, prospective cohort study.
-	Subcutaneous administrationof interferon beta-1a for COVID-19: A noncontrolled prospective trial.
32543164	The comparison of the effectiveness of lincocin® and azitro® in the treatment of covid-19-associated pneumonia: A prospective study.
32535078	Vaccination strategies to combat novel corona virus SARS-CoV-2.
32563812	Promising Antiviral Candidate Drug for the COVID-19 Pandemic: A Mini-Review of Remdesivir.
32533556	Persistent viral RNA shedding after COVID-19 symptom resolution in older convalescent plasma donors.
32534189	Macrolides and viral infections: focus on azithromycin in COVID-19 pathology.
32527327	Flight of the COVID-19 patient: experience with a Wuhan evacuee: a case report.
32530808	Recovery of severely ill COVID-19 patients by intravenous immunoglobulin (IVIG) treatment: A case series.
33019825	A Case Series of Patients Coinfected With Influenza and COVID-19.
-	Can steroids reverse the severe COVID-19 induced 'cytokine storm'?
-	COVID-19 in a patient with multiple sclerosis treated with natalizumab: may the blockade of integrins have a protective role?
32531138	Clinical course and treatment efficacy of COVID-19 near Hubei Province, China: a multicentre, retrospective study.
35598055	Association between renin-angiotensin system inhibitors and COVID-19 complications.
-	Eficacia de los pulsos de corticoides en pacientes con síndrome de liberación de citocinas inducido por infección por SARS-CoV-2.
32529737	Should cyclosporine be useful in renal transplant recipients affected by SARS-CoV-2?
32530369	Lopinavir/ritonavir as a third agent in the antiviral regimen for SARS-CoV-2 infection.
32519302	Mesenchymal stem cell therapy for acute respiratory distress syndrome: from basic to clinics.
32519894	Heparin as a Therapy for COVID-19: Current Evidence and Future Possibilities.
32508168	Effectiveness and safety of available treatments for COVID-19 during pregnancy: a critical review
32516839	Early experience with convalescent plasma as immunotherapy for COVID-19 in China: Knowns and unknowns.
-	Thromboprophylaxis in a patient with COVID-19 and severe hemophilia A on emicizumab prophylaxis.
-	COVID-19 in a severe eosinophilic asthmatic receiving benralizumab – a case study.
32522597	Treatment of SARS-CoV-2 with high dose oral zinc salts: A report on four patients
32518419	The Janus kinase 1/2 inhibitor ruxolitinib in COVID-19 with severe systemic hyperinflammation
32524611	Clinical characteristics of 182 pediatric COVID-19 patients with different severities and allergic status.
32566562	Effectiveness of intravenous immunoglobulin for children with severe COVID-19: a rapid review.
32566556	Efficacy and Safety of Antibiotic Agents in Children with COVID-19: A Rapid Review.
-	Does Adding of Hydroxychloroquine to the Standard Care Provide any Benefit in Reducing the Mortality among COVID-19 Patients?: a Systematic Review.
32514689	The potential of drug repositioning as a short-term strategy for the control and treatment of COVID-19 (SARS-CoV-2): a systematic review.
32574263	MSC Therapies for COVID-19: Importance of Patient Coagulopathy, Thromboprophylaxis, Cell Product Quality and Mode of Delivery for Treatment Safety and Efficacy.
32486469	COVID-19 related coagulopathy: a distinct entity?
35887042	The Current Update of Vaccines for SARS-CoV-2.
-	A case of Bacillus cereus bacteremia in a COVID-19 patient treated with steroids.
32516429	Anticoagulation with Argatroban in patients with acute antithrombin deficiency in severe COVID -19.
-	Higher levels of IL-6 early after tocilizumab distinguish survivors from non-survivors in COVID-19 pneumonia: a possible indication for deeper targeting IL-6.
35754120	Diagnosis and management of the drug hypersensitivity reactions in coronavirus disease 19
33599835	Clinical Characteristics of 58 Children With a Pediatric Inflammatory Multisystem Syndrome Temporally Associated With SARS-CoV-2.
34485878	Multisystem Inflammatory Syndrome Related to COVID-19 in Previously Healthy Children and Adolescents in New York City
32511678	Use of RAAS inhibitors and risk of clinical deterioration in COVID-19: results from an Italian cohort of 133 hypertensives.
-	A study on clinical effect of Arbidol combined with adjuvant therapy on COVID‐19.
32512007	Efficacy of Almitrine in The Treatment of Hypoxemia in Sars-Cov-2 Acute Respiratory Distress Syndrome
-	COVID-19: The Potential Role of Copper and N-acetylcysteine (NAC) in a Combination of Candidate Antiviral Treatments Against SARS-CoV-2.
32501538	A comparative study on the time to achieve negative nucleic acid testing and hospital stays between Danoprevir and Lopinavir/Ritonavir in the treatment of patients with COVID-19.
32496210	Combination antiviral therapy with lopinavir/ritonavir, arbidol and interferon-α1b for COVID-19
35664523	Tocilizumab in the treatment of a critical COVID-19 patient: a case report.
32514354	High‐dose, short‐term corticosteroids for ARDS caused by COVID‐19: a case series. Respirology Case Reports.
32500936	Case series of six kidney transplanted patients with COVID-19 pneumonia treated with tocilizumab.
32499303	Famotidine use and quantitative symptom tracking for COVID-19 in non- hospitalised patients: a case series.
32500224	Severe exacerbation of immune thrombocytopenia and COVID-19: the favorable response to corticosteroid-based therapy—a case report.
-	Tocilizumab administration in a refractory case of COVID-19.
-	Clinical Management of Adult Coronavirus Infection Disease 2019 (COVID-19) Positive in the Setting of Low and Medium Intensity of Care: a Short Practical Review.
-	A case report of serious haemolysis in a glucose-6-phosphate dehydrogenase-deficient COVID-19 patient receiving hydroxychloroquine.
32512349	Anticardiolipin antibodies and COVID-19 - A Case Report from America.
32835251	Canakinumab in subgroup of patients with COVID-19.
33500209	Combination of thrombolytic and immunosuppressive therapy for coronavirus disease 2019: A case report.
32508009	Thalidomide combined with low-dose short-term glucocorticoid in the treatment of critical Coronavirus Disease 2019.
32490532	HyPE study: hydroxychloroquine prophylaxis-related adverse events' analysis among healthcare workers during COVID-19 pandemic: a rising public health concern
33705440	Association of hypertension and antihypertensive treatment with COVID-19 mortality: a retrospective observational study.
32495917	Viral kinetics and factors associated with rapid viral clearance during lopinavir/ritonavir-based combination therapy in non-severe COVID-19 patients.
32889105	Early treatment of COVID-19 patients with hydroxychloroquine and azithromycin: A retrospective analysis of 1061 cases in Marseille, France.
-	Efficacy and safety of antiviral treatment for COVID-19 from evidence in studies of SARSCoV-2 and other acute viral infections: a systematic review and meta-analysis.
-	USO DE IVERMECTINA PARA EL TRATAMIENTO DE PACIENTES ADULTOS CON COVID-19
32491104	Clinical characteristics and therapeutic procedure for a critical case of novel coronavirus pneumonia treated with glucocorticoids and non-invasive ventilator treatment.
-	Convalescent (immune) plasma treatment in a myelodysplastic COVID-19 patient with disseminated tuberculosis.
32426243	The use of convalescent plasma therapy and remdesivir in the successful management of a critically ill obstetric patient with novel coronavirus 2019 infection: A case report.
35905409	Remdesivir and Tocilizumab: Mix or Match.
32492211	Lopinavir/ritonavir and interferon combination therapy may help shorten the duration of viral shedding in patients with COVID-19: a retrospective study in two designated hospitals in Anhui, China.
34487951	COVID-19 patients benefit from early antiviral treatment: a comparative, retrospective study.
32492084	Effect of Convalescent Plasma Therapy on Time to Clinical Improvement in Patients With Severe and Life-threatening COVID-19: A Randomized Clinical Trial
35157053	A Randomized Trial of Hydroxychloroquine as Postexposure Prophylaxis for Covid-19
35897400	Characteristics of registered studies for Coronavirus disease 2019 (COVID-19): A systematic review.
35163923	Cytokine storm in COVID-19: pathogenesis and overview of anti-inflammatory agents used in treatment.
32447629	COVID-19 and NSAIDS: A Narrative Review of Knowns and Unknowns.
35906093	Use of corticosteroids in asthma and COPD patients with or without COVID-19.
-	Tociluzumab challenge: A series of cytokine storm therapy experience in hospitalized Covid-19 pneumonia patients.
-	Persisting SARS-CoV-2 viremia after rituximab therapy: Two cases with fatal outcome and a review of literature.
32475761	Dexmedetomidine and worsening hypoxemia in the setting of COVID-19: A case report.
34215520	Covid-19 infection in psoriasis patients treated with cyclosporin.
32484915	Feasibility of Tocilizumab in ICU patients with COVID-19.
32485061	Incidence and Determinants of QT Interval Prolongation in COVID-19 Patients Treated with Hydroxychloroquine and Azithromycin.
32482597	Efficacy and safety of tocilizumab in severe COVID-19 patients: a single-centre retrospective cohort study.
32479824	Baseline Disease Activity and Steroid Therapy Stratify Risk of COVID-19 in Patients with Inflammatory Bowel Disease.
32360583	Efficacy and safety of current therapeutic options for COVID-19 - lessons to be learnt from SARS and MERS epidemic: A systematic review and meta-analysis.
32473812	Chloroquine and hydroxychloroquine in the management of COVID-19: Much kerfuffle but little evidence
32447429	Trials and tribulations: so many potential treatments, so few answers
-	Chloroquine-induced torsades de pointes in a patient with coronavirus disease 2019.
-	Interleukin-6 Blockade Treatment for COVID-19 associated Cytokine Release Syndrome in a Patient with Poorly Controlled Chronic Myeloid Leukaemia.
32463348	Experience with Hydroxychloroquine and Azithromycin in the COVID-19 Pandemic: Implications for QT Interval Monitoring
-	First case of drug‐induced liver injury associated with the use of tocilizumab in a patient with COVID‐19.
-	Tocilizumab therapy in five solid and composite tissue transplant recipients with early ARDS due to SARS‐CoV‐2.
35576027	Successful use of methylprednisolone for treating severe COVID-19.
32470602	Three cases of treatment with Nafamostat in elderly patients with COVID-19 pneumonia who need oxygen therapy.
35689346	The association between treatment with heparin and survival in patients with Covid-19.
32474860	Potential of Arbidol for Post-exposure Prophylaxis of COVID-19 Transmission—A Preliminary Report of a Retrospective Cohort Study.
32449091	Lack of viral clearance by the combination of hydroxychloroquine and azithromycin or lopinavir and ritonavir in SARS-CoV-2-related acute respiratory distress syndrome.
32451823	Systematic assessment of venous thromboembolism in COVID-19 patients receiving thromboprophylaxis: incidence and role of D-dimer as predictive factors.
35878897	Remdesivir in Treatment of COVID-19: A Systematic Benefit–Risk Assessment
-	Glucocorticoid therapy delays the clearance of SARS-CoV-2 RNA in an asymptomatic COVID-19 patient
32460839	Intravenous infusion of human umbilical cord Wharton’s jelly-derived mesenchymal stem cells as a potential treatment for patients with COVID-19 pneumonia.
35904406	Treatment of COVID-19 Patients with Convalescent Plasma
32469614	A Case Series of Five People Living with HIV Hospitalized with COVID-19 in Chicago, Illinois
32473230	Early administration of ritonavir-boosted lopinavir could prevent severe COVID-19.
32474087	Clinical impact of pre-admission antithrombotic therapy in hospitalized patients with COVID-19: a multicenter observational study
32473657	Description of COVID-19 in HIV-infected individuals: a single-centre, prospective cohort
33455920	Anakinra for severe forms of COVID-19 : a cohort study
-	COVID-19 patients with hypertension have more severity condition, and ACEI/ARB treatment have no infulence on the clinical severity and outcome
-	Ruxolitinib in treatment of severe coronavirus disease 2019 (COVID-19): A multicenter, singleblind, randomized controlled trial
35563515	Ramipril in High Risk Patients with COVID-19
33719819	Clinical evidence for repurposing chloroquine and hydroxychloroquine as antiviral agents: a systematic review
32472653	Cell-based therapy to reduce mortality from COVID-19: Systematic review and meta-analysis of human studies on acute respiratory distress syndrome
-	Remdesivir para el tratamiento de infeccion por Covid-19. Informe de Revisión Rápida
-	An Updated Systematic Review of the Therapeutic Role of Hydroxychloroquine in Coronavirus Disease‑19 (COVID‑19)
35897103	Pharmacological treatment for the Novel Coronavirus Disease 2019 (COVID-19 Infection)
35866236	COVID-19, hypertension and cardiovascular diseases: Should we change the therapy?
-	Early outpatient treatment of symptomatic, high-risk Covid-19 patients that should be ramped-up immediately as key to the pandemic crisis
32458149	Can Zn Be a Critical Element in COVID-19 Treatment?
32460133	Considerations for interactions of drugs used for the treatment of COVID-19 with anti-cancer treatments
35891168	Could BCG Vaccination Induce Protective Trained Immunity for SARS-CoV-2?
32467007	Successful treatment of a centenarian with coronavirus disease 2019 (COVID-19) using convalescent plasma
32483527	Treatment of severe pneumonia due to COVID-19 with peginterferon alfa 2a
32463179	Exposure to DPP-4 inhibitors and COVID-19 among people with type 2 diabetes.
33478708	QT Interval Prolongation and Torsade de Pointes in Patients with COVID-19 treated with Hydroxychloroquine/Azithromycin
35891186	Non-steroidal anti-inflammatory drugs in management of COVID-19
-	Treatments Administered to the First 9152 Reported Cases of COVID-19: A Systematic Review
32459046	Scientific and Standardization Committee Communication: Clinical Guidance on the Diagnosis, Prevention and Treatment of Venous Thromboembolism in Hospitalized Patients with COVID‐19
32458425	Compassionate use of hzVSF-v13 in two patients with severe COVID-19
32455478	A case of cefditoren-induced Acute Generalized Exanthematous Pustulosis during COVID-19 pandemics
-	Mild course of Coronavirus disease 2019 and spontaneous severe acute respiratory syndrome coronavirus 2 clearance in a patient with depleted peripheral blood B-cells due to treatment with rituximab
35529095	Early tocilizumab treatment could improve survival among COVID-19 patients
32441771	COVID‐SAFER: Deprescribing Guidance for Hydroxychloroquine Drug Interactions in Older Adults
35905562	Remdesivir for 5 or 10 Days in Patients with Severe Covid-19
35677110	Remdesivir for the Treatment of COVID-19: A Systematic Review of the Literature
34088524	Decreased Mortality of COVID-19 with Renin-Angiotensin-Aldosterone System Inhibitors Therapy in Patients with Hypertension: A Meta-Analysis
35905465	Hydroxychloroquine or Chloroquine for Treatment or Prophylaxis of COVID-19: A Living Systematic Review
-	A review on possible modes of actions of Chloroquine / Hydroxychloroquine: Repurposing against SAR-COV-2 (COVID 19) pandemic
-	Severe SARS-CoV-2 pneumonia in a 58-year-old patient with HIV: a clinical case report from the Republic of Cyprus
32448377	Stem cell therapy: a potential approach for treatment of influenza virus and coronavirus-induced acute lung injury
35533833	Corticosteroid treatment in severe COVID-19 pneumonia: two cases and literature review
35733306	Efficacy of therapeutic plasma exchange in severe COVID-19 patients
-	Apremilast as a potential treatment option for COVID-19: no symptoms of infection in a psoriatic patient
32449235	Successful recovery from severe COVID-19 pneumonia after kidney transplantation: the interplay between immunosuppression and novel therapy including tocilizumab
32425661	Utilizing tocilizumab for the treatment of cytokine release syndrome in COVID-19
35852985	COVID-19 and systemic lupus erythematosus: a case series
32449022	Acetic acid disinfection as a potential adjunctive therapy for non-severe COVID-19
32437014	A preliminary evaluation on the efficacy of ozone therapy in the treatment of COVID-19
32438464	COVID-19 and Liver Transplantation: lessons learned from three reported cases
32447102	Negative impact of hyperglycaemia on tocilizumab therapy in Covid-19 patients
-	Metformin Treatment Was Associated with Decreased Mortality in COVID-19 Patients with Diabetes in a Retrospective Analysis
32439366	Arrhythmic profile and 24-hour QT interval variability in COVID-19 patients treated with hydroxychloroquine and azithromycin
32445881	Arbidol/IFN-α2b Therapy for Patients With Corona Virus Disease 2019: A Retrospective Multicenter Cohort Study
32444482	Efficacy and safety of convalescent plasma for severe COVID-19 based on evidence in other severe respiratory viral infections: a systematic review and meta-analysis
32437739	Safety and efficacy of early high-dose IV anakinra in severe COVID-19 lung disease
35903291	Convalescent plasma: A possible treatment protocol for COVID- 19 patients suffering from diabetes or underlying liver diseases
32446287	Remdesivir: Review of pharmacology, pre-clinical data and emerging clinical experience for COVID-19
34528484	COVID-19 vaccines: knowing the unknown
32449224	Analysis of the clinical characteristics, drug treatments and prognoses of 136 patients with coronavirus disease 2019
34643857	COVID-19 and QT interval prolongation: more than just drug toxicity?
35728853	Heparin resistance in COVID-19 patients in the intensive care unit
35645037	Coronavirus disease 2019 in children: Characteristics, antimicrobial treatment, and outcomes
32448770	Off-label use of tocilizumab for the treatment of SARS-CoV-2 pneumonia in Milan, Italy [published online ahead of print
32442285	Association of renin-angiotensin-aldosterone system inhibitors with COVID-19-related outcomes in Korea: a nationwide population-based cohort study
35423847	Remdesivir for the Treatment of Covid-19 — Preliminary Report
35870265	QT prolongation, torsades de pointes and sudden death with short courses of chloroquine or hydroxychloroquine as used in COVID-19: a systematic review
32426374	Cardiovascular Impairment in COVID-19: Learning From Current Options for Cardiovascular Anti-Inflammatory Therapy
35878964	Hepatic complications of COVID‐19 and its treatment
34649116	Convalescent Plasma Therapy: A Passive Therapy for An Aggressive COVID-19
34315190	The immunology of COVID-19: is immune modulation an option for treatment?
-	Role of adjunctive treatment strategies in COVID-19 and a review of international and national clinical guidelines
32426753	Rationale for Prolonged Corticosteroid Treatment in the Acute Respiratory Distress Syndrome Caused by Coronavirus Disease 2019
-	Pharmaco-invasive Therapy for STEMI in a Patient with COVID-19: A Case Report
35874315	Extracorporeal Membrane Oxygenation as Treatment of Severe COVID-19 Infection: A Case Report
32437019	Baricitinib: a chance to treat COVID‐19?
-	COVID-19 infection in a patient with multiple sclerosis treated with fingolimod
32427774	Early Outcomes with Utilization of Tissue Plasminogen Activator in COVID-19 Associated Respiratory Distress: A series of five cases
32430456	Outcomes in Patients With Hyperglycemia Affected by Covid-19: Can We Do More on Glycemic Control?
35905465	Hydroxychloroquine or chloroquine with or without a macrolide for treatment of COVID-19: a multinational registry analysis
32430428	Factors associated with prolonged viral shedding and impact of Lopinavir/Ritonavir treatment in hospitalised non-critically ill patients with SARS-CoV-2 infection
-	SARS2-CoV-2 and Stroke in a New York Healthcare System
33950993	Adjuvant corticosteroid therapy for critically ill patients with COVID-19
32450106	Safety, tolerability, and immunogenicity of a recombinant adenovirus type-5 vectored COVID-19 vaccine: a dose-escalation, open-label, non-randomised, first-in-human trial
32432527	Hydroxychloroquine against COVID-19: A critical appraisal of the existing evidence
32436994	Clinical Outcomes in COVID-19 Patients Treated with Tocilizumab: An Individual Patient Data Systematic Review
-	Hydroxychloroquine for COVID-19: A review and a debate based on available clinical trials/case studies
35839363	COVID-19 pandemic and therapy with ibuprofen or renin-angiotensin system blockers: no need for interruptions or changes in ongoing chronic treatments
35894019	Thrombotic risk in COVID-19: a case series and case–control study
32424851	Therapy for probable COVID-19 associated erythema pernio-like lesions in pediatric age. Case report
-	Pericarditis aguda secundaria a COVID-19
35813652	Successful Intravenous Immunoglobulin Treatment in Severe COVID-19 Pneumonia
32769063	Are Type 1 Interferons treatment in Multiple Sclerosis as a potential therapy against COVID-19?
32784326	Effective Use of Angiotensin II in Coronavirus Disease 19–Associated Mixed Shock State: A Case Report
32427773	Rescue Therapy for Severe COVID-19 Associated Acute Respiratory Distress Syndrome (ARDS) with Tissue Plasminogen Activator (tPA): A Case Series
35865529	The potential role of TNFα in 2019 novel coronavirus pneumonia
24635331	Corticosteroids, but not TNF Antagonists, are Associated with Adverse COVID-19 Outcomes in Patients With Inflammatory Bowel Diseases: Results from an International Registry
33523727	Deep Vein Thrombosis in Hospitalized Patients with Coronavirus Disease 2019 (COVID-19) in Wuhan, China: Prevalence, Risk Factors, and Outcome
-	Profiling COVID-19 pneumonia progressing into the cytokine storm syndrome: results from a single Italian Centre study on tocilizumab versus standard of care
32460209	The Effect of Potential Therapeutic Agents on QT Interval in Patients With COVID-19 Infection: The Importance of Close Monitoring and Correction of Electrolytes
34479246	Early Short Course Corticosteroids in Hospitalized Patients with COVID-19
35748258	A Systematic Literature Review of Current Therapeutic Approaches for COVID-19 Patients
35899955	Antivirals for COVID-19
32418917	Immunoglobulins in the treatment of COVID-19 infection: Proceed with caution!
35782477	Non-steroidal anti-inflammatory drugs, pharmacology, and COVID-19 infection
33648584	Chloroquine and hydroxychloroquine during pregnancy: What do we know?
32397275	Potential Role of Vitamin D in the Elderly to Resist COVID-19 and to Slow Progression of Parkinson’s Disease
35088108	Cutaneous Sıde-Effects of the Potentıal Covıd-19 Drugs
32401359	Recovery from COVID-19 in two patients with coexisted HIV infection
32425356	Unique skin manifestations of COVID-19: Is drug eruption specific to COVID-19?
-	COVID-19 Managed With Early Non-Invasive Ventilation and a Bundle Pharmacotherapy: A Case Report
32424429	Neurologically Devastating Intraparenchymal Hemorrhage in COVID-19 Patients on Extracorporeal Membrane Oxygenation: A Case Series
32422376	Interleukin-1 receptor antagonist anakinra in association with remdesivir in severe Coronavirus disease 2019: A case report
32574332	Three Novel COVID-19 Pneumonia Cases Successfully Treated With Lopinavir/Ritonavir
32418730	‘‘Off-label’’ use of hydroxychloroquine, azithromycin, lopinavir-ritonavir and chloroquine in COVID-19: A survey of cardiac adverse drug reactions by the French Network of Pharmacovigilance Centers
32422152	Mesenchymal stem cell therapy in severe COVID-19: a retrospective study of short-term treatment efficacy and side effects
-	Acute heart failure in multisystem inflammatory syndrome in children (MIS-C) in the context of global SARS-CoV-2 pandemic
32413736	Towards treatment planning of COVID-19: Rationale and hypothesis for the use of multiple immunosuppressive agents: Anti-antibodies, immunoglobulins, and corticosteroids
32421092	SARS-CoV-2 and COVID-19: is interleukin-6 (IL-6) the 'culprit lesion' of ARDS onset? What is there besides Tocilizumab? SGP130Fc
35888593	Is COVID-19 a New Hematologic Disease?
35512885	Advances in the Relationship Between Coronavirus Infection and Cardiovascular Diseases
35903472	A late onset widespread skin rash in a previous Covid-19 infected patient: viral or multidrug effect?
-	Clinical Course of COVID-19 in a Liver Transplant Recipient on Hemodialysis and Response to Tocilizumab Therapy: A Case Report
-	COVID-19 infection in a patient with severe chronic rhinosinusitis with nasal polyps during therapy with dupilumab
35238935	Early experience with remdesivir in SARS-CoV-2 pneumonia
35418803	Coronavirus disease 2019 in renal transplant recipients: report of two cases
32417380	Coronavirus Disease 2019 in Heart Transplant Recipients in Southeastern Michigan – Case Series
34919080	A Case of Coronavirus Disease 2019 Treated With Ciclesonide
32460086	B-cell depleting therapies may affect susceptibility to acute respiratory illness among patients with Multiple Sclerosis during the early COVID-19 epidemic in Iran
-	First experience of SARS-CoV-2 infections in solid organ transplant recipients in the Swiss Transplant Cohort Study
32554525	Clinical efficacy of hydroxychloroquine in patients with covid-19 pneumonia who require oxygen: observational comparative study using routine care data
-	Complement activation in patientswith COVID-19: A novel therapeutictarget
-	The role of passive immunization in the age of SARS‑CoV‑2: an update
-	A fine balance: Immunosuppression and immunotherapy in a patient with multiple sclerosis and COVID-19
32412681	Appearance of Skin Rash in Pediatric Patients with COVID-19: Three Case Presentations
34902262	Use of subcutaneous tocilizumab in patients with COVID-19 pneumonia
-	Assessment of QT Intervals in a Case Series of Patients With Coronavirus Disease 2019 (COVID-19) Infection Treated With Hydroxychloroquine Alone or in Combination With Azithromycin in an Intensive Care Unit
32572809	Low dose of hydroxychloroquine reduces fatality of critically ill patients with COVID-19
32409150	An evaluation of co-use of chloroquine or hydroxychloroquine plus azithromycin on cardiac outcomes: A pharmacoepidemiological study to inform use during the COVID19 pandemic
32410760	An outbreak of severe Kawasaki-like disease at the Italian epicentre of the SARS-CoV-2 epidemic: an observational cohort study
32411566	Nifedipine and Amlodipine are associated with improved mortality and decreased risk for intubation and mechanical ventilation in elderly patients hospitalized for COVID-19
32359035	Pilot prospective open, single-arm multicentre study on off-label use of tocilizumab in patients with severe COVID-19
-	Clinical characteristics and drug therapies in patients with the common‑type coronavirus disease 2019 in Hunan, China
32407959	Compassionate  remdesivir treatment of severe Covid-19 pneumonia in intensive care unit (ICU) and Non-ICU patients: Clinical outcome and differences in post-treatment hospitalisation status
35905935	Should Clinicians Use Chloroquine or Hydroxychloroquine Alone or in Combination With Azithromycin for the Prophylaxis or Treatment of COVID-19?
35691607	A review of the safety of favipiravir - a potential treatment in the COVID-19 pandemic?
32428865	Remdesivir in COVID-19: A critical review of pharmacology, pre-clinical and clinical studies
34394121	Combating COVID-19 with Mesenchymal Stem Cell therapy
35537738	A systematic review on use of aminoquinolines for the therapeutic management of COVID-19: Efficacy, safety and clinical trials
33405402	Acute generalized exanthematous pustulosis after COVID-19 treatment with hydroxychloroquine
-	Conduction abnormalities in hydroxychloroquine add on therapy to lopinavir/ritonavir in COVID-19
-	Tolicizumab in severe COVID-19 pneumonia and concomitant cytokine release syndrome
32399655	Allogeneic cardiosphere‐derived cells (CAP‐1002) in critically ill COVID‐19 patients: compassionate‐use case series
35847408	Use of anakinra in severe COVID-19: a case report
32972235	Favorable anakinra responses in severe COVID-19 patients with secondary hemophagocytic lymphohistiocytosis
32416785	Use of renin–angiotensin–aldosterone system inhibitors and risk of COVID-19 requiring admission to hospital: a case-population study
34698601	Interferon-α2b Treatment for COVID-19. 2020
32405160	Impact of low dose tocilizumab on mortality rate in patients with COVID-19 related pneumonia
32397399	Tocilizumab for Treatment of Severe COVID-19 Patients: Preliminary Results from SMAtteo COvid19 REgistry (SMACORE)
33790308	Hydroxychloroquine in patients with mainly mild to moderate coronavirus disease 2019: open label, randomised controlled trial
35904406	Convalescent plasma or hyperimmune immunoglobulin for people with COVID-19: a rapid review
35253579	Hydroxychloroquine in patients with COVID-19: A Systematic Review and meta-analysis
35669696	Should azithromycin be used to treat COVID-19? A rapid review
32397688	SARS-CoV-2/COVID-19: Viral Genomics, Epidemiology, Vaccines, and Therapeutic Interventions
35331159	SARS-CoV-2 receptor ACE2 gene expression and RAAS inhibitors
32401274	SARS-CoV-2 Rates in BCG-Vaccinated and Unvaccinated Young Adults
32322397	Potential use of hydroxychloroquine, ivermectin and azithromycin drugs in fighting COVID-19: trends, scope and relevance
35876061	Perspectives for repurposing drugs for the coronavirus disease 2019
32365466	The Human Coronavirus Disease COVID-19: Its Origin, Characteristics, and Insights into Potential Drugs and Its Mechanisms
32402156	Case 17-2020: A 68-Year-Old Man with Covid-19 and Acute Kidney Injury
34747359	2019 Novel Coronavirus Pneumonia With Onset of Dizziness: a Case Report
-	COVID‐19 in people living with human immunodefciency virus: a case series of 33 patients
32395179	Successful COVID-19 rescue therapy by extra-corporeal membrane oxygenation (ECMO) for respiratory failure: a case report
32377399	COVID-19 vaccines: breaking record times to first-in-human trials
33186327	The effect of RAS blockers on the clinical characteristics of COVID-19 patients with hypertension
35892576	A global treatments for coronaviruses including COVID-19
32391169	Is the use of RAS inhibitors safe in the current era of COVID-19 pandemic?
32375085	Pathophysiological characteristics and therapeutic approaches for pulmonary injury and cardiovascular complications of coronavirus disease 2019
34189400	A Case of Coronavirus Disease 2019 With Concomitant Acute Cerebral Infarction and Deep Vein Thrombosis
32389697	Plasmapheresis treatment in COVID-19–related autoimmune meningoencephalitis: Case series
35831388	A Hemodialysis Patient with Severe COVID-19 Pneumonia
32392288	Characteristics and Outcomes of Children With Coronavirus Disease 2019 (COVID-19) Infection Admitted to US and Canadian Pediatric Intensive Care Units
32390367	Clinical Features and Outcomes of 98 Patients Hospitalized with SARS-CoV-2 Infection in Daegu, South Korea: A Brief Descriptive Study
-	COVID-19 cases are less prevalent in countries where malaria is endemic, suggesting a role for anti-malarial drugs as prophylaxis
32391519	Clinical course of severe and critical COVID-19 in hospitalized pregnancies: a US cohort study
35774786	Use of Corticosteroids in Coronavirus Disease 2019 Pneumonia: A Systematic Review of the Literature
32388331	COVID-19 and diabetes mellitus: An unholy interaction of two pandemics
-	A comparison analysis on Remdesivir, Favipiravir, Hydroxychloroquine, Chloroquine and Azithromycin in the treatment of corona virus disease 2019 (Covid-19) - A Review
33115543	Adverse Cardiac Events Related to Hydroxychloroquine Prophylaxis and Treatment of COVID-19
32792889	Maculopapular rash in COVID-19 patient treated with lopinavir/ritonavir
-	COVID-19 occurring during Natalizumab treatment: a case report in a patient with extended interval dosing approach
-	Hydroxychloroquine for treatment of SARS-CoV-2 infection? Improving our confidence in a model-based approach to dose selection.
35905465	Association of Treatment With Hydroxychloroquine or Azithromycin With In-Hospital Mortality in Patients With COVID-19 in New York State
35905935	Tocilizumab therapy reduced intensive care unit admissions and/or mortality in COVID-19 patients
35548940	Angiotensin-Converting Enzyme 2 and Antihypertensives (Angiotensin Receptor Blockers and Angiotensin-Converting Enzyme Inhibitors) in Coronavirus Disease 2019
32384798	Potential Cytoprotective Activity of Ozone Therapy in SARS-CoV-2/COVID-19
35795303	COVID-19: treating and managing severe cases
-	Early Experience of COVID-19 in Two Heart Transplant Recipients: Case Reports and Review of Treatment Options
34889230	Novel coronavirus 2019 (COVID-19): A case report and review of treatments. Medicine (Baltimore)
-	Case Report: Right Bundle Brunch Block and QTc Prolongation in a Patient with Novel Coronavirus Disease (COVID-19) Treated with Hydroxychloroquine
35903906	Continuous hydroxychloroquine or colchicine therapy does not prevent infection with SARS-CoV-2: Insights from a large healthcare database analysis
32376398	Tocilizumab for the treatment of severe COVID-19 pneumonia with hyperinflammatory syndrome and acute respiratory failure: A single center study of 100 patients in Brescia, Italy
32501454	Interleukin-1 blockade with high-dose anakinra in patients with COVID-19, acute respiratory distress syndrome, and hyperinflammation: a retrospective cohort study
32401715	Triple combination of interferon beta-1b , lopinavir – ritonavir, and ribavirin in the treatment of patients admitted to hospital with COVID-19 : an open-label, randomised, phase 2 trial
32378648	Rapid review for the anti-coronavirus effect of remdesivir
32372695	Cardiac safety of off-label COVID-19 drug therapy: a review and proposed monitoring protocol
35894360	Efficacy of chloroquine and hydroxychloroquine in the treatment of COVID-19
35248659	A new era for the therapeutic management of the ongoing COVID-19 pandemic
32362051	Drug reaction with eosinophilia and systemic symptoms syndrome to hydroxychloroquine, an old drug in the spotlight
35899637	Tocilizumab for the Treatment of Severe COVID-19
35401220	Observational Study of Hydroxychloroquine in Hospitalized Patients with Covid-19
35642193	Impact of corticosteroid therapy on outcomes of persons with SARS-CoV-2, SARS-CoV, or MERS-CoV infection: a systematic review and meta-analysis.
34645374	Potential Therapeutic Targets and Promising Drugs for Combating SARS-CoV-2
34565108	Early treatment of COVID-19 patients with hydroxychloroquine and azithromycin: A retrospective analysis of 1061cases in Marseille, France
33407777	Combined treatment of tocilizumab and chloroquine on severe COVID-19: a case report
32362440	Therapeutic potential of ciclesonide inahalation for COVID-19 pneumonia: Report of three cases
33735262	Association of use of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers with testing positive for Coronavirus Disease 2019 (COVID-19)
35807895	Cytokine storm intervention in the early stages of COVID-19 pneumonia
35611385	Convalescent Plasma: Therapeutic Hope or Hopeless Strategy in the SARS-CoV-2 Pandemic
35874956	Review: Hydroxychloroquine and Chloroquine for Treatment of SARS-CoV-2 (COVID-19
35903092	Candidate drugs against SARS-CoV-2 and COVID-19
34634853	Quadruple therapy for asymptomatic COVID-19 infection patients
32339007	Discontinuation of antiviral drugs may be the reason for recovered COVID-19 patients testing positive again
32360516	The first case of COVID-19 treated with the complement C3 inhibitor AMY-101
35874909	Efficacy and safety of lopinavir/ritonavir or arbidol in adult patients with mild/moderate COVID-19: an exploratory randomized controlled trial
35906092	Evidence for Use or Disuse of Renin–Angiotensin System Modulators in Patients Having COVID-19 With an Underlying Cardiorenal Disorder
32350928	Rethinking the role of hydroxychloroquine in the treatment of COVID-19
-	Efetividade e toxicidade da cloroquina e da hidroxicloroquina associada (ou não) à azitromicina para tratamento da COVID-19. O que sabemos até o momento?
32357553	Repurposing Antiviral Protease Inhibitors Using Extracellular Vesicles for Potential Therapy of COVID-19
35891331	COVID-19: Immunology and treatment options
35822173	COVID-19: Therapeutics and Their Toxicities
35809024	Convalescent plasma: possible therapy for novel coronavirus disease 2019
32766266	A Coronavirus Disease 2019 (COVID-19) Patient with Multifocal Pneumonia Treated with Hydroxychloroquine
35839363	Cardiovascular Disease, Drug Therapy, and Mortality in Covid-19
35846737	Renin-Angiotensin-Aldosterone System Blockers and the Risk of Covid-19
35899637	Effective treatment of severe COVID-19 patients with tocilizumab
35846737	Renin–Angiotensin–Aldosterone System Inhibitors and Risk of Covid-19
32350818	Chloroquine-induced QTc prolongation in COVID-19 patients
35665313	Convalescent plasma transfusion for the treatment of COVID-19: Systematic review
32359203	A Rapid Systematic Review of Clinical Trials Utilizing Chloroquine and Hydroxychloroquine as a Treatment for COVID-19
35677110	Supportive Treatment with Tocilizumab for COVID-19: A Systematic Review
35899173	Coronavirus Infections in Children Including COVID-19
-	The role of afferent pulmonary innervation in ARDS associated with COVID-19 and potential use of resiniferatoxin to improve prognosis of patients in advanced disease state: A review
35871137	Treatment for emerging viruses: Convalescent plasma and COVID-19
35894609	Renin–Angiotensin–Aldosterone System Inhibitors in Patients with Covid-19
-	Co-Infection with SARS-COV-2 and Parainfluenza in a young adult patient with pneumonia: Case Report
-	Effects Of ARBs And ACEIs On Virus Infection, Inflammatory Status And Clinical Outcomes In COVID-19 Patients With Hypertension: A Single Center Retrospective Study
32898238	Effect of Convalescent Plasma Therapy on Viral Shedding and Survival in COVID-19 Patients
33213530	Experimental Treatment with Favipiravir for COVID-19: An Open-Label Control Study
32351873	Will the antimalarial drug take over to combat COVID-19?
32341442	Interactions of coronaviruses with ACE2, angiotensin II, and RAS inhibitors-lessons from available evidence and insights into COVID-19
32328576	Can early and high intravenous dose of vitamin C prevent and treat coronavirus disease 2019 (COVID-19)?
32344202	Impact of immune enhancement on Covid-19 polyclonal hyperimmune globulin therapy and vaccine development
35890048	Darunavir does not prevent SARS-CoV-2 infection in HIV patients
-	Use of tocilizumab for COVID-19 infection-induced cytokine release syndrome: A cautionary case report
-	SARS-CoV-2 infection in a patient on chronic hydroxychloroquine therapy: Implications for prophylaxis
35691607	Umifenovir treatment is not associated with improved outcomes in patients with coronavirus disease 2019: A retrospective study
32423584	Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trial
32299202	COVID-19, immune system response, hyperinflammation and repurposing anti-rheumatic drugs
35900758	Pharmacotherapy in COVID-19
35530725	COVID-19: An update on diagnostic and therapeutic approaches
32320825	Recent progress and challenges in drug development against COVID-19 coronavirus (SARS-CoV-2) - an update on the status
35746700	Treatment of SARS-CoV-2: How far have we reached?
-	Coronavirus Disease 19 (COVID-19) complicated with pneumonia in a patient with rheumatoid arthritis receiving conventional disease-modifying antirheumatic drugs
34662075	Two distinct cases with COVID-19 in kidney transplant recipients
34894345	Rational Use of Tocilizumab in the Treatment of Novel Coronavirus Pneumonia
32305589	Combating Devastating COVID -19 by Drug Repurposing
-	Pharmacologic perspective: glycyrrhizin may be an efficacious therapeutic agent for COVID-19
32335561	Update on treatment of COVID-19: ongoing studies between promising and disappointing results
-	The cytokine release syndrome (CRS) of severe COVID-19 and Interleukin-6 receptor (IL-6R) antagonist Tocilizumab may be the key to reduce the mortality
32334062	Current status of potential therapeutic candidates for the COVID-19 crisis
32235575	The First 75 Days of Novel Coronavirus (SARS-CoV-2) Outbreak: Recent Advances, Prevention, and Treatment
32333398	A hypothesis for pathobiology and treatment of COVID-19: the centrality of ACE1/ACE2 imbalance
32333818	COVID-19: lambda interferon against viral load and hyperinflammation
-	Successful recovery of COVID-19 pneumonia in a patient from Colombia after receiving chloroquine and clarithromycin
-	Clinical course of coronavirus disease 2019 (COVID-19) in a series of 17 patients with systemic lupus erythematosus under long-term treatment with hydroxychloroquine
-	Fibrinolytic abnormalities in acute respiratory distress syndrome (ARDS) and versatility of thromobolytic drugs to treat COVID-19
32329520	Current pharmacological treatments for COVID-19: what’s next?
32329877	SARS-CoV-2 causing pneumonia-associated respiratory disorder (COVID-19): diagnostic and proposed therapeutic options
32320478	Risks of ACE inhibitor and ARB usage in COVID-19: evaluating the evidence
32317431	Therapeutic opportunities to manage COVID-19/SARS-CoV-2 infection: Present and future
32317220	The anti-viral facet of anti-rheumatic drugs: Lessons from COVID-19
-	Depriving Iron Supply to the Virus Represents a Promising Adjuvant Therapeutic Against Viral Survival
32329881	Eculizumab treatment in patients with COVID-19: preliminary results from real life ASL Napoli 2 Nord experience
32317225	A sporadic COVID-19 pneumonia treated with extracorporeal membrane oxygenation in Tokyo, Japan: A case report
35222849	Association of Renin-Angiotensin System Inhibitors With Severity or Risk of Death in Patients With Hypertension Hospitalized for Coronavirus Disease 2019 (COVID-19) Infection in Wuhan, China
-	Myocarditis in a patient with COVID-19: a cause of raised troponin and ECG changes
32324898	Incidence of Adverse Drug Reactions in COVID-19 patients in China: an active monitoring study by Hospital Pharmacovigilance System
32812199	High incidence of venous thromboembolic events in anticoagulated severe COVID-19 patients
32318327	Potential therapeutic effects of dipyridamole in the severely ill patients with COVID-19
34991982	A Trial of Lopinavir–Ritonavir in Adults Hospitalized with Severe COVID-19
32323646	Chloroquine and Hydroxychloroquine for the Prevention or Treatment of Novel Coronavirus Disease (COVID-19) in Africa: Caution for Inappropriate Off-Label Use in Healthcare Settings
-	COVID-19 pneumonia in a kidney transplant recipient successfully treated with Tocilizumab and Hydroxychloroquine
-	COVID-19 infection and treatment with hydroxychloroquine cause severe haemolysis crisis in a patient with glucose-6-phosphate dehydrogenase deficiency
-	A Case of SARS-CoV-2-pneumonia with successful antiviral therapy in a 77-year-old male with heart transplant
35905465	Safety signals for QT prolongation or Torsades de Pointes associated with azithromycin with or without chloroquine or hydroxychloroquine
32321905	Neuropsychiatric adverse events of chloroquine: a real-world pharmacovigilance study using the FDA Adverse Event Reporting System (FAERS) database
32330277	Effect of High vs Low Doses of Chloroquine Diphosphate as Adjunctive Therapy for Patients Hospitalized With Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection A Randomized Clinical Trial
35847679	Emerging Therapeutic Strategies for COVID-19 patients
35403487	Prevention and Treatment of Venous Thromboembolism Associated with Coronavirus Disease 2019 Infection: A Consensus Statement before Guidelines
35888774	Janus Kinase inhibitor baricitinib is not an ideal option for management of COVID-19
32313880	PAK1-blockers: Potential Therapeutics against COVID-19
32313885	COVID-19 Clinical Trials: A Primer for the Cardiovascular and Cardio-Oncology Communities
-	COVID-19 in a MS patient treated with ocrelizumab: does immunosuppression have a protective role?
32319102	Points to consider in the preparation and transfusion of COVID-19 convalescent plasma
-	Case Report: Hepatotoxicity Associated with the Use of Hydroxychloroquine in a Patient with Novel Coronavirus Disease (COVID-19)
35849960	Therapeutic strategies for critically ill patients with COVID-19
-	A short review on antibody therapy for COVID-19
34444055	Treatment options for COVID-19: The reality and challenges
32248575	Natural products and their derivatives against coronavirus: A review of the non-clinical and pre-clinical data
32308732	Treatment efficacy analysis of traditional Chinese medicine for novel coronavirus pneumonia (COVID-19): an empirical study from Wuhan, Hubei Province, China
-	"Antiviral Therapy in Man-agement of COVID-19: a Systematic Review on Current Evidence"
32305588	Cytokine storm and immunomodulatory therapy in COVID-19: role of chloroquine and anti-IL-6 monoclonal antibodies
-	American Society for Transplantation and Cellular Therapy Pharmacy Special Interest Group Position Statement on Pharmacy Practice Management and Clinical Management for COVID-19 in Hematopoietic Q1 Cell Transplantation and Cellular Therapy Patients in the United States
32306836	Novel 2019 Coronavirus Structure, Mechanism of Action, Antiviral drug promises and rule out against its treatment
-	COVID-19 in a patient with long-term use of glucocorticoids: A study of a familial cluster
34829969	Progress and Prospects on Vaccine Development against SARS-CoV-2
33583366	Clinical Implications of SARS-CoV-2 Interaction with Renin Angiotensin System
32322402	Review on the global epidemiological situation and the efficacy of chloroquine and hydroxychloroquine for the treatment of COVID-19
32251732	Perspectives: Potential Therapeutic Options for SARS-CoV-2 Patients Based on Feline Infectious Peritonitis Strategies: Central Nervous System Invasion and Drug Coverage
-	Dos terapias conocidas podrían ser efectivas como adyuvantes en el paciente crítico infectado por COVID-19
-	Antiplatelet Therapy Following Percutaneous Coronary Intervention in Patients Complicated by COVID-19: Implications from Clinical Features to Pathological Findings
32473904	Comorbidities in COVID-19: Outcomes in hypertensive cohort and controversies with renin angiotensin system blockers
32301957	Weak Induction of Interferon Expression by SARS-CoV-2 Supports Clinical Trials of Interferon Lambda to Treat Early COVID-19
32302411	Clinical Pharmacology Perspectives on the Antiviral Activity of Azithromycin and Use in COVID-19
34833873	Cardiovascular Pharmacology in the Time of COVID-19: A Focus on Angiotensin Converting Enzyme 2
32302280	Brief Summary of Potential SARS-CoV-2 Prophylactic and Treatment Drugs in the Emergency Department
35905240	Antiviral treatment of COVID-19
35887802	A Review of SARS-CoV-2 and the Ongoing Clinical Trials
-	Coronavirus Disease 2019 (COVID-19) Pneumonia in a Hemodialysis Patient
35902817	The epidemiology and clinical information about COVID-19
-	COVID-19 for the Cardiologist: A Current Review of the Virology, Clinical Epidemiology, Cardiac and Other Clinical Manifestations and Potential Therapeutic Strategies
-	Successful treatment of plasma exchange followed by intravenous immunogloblin in a critically ill patient with 2019 novel coronavirus infection
35746803	Treatment with convalescent plasma for COVID‐19 patients in Wuhan, China
34883292	Evaluation of Antiviral Therapies for Coronavirus Disease 2019 (COVID-19) Pneumonia in Shanghai, China
35904710	Systematic review of the efficacy and safety of antiretroviral drugs against SARS, MERS or COVID-19: initial assessment
35905465	Hydroxychloroquine and covid-19
32363145	An algorithm for managing QT prolongation in coronavirus disease 2019 (COVID-19) patients treated with either chloroquine or hydroxychloroquine in conjunction with azithromycin: Possible benefits of intravenous lidocaine.
33573530	Virological and Clinical Cure in Covid-19 Patients Treated with Hydroxychloroquine: A Systematic Review and Meta-Analysis
32285293	Searching therapeutic strategy of new coronavirus pneumonia from angiotensin-converting enzyme 2: the target of COVID-19 and SARS-CoV
35665014	Coronavirus Disease 2019 Treatment: A Review of Early and Emerging Options
33715009	Can we use interleukin-6 (IL-6) blockade for coronavirus disease 2019 (COVID-19)-induced cytokine release syndrome (CRS)?
-	Remdesivir, la esperanza antiviral frente al SARS-CoV-2
35782071	Mesenchymal stem cells and management of COVID-19 pneumonia
32289548	Clinical and microbiological effect of a combination of hydroxychloroquine and azithromycin in 80 COVID-19 patients with at least a six-day follow up: a pilot observational study
35905562	Cytokine Storm in COVID-19 and Treatment
32279655	Can Hepatitis A Vaccine Provide Protection Against COVID-19?
35906086	Mesenchymal Stem Cell Therapy for COVID-19: Present or Future
32283223	Plausibility of therapeutic effects of Rho kinase inhibitors against Severe Acute Respiratory Syndrome Coronavirus 2 (COVID-19)
32283143	Arbidol Monotherapy is Superior to Lopinavir/ritonavir in Treating COVID-19
35897310	Low-dose corticosteroid therapy does not delay viral clearance in patients with COVID-19
35364003	The effect of corticosteroid treatment on patients with coronavirus infection: a systematic review and meta-analysis
32283154	Effect of regular intravenous immunoglobulin therapy on prognosis of severe pneumonia in patients with COVID-19
32281679	COVID-19: Herd Immunity and Convalescent Plasma Transfer Therapy
32281317	Use of Convalescent Plasma Therapy in Two COVID-19 Patients with Acute Respiratory Distress Syndrome in Korea
32281481	Challenges and cares to promote rational use of chloroquine and hydroxychloroquine in the management of coronavirus disease 2019 (COVID-19) pandemic: a timely review
35900992	Pharmacologic Treatments for Coronavirus Disease 2019 (COVID-19)
35874688	Traditional Chinese medicine for treatment of coronavirus disease 2019: a review.
35831333	Drug repositioning an alternative for the treatment of coronavirus COVID-19
-	Delayed Initiation of Remdesivir in a COVID-19 Positive Patient.
35820424	The possible of immunotherapy for COVID-19: A systematic review
-	First case of COVID-19 in a patient with multiple myeloma successfully treated with tocilizumab
-	Favorable changes of CT findings in a patient with COVID-19 pneumonia after treatment with tocilizumab
32278175	COVID-19: A promising cure for the global panic
32276453	Exploring the Relevance of Senotherapeutics for the Current SARS-CoV-2 Emergency and Similar Future Global Health Threats
32653526	Cardiovascular risks of hydroxychloroquine in treatment and prophylaxis of COVID-19 patients: A scientific statement from the Indian Heart Rhythm Society
-	Threatening drug-drug interaction in a kidney transplant patient with Coronavirus Disease 2019 (COVID-19)
-	Síntesis rápida: Tratamiento farmacológico de la infección por COVID-19 en adultos (Pharmacological interventions for adults with COVID-19 infection: Rapid Synthesis – Up to date)
35087781	Hospital pharmacists’ pharmaceutical care for hospitalized patients with COVID-19: Recommendations and guidance from clinical experience
32276137	Individual risk management strategy and potential therapeutic options for the COVID-19 pandemic
32271462	Inositol and pulmonary function. Could myo-inositol treatment downregulate inflammation and cytokine release syndrome in SARS-CoV-2?
35903158	Successful treatment of COVID-19 using extracorporeal membrane oxygenation, a case report
33590886	Does recombinant human Erythropoietin administration in critically ill COVID-19 patients have miraculous therapeutic effects?
35903070	Corticosteroid treatment of patients with coronavirus disease 2019 (COVID-19)
32275753	Plasminogen improves lung lesions and hypoxemia in patients with COVID-19
35874909	Clinical efficacy of lopinavir/ritonavir in the treatment of Coronavirus disease 2019
34852751	Compassionate Use of Remdesivir for Patients with Severe Covid-19
32267081	Continuous Intravenous Anakinra Infusion to Calm the Cytokine Storm in Macrophage Activation Syndrome
-	Quantifying treatment effects of hydroxychloroquine and azithromycin for COVID-19: a secondary analysis of an open label non-randomized clinical trial (Gautret et al, 2020)
35879980	Should chloroquine and hydroxychloroquine be used to treat COVID-19? A rapid review
-	Clinical Outcomes of Hydroxychloroquine in Hospitalized Patients with COVID-19: A Quasi-Randomized Comparative Study
-	Tratamento precoce de 1061 pacientes COVID-19 com hidroxicloroquina e azitromicina, Marselha, França
32258351	Current knowledge about the antivirals remdesivir (GS-5734) and GS-441524 as therapeutic options for coronaviruses
32256706	COVID-19 and treatment with NSAIDs and corticosteroids: should we be limiting their use in the clinical setting?
33472840	Evidence that Vitamin D Supplementation Could Reduce Risk of Influenza and COVID-19 Infections and Deaths
35905679	Metronidazole
35766218	Tocilizumab treatment in COVID-19: a single center experience
32258207	High-Dose Intravenous Immunoglobulin as a Therapeutic Option for Deteriorating Patients With Coronavirus Disease 2019
-	Novel coronavirus in a 15-day-old neonate with clinical signs of sepsis, a case report
32257537	Transplantation of ACE2- Mesenchymal Stem Cells Improves the Outcome of Patients with COVID-19 Pneumonia
32256705	Associations between immune-suppressive and stimulating drugs and novel COVID-19—a systematic review of current evidence
35020754	Deployment of convalescent plasma for the prevention and treatment of COVID-19
35733306	Effectiveness of convalescent plasma therapy in severe COVID-19 patients
32259313	Heavner MS. Review of Emerging Pharmacotherapy for the Treatment of Coronavirus Disease 2019
35311493	Subunit Vaccines Against Emerging Pathogenic Human Coronaviruses
35890156	Current Drugs with Potential for Treatment of COVID-19: A Literature Review
-	Estudo Preliminar de Sintomas e Medicamentos Prevalentes do “Gênio Pandêmico” da Pandemia de Covid-19 no Brasil
32881340	The potential of low molecular weight heparin to mitigatie cytokine storm in severe covid-19 patients: a retrospective clinical study
35875023	Intensive care management of coronavirus disease 2019 (COVID-19): challenges and recommendations
-	Infuenza and obesity: its odd relationship and the lessons for COVID‑19 pandemic
-	Diference of coagulation features between severe pneumonia induced by SARS-CoV2 and non-SARS-CoV2
32243270	Potential therapeutic agents against COVID-19: What we know so far
34909060	Favipiravir: pharmacokinetics and concerns about clinical trials for 2019-nCoV infection
32240545	Collecting and evaluating convalescent plasma for COVID-19 treatment: why and how
35904406	Treatment with convalescent plasma for critically ill patients with SARS-CoV-2 infection
-	Clinical Features and Short-term Outcomes of 102 Patients with Corona Virus Disease 2019 in Wuhan, Chin
